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Single ventricle (SV) anomalies account for one-fourth of all cases of congenital Heart
disease. The conventional second and third stage i.e. Comprehensive stage II and Fontan
procedure of the existing three-staged surgical approach serving as a palliative treatment
for this anomaly, entails multiple complications and achieves a survival rate of 50%.
Hence, to reduce the morbidity and mortality rate associated with the second and third
stages of the existing palliative procedure, the novel alternative techniques called “Hybrid
Comprehensive Stage II” (HCSII), and a “Self-powered Fontan circulation” have been
proposed. The goal of this research is to conduct in-vitro investigations to validate
computational and clinical findings on these proposed novel surgical techniques. The
research involves the development of a benchtop study of HCSII and self-powered Fontan
circulation.
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1. Introduction
In human anatomy, the cardiovascular system comprises the heart and the system of vessels
that include the arteries, veins, and capillaries. The heart plays a vital role in the circulatory
system. The heart's main function is to pump the continuous flow of blood throughout the
body's circulatory system. The circulatory system consists of systemic and pulmonary
circulations. In the systemic circulation, the heart pumps oxygenated blood to the body
through arteries, and the deoxygenated blood gets transported back to the heart through
veins. In the pulmonary circulation, blood is transported between the heart and lungs to
exchange carbon dioxide with oxygen during the respiration process. The heart comprises
four chambers. The two lower chambers are ventricles, and the two upper chambers are
atria. Two ventricles (left and right) are separated by a wall called the interventricular
septum. Two atria (left and right) are separated by a wall called the interatrial septum. The
deoxygenated blood from the systemic circulation returns to the heart's right atrium through
two large veins. The blood from the lower systemic circulation returns through the inferior
vena cava (IVC), and the upper systemic circulation returns through the superior vena cava
(SVC). The deoxygenated blood from the myocardium returns to the right atrium through
the coronary sinus.
The deoxygenrated blood flows through the tricuspid valve from the atrium to the ventricle
during atrial contraction in the right heart. When the right ventricle contracts, the tricuspid
valve closes, and the blood flows through the pulmonary valve into the pulmonary trunk.
The pulmonary trunk is bifurcated into left and right pulmonary arteries to flow the blood
to the right and left lung through the arterioles and into the capillaries present in the lungs.
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The oxygenated blood returns from the lungs to the left atrium through pulmonary veins in
the left heart. Then the blood is pumped from the left atrium to the left ventricle through
the mitral valve and finally into the aorta through the aortic valve for systemic circulation.
Figure 1 depicts the human circulatory system.

Figure 1 Human Circulatory System [1]
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The human heart functions in a cardiac cycle. The cardiac cycle consists of four major
stages :
1. Isovolumic relaxation
2. Inflow,
3. Isovolumic contraction
4. Ejection
The Wiggers diagram shows these four significant stages during a cardiac cycle [2], as
shown in Figure 2. Stages of “Isovolumic relaxation” and “Inflow” comprise the atrial
“Systole” and the ventricular "Diastole" period. In this period, blood returns into the
relaxed ventricle of the heart by flowing through the atria. Notably, towards the end of the
"Diastole," the atria contract and pump blood into the ventricles. This pressurized blood
flow from atria to ventricles during the ventricular diastole period is called the atrial systole
(“atrial kick”).

Stages of

“Isovolumic contraction” and “Ejection” comprise the

ventricular “Systole” period. In this period, simultaneous pumping of both ventricles
occurs to push blood to the pulmonary trunk and aorta.
1.1. Blood Flow
In the circulatory system, the blood flow is primarily considered as laminar in major
conduits and turbulent in specific regions. Typically, a healthy adult's average cardiac
output (CO) is around 5-6 L

min

at a resting condition [3]. In a vessel, the blood flow is

related to the difference in pressure and the resistance (R) in that vessel. Blood flow occurs
from higher pressure (P1) to lower pressure (P2). This is represented in Equation (1)
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Q

P1  P 2
R

(1)

CO is defined as the amount of blood pumped out by the left ventricle per minute. This is
a product of heart rate and stroke volume.

Figure 2 Wiggers Diagram for Cardiac Cycle [2]

1.2 Blood Pressure
Blood pressure is an essential hemodynamic parameter in the cardiovascular system.
Typically for normal physiology, the peak systolic and diastolic aortic pressures are 120
mmHg and 80 mmHg [4]. The difference between systolic and diastolic is known as
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“pulse pressure”. The compliance level and stroke volume dictate the pulse pressure. The
pulse pressure increases based on the increase in the stroke volume and decrease in vascular
compliance. The pressure decreases if the stroke volume decreases and vascular
compliance increases.
Mean Arterial Pressure (MAP) is defined as the average aortic pressure over one cardiac
cycle. This pressure is lower than the average systolic (30% of the cardiac cycle) and
diastolic (70% of the cardiac cycle) pressures. MAP can be computed by multiplying the
CO and systemic vascular resistance and summing with central venous pressure. Figure 3
shows the mean pressure and the percentage of total CO present in major vessels of the
cardiovascular system.

Figure 3 Mean blood pressures and percent volumes in major vessels [5]
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1.3. Frank-Starling Law
This law states that the heart has an intrinsic capability of increasing its contraction force
and the corresponding stroke volume due to an increase in the end-diastolic volume (EDV)
[5]. Deconstructing the law, the heart works harder to increase CO to synchronize with the
venous return. To satisfy the law of conservation of mass in the circulatory system, what
goes into each ventricle must come out. Due to this mechanism, as a larger blood volume
flows into the ventricle, the cardiac muscle gets stretched and increases in contraction
force. Figure 4 shows that the EDV increases as more blood is pumped into the ventricle.
This increases the force of contraction and increases stroke volume to maintain a constant
end-systolic volume (ESV).

Figure 4 Frank-Starling mechanism [5]

1.4. Single ventricular disease
Congenital Heart Diseases or defects (CHD) are the problems with the heart's structure that
are present at birth. There are various types of CHD [6]. Single ventricle (SV) anomalies
account for one-fourth of all cases of CHD. Generally, the most complex form of CHDs
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falls under the category of SV anomalies. Untreated, the anomaly is uniformly fatal.
Despite surgical and pharmaceutical advances for the treatment of SV anomaly, this
anomaly remains the significant cause of morbidity and mortality in the pediatric CHD
population.
A single ventricle is a defect in the heart where one ventricle of the heart is malformed. As
a result, the heart has one pumping chamber. This causes the oxygenated blood to mix with
the deoxygenated blood, thereby reducing the amount of oxygenated blood getting to the
systemic circulation. As a result of this abnormal circulation, various symptoms like
cyanosis (blue or purple tint to the skin), difficulty in breathing and feeding, and lethargy
can be seen in this subset of patients.
Single ventricle defects are classified into


Hypoplastic left heart syndrome (HLHS)



Pulmonary atresia



Tricuspid Atresia



Univentricular heart
1.4.1. Hypoplastic left heart syndrome

Hypoplastic left heart syndrome (HLHS) is a congenital heart condition where the left
ventricle, mitral and aortic valves, and aorta are underdeveloped and unable to function.
Lev initially coined this in 1952 as hypoplasia of the aortic tract complex [7]. Figure 5
shows the comparison between normal heart anatomy and HLHS heart anatomy. In HLHS,
the remaining ventricle becomes the pump for both the pulmonary and systemic circulation.
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Two options exist to treat HLHS: a series of staged palliations using a single ventricle
strategy [8], [9] or primary cardiac transplantation. The transplantation procedure is limited
due to the availability of infant organs, the limited lifespan of the organ, and the need for
continued anti-rejection therapy. The surgical technique depends on the patient's
physiological condition and the institution's surgical planning. The mortality rate remains
high even after treatment. A three-stage palliative procedure was developed to improve the
survival rate.

Figure 5 Anatomy of Normal heart (L) and HLHS heart (R) (The Children's Hospital of
Philadelphia, n.d)

1.4.2. Three-stage palliative procedure
In the last few decades, different strategies were implemented to treat HLHS. The threestaged palliative procedure was developed to convert the parallel circulation to series
circulation with one ventricle and bypass the underdeveloped chamber. Deoxygenated
venous blood is not mixed with the oxygenated blood, as shown in Figure 6.
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Stage 1: Norwood Procedure

In this stage, atrial septectomy is performed. Then hypoplastic aorta is reconstructed and
connected to the right ventricle in place of the pulmonary root. A Blalock Taussig (BT)
shunt is implanted between the innominate artery and the pulmonary arteries to create a
parallel path between the systemic circulation and the pulmonary circulation. The
Norwood procedure is performed very shortly after birth [10], [11].

Figure 6. HLHS circulation before three staged procedure (L) and rectified circulation after three
staged procedure (R)



Stage 2: Glenn Procedure

In this stage, SVC is disconnected from the right atrium and connected directly to the right
pulmonary artery, and the BT shunt is disconnected. The primary purpose of this surgery
is to send the deoxygenated blood flow from the upper systemic circulation to the
pulmonary circulation. The Glenn procedure is performed between three and six months
after the first stage [12].
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Stage 3: Fontan Procedure

IVC is disconnected from the right atrium in this stage and connected directly to the pulmonary
arteries for a Total Cavopulmonary Connection (TCPC). This surgery results in total passive
drainage of the caval blood flow to the pulmonary circulation, relieving the single ventricle from
pumping blood to the pulmonary circulation. The atrial septal defect is closed. The Fontan
procedure is performed around six months to a year after the second stage.

1.5. Significance of Study
Though the three-staged palliative procedure is established as the most viable option to
treat this HLHS anomaly but this three-staged procedure is still flawed. The research topic
is at the interface of the engineering and pediatric congenital heart disease domain. It
combines in-vitro modeling techniques to analyze the hemodynamics of two novel
alternative palliative procedures for single ventricular disease.
This study will elucidate the various in-vitro modeling techniques used to investigate the
hemodynamics and efficacy of the following alternative surgical techniques:


In-vitro validation of Hybrid Comprehensive stage II (HCSII) circulation



In-vitro validation of self-powered Fontan circulation

The outcome of these studies can significantly contribute to the positive outcome of patient
care and provide additional insight into the hemodynamics of these palliative procedures.
1.6. Problem Statement – 1
The existing three staged palliative procedure for the single ventricular anomaly entails
multiple complications and achieves a survival rate of 50%. To reduce the trauma
associated with the second stage of the existing procedure, a novel alternative surgical
procedure, i.e., hybrid comprehensive stage 2 (HCSII), has been developed by the clinical
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collaborators in Arnold Palmer children’s hospital. This palliative procedure can be an
alternative for a select subset of SV patients with the adequate antegrade aortic flow. The
procedure reduces surgical trauma in patients by introducing a stented intrapulmonary
baffle to avoid dissection of the pulmonary arteries and reconstruction of the aortic arch
while obviating the dissection of the distal arch and ductal continuation.
The goal of this study is to validate in-silico results relative to stented baffle deformation
and particle tracking. This in-vitro model is tuned to match the catheter data and then used
to verify whether pulmonary arteries are obstructed due to systemic pressure loads and
track particles to identify the potential pathological flow fields and the possibility of
thrombus formation.
1.7. Problem Statement -2
Although the Fontan circulation has been successfully established as the final stage in the
palliative procedure for treating HLHS but can lead to failures. The major reason for
failures comprise


High pressure in IVC



High Pulmonary vascular resistance (PVR)



Ventricular dysfunction

These reasons can lead to a multitude of diseases. Many techniques to improve the failing
Fontan circulation have been proposed over decades. These techniques involve improving
geometrical parameters of total cavopulmonary connection (TCPC) and active powering
of Fontan circulation. But most of the proposed ideas involved issues. These issues include
pulmonary embolism, driveline infections, and various types of pathological flow
conditions.
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A novel, innovative, rapidly testable alternative is proposed to achieve the same endpoints
as a synthetic pump in the Fontan circulation. Through this procedure, the reserve
mechanical energy of the heart itself is tapped to “assist” the Fontan circulation by creating
a novel bifurcation graft, henceforth called the Injection Jet Shunt (IJS), seen in Figure 7.
A new, technically straightforward surgical operation is proposed in which this graft,
originating from either the ventricle or aorta, bifurcates with each tapered distal limb
sutured into the pulmonary arteries (PA) in such a way that flow is directed parallel to each
PA and the energy and momentum of this flow is efficiently transferred. The hypothesis is
as follows: The inclusion of an IJS of suitable geometry into the “failing Fontan”
circulation can (1) decrease IVC pressure and (2) increase systemic oxygen delivery while
limiting the obligatory left-to-right shunt through the graft to a clinically acceptable value.
The approach challenges the existing paradigm that a synthetic pump is required to assist
the Fontan circulation. It addresses the critical barriers to progress in this field by offering
an alternative, effective palliation for the failing Fontan while delaying or circumventing
the need for heart transplantation and implantation of synthetic pumps with their wellknown complications.

Figure 7 Proposed Fontan surgery with proposed injection jet shunt (IJS)
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This study aims to validate the Computational Fluid Dynamics (CFD) results and
characterize the jet flow field in the Fontan circulation. Increased inferior vena cava
pressure has been identified as a clinically significant parameter for Fontan failure. The invitro model helps to elucidate the relevant hemodynamics that can lead to optimal
implementation of an injection jet to reduce the pressure in the inferior cava.
1.8. Limitations and Assumptions
In-vitro efforts have seen the implementation of lumped parameter models of the peripheral
circulation as well as the region of interest. To simplify the modeling, the lumped
parameter has been reduced to four compartments, i.e., upper and lower systemic
circulations and left and right pulmonary circulations. In the lumped parameter model, the
inertance effect is not replicated. Moreover, the region of interest in Mock Flow Loop
(MFL) has been assumed to be rigid. The blood model used in MFL studies is assumed to
be Newtonian.
1.9. Definition of terms

A

Area of the conduit



V

Average velocity of the fluid

C

Compliance

L

Containment limit

p

Containment probability

ac

Critical crack growth

K

Cyclic stress intensity factor



Density of blood
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t fall

Fall time

.

Qent

Flow entrainment rate

Q

Flowrate

g

Gravitational constant

h

Head loss in fluid

 hoop

Hoop stress

Li

Inertance



Infinite-shear viscosity

ai

Initial crack growth

QIJS

Injection jet shunt flow

 1

Inverse normal distribution

trel

Jet relaxation time

L

Length of the conduit/Inductance

K

Loss coefficient

QIVC

Lower body blood flowrate

Clower

Lower compliance



Mean

N

Number of cycles to failure

P

Pressure

P

Pressure drop in fluid
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1

Principal stress

Qp

Pulmonary flow

r

radius of conduit

da
dN

Rate of crack growth



Relaxation time constant

R

Resistance

trise

Rise time



Shear rate



Standard deviation

x

Strain in x-direction

y

Strain in y-direction

x

Stress in x-direction

y

Stress in y-direction

Qs

Systemic flow

Cao2

Systemic oxygen concentration

C SVCo2

Systemic venous concentration

QSVC

Upper body flowrate



Viscosity

v

Von-misses stress

 yp

Yield stress
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E

Young’s modulus

0

Zero-shear viscosity
1.10.

List of Acronyms

ABS

Acrylonitrile butadiene styrene

ABG

Assisted bi-directional Glenn

APC

Atriopulmonary connection

BDG

Bidirectional Glenn

BSA

Body surface area

CO

Cardiac output

CPB

Cardiopulmonary bypass

CVP

Central venous pressure

CFD

Computational Fluid Dynamics

CAD

Computer Aided Design

CHD

Congenital Heart Diseases

DHCA

Deep hypothermic circulatory arrest

EDV

End-diastolic volume

ESV

End-systolic volume

HCSII

Hybrid comprehensive stage II

ICPC

Inferior cavopulmonary connection

IVC

Inferior vena cava

IJS

Injection jet shunt

LCA

Left carotid artery

LPA

Left pulmonary artery
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LSA

Left subclavian artery

LPM

Lumped parameter model

MRI

Magnetic resonance imaging

MPA

Main pulmonary pressure

MAP

Mean arterial pressure

MFL

Mock flow loop

PRT

Particle residence time

PTFE

Polytetrafluoroethylene

PA

Pulmonary arteries

PVR

Pulmonary vascular resistance

RCA

Right carotid artery

RPA

Right pulmonary artery

RSA

Right subclavian artery

RV

Right ventricle

SV

Single ventricle

SVC

Superior vena cava

SVR

Systemic vascular resistance

TCPC

Total cavopulmonary connection

VVC

Veno-venous collateral vessel

VAD

Ventricular assist device

WSS

Wall shear stress
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2. Review of the Relevant Literature
2.1.1. Stage 1: Norwood Surgical Procedure

Figure 8 Norwood with mBT shunt

Figure 8 represents the stage I Norwood surgery. The primary aim of this surgical
procedure is to provide an unrestrictive systemic blood flow while balancing the pulmonary
flow, i.e., the Q p / Qs ratio. To achieve this physiology, a neo-aorta is constructed using the
autologous aorta and pulmonary artery, followed by placing a shunt in the pulmonary
artery. Depending on the patient’s condition, an alternative procedure is to band the
pulmonary artery and stent the descending aorta. The mixing of oxygenated and
deoxygenated blood occurs due to the doubling of volumetric load on the single ventricle.
The diameter of the shunt is designed to provide a balanced pulmonary flow with the
systemic flow. Figure 9 highlights the outcome of creating parallel pulmonary and systemic
circulation. Pulmonary Vascular Resistance (PVR) and Systemic Vascular Resistance
(SVR) must be controlled for a balanced circulation with adequate systemic oxygen. The
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relative resistance from the PVR and SVR determines the distribution of blood to the
systemic and pulmonary as the single ventricle supplies the blood.

Figure 9 Normal circulation (L) and stage 1 reconstructed (R) parallel pulmonary and systemic
circulation. LV= left ventricle, RV= right ventricle, SC= systemic circulation, PC= pulmonary
circulation, SPAS= systemic to pulmonary artery shunt

In 1945 Blalock and Taussig [13] [13] developed a shunt to treat tetralogy of Fallot. The
original procedure proposed was to connect the cut end of the subclavian artery or carotid
artery to the pulmonary artery. The main disadvantage of BT shunt includes phrenic nerve
injury and operative dissection time. In addition, some of the blood supply to the upper
body is interrupted due to the occluded artery [14].[14]. To overcome the disadvantage of
BT shunt, a modified BT shunt (mBT shunt) was developed, which involves the
introduction of polytetrafluoroethylene (PTFE) as a biomaterial. The mBT shunt is placed
in between the pulmonary artery and subclavian or carotid artery. Diastolic runoff and high
pulse pressure are characteristics of mBT shunt physiology. As a result, diastolic coronary
circulation is reduced, thereby giving rise to myocardial ischemia and circulatory
instability, leading to the patient's death [15][15].
In 1961 central shunt or Waterson shunt (WS) was reported to treat the tetralogy of Fallout.
A conduit is installed between the pulmonary artery and ascending aorta, giving a balanced
flow between two pulmonary arteries. The Waterson shunt is considered as an alternative
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for neonates having a small subclavian artery. The Sano shunt or right ventricle shunt is a
variation where a conduit is inserted between the pulmonary artery and the right ventricle
.[16]. As the Sano shunt is larger in diameter, less diastolic pressure runoff is possible due
to a more pulsatile pulmonary blood flow and less pulsatile systemic flow.
Bilateral Pulmonary Artery banding (bPAB) is an alternative option for the Stage I
procedure. The aim of bPAB is to reduce the excess pulmonary blood flow and pulmonary
artery pressure. A band is installed around one or both sides of the pulmonary artery,
thereby reducing the blood flow in the lungs, which prevents the pulmonary over
circulation that regulates the Q p / Qs . Resistance at the banded location is sensitive to the
band’s tightness; it is difficult to achieve the optimal tightness followed by the desired
balance of pressure and flows, making it bPaB’s limitation. This technique is useful when
the ductus arteriosus is kept patent or there is a sufficient section of the native aorta is
present to provide systemic circulation.
In Sano et al. [16][16] study, improvement was seen in short and long-term RVS patient
survival compared to mBT patients. RVS eliminated the diastolic runoff, and hence the
diastolic pressure was restored, ventricular work reduced, and systolic hypertension was
relieved. Sano et al.'s [16]Sano et al.'s [16] study were successful as hemodynamic
instabilities did not occur in patients, and it was successful with low-weight patients. There
was an increase in the transconduit pressure, and diastolic reverse flow decreased months
after the procedure. Keeping a transplant-free 12 months as a criterion, a clinical study was
conducted at 15 centers across the USA; based on a sample of RVS and mBT shunts,
patients with RVS shunts were healthier compared to the patients with mBT shunt. A study
was conducted to compare the interventions after the Norwood procedure using Sano and
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mBT shunt. A sample size showed that more interventions were required with Sano shunt
as complications included cerebral embolic, cardiopulmonary resuscitation, and femoral or
subclavian veins closure.
Different shunts have been developed to overcome the drawbacks associated with the BT
and mBT shunts. Changes to physiological conditions make Norwood's procedure difficult.
As the lungs of a neonate develop, the PVR decreases significantly, which results in
increased pulmonary flow rate and decreases systemic flow rate, thereby causing an
unbalanced Q p / Qs . Placement of shunt and surgical anastomosis design influences the
final surgical results. In addition, a variety of native aortic arch morphologies and
coarctations exist. They range from tubular, dilated, and typical for native arch and
localized for coarctation.
2.1.2. Stage 2: Bi-direction Glenn and Comprehensive Stage II Surgical
Procedure

Figure 10 Bidirectional Glenn Surgical Procedure
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Two different processes usually perform the stage II surgical procedure. Figure 10
represents the Bidirectional Glenn (BDG) surgical procedure. This procedure is performed
during six to eight months of age. The surgical procedure aims to lower the load on the
right ventricle and provide a low-pressure pulmonary flow. The BDG procedure involves
removing mBT shunt and dissection of SVC from the right atrium and anastomosed to
Right Pulmonary Artery (RPA). The deoxygenated blood from the upper body returns to
the lungs. The Norwood procedure has been the option to achieve the stage I palliation
aim for the past twenty years [17], [18]..[17], [18]. Early mortality remains as high as 2030% after the palliation despite significant improvement in survival [19], [20] [21], [22],
[23]. [19], [20], [21], [22], [23]. This procedure avoids cardiopulmonary bypass (CPB),
deep hypothermic circulatory arrest (DHCA), and cardiac arrest.

The potential

disadvantages of the hybrid procedure include malperfusion, which arises due to the
retrograde aortic arch obstruction and mechanical distortion of the branch PAs. Due to the
learning curve of the new technology, high morbidity and mortality were reported [21],
[22], [24]. [21], [22], [24]. This places a greater surgical requirement on the comprehensive
stage II palliation.

Figure 11 Comprehensive Stage II procedure [25]
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Akintuerk et al. [23] [23] reported success in the comprehensive stage II procedure, an
alternative surgical procedure to BDG. The surgical technique is considered complex and
is conducted during 4-6 months of age. As shown in Figure 11, the comprehensive stage II
involves the patent ductus arteriosus stent removal followed by the bands on pulmonary
arteries. Following this, the aortic arch reconstruction occurs, followed by atrial
septectomy and bidirectional cavopulmonary anastomosis creation. This procedure also
involves the creation of the Damus-Kaye Stansel connection. Same physiology is
established between comprehensive stage II and Bi-directional Glenn procedure.
Gibbs et al. [26] [26] proposed and reported various results when comparing the hybrid
procedure to Norwood. The combined surgical and interventional technique is an alternate
to stage I palliation. Ruiz et al. [27] [27] reported a patient undergoing a heart transplant
after ductal stenting. Mitchell et al. [28] [28] reported the PA banding as a bridge to
transplantation to prevent irreversible pulmonary vascular disease. Galantowicz et al. [22]
[29] [22], [29] pioneered and popularized the hybrid approach and intended to use this
approach on neonates with HLHS conditions.No difference in PA pressure existed between
Norwood and hybrid during the pre-stage II hemodynamics. No difference between arterial
saturation Q p / Qs . Both groups had equivalent parameters during the pre-stage II
evaluation.
The crucial cause of failure in staged palliation for HLHS is progressive systemic
ventricular dysfunction. The mechanism of failure for the right ventricular may be related
to the myocardial damage during the Norwood procedure with cardiac arrest DHCA, high
afterload on the right ventricle, and volume overload, which occurs due to the systemicpulmonary shunt being controlled inadequately. The progressive systemic ventricular
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dysfunction is one of the primary indicators for a heart transplant. Patients who completed
the pre-stage II palliation, a patient, had atrioventricular valve insufficiency. The
atrioventricular valve was corrected by valve repair during stage II palliation. Norwood
group had patients with mild ventricular dysfunction and patients with a severe condition
requiring transplantation. Patients had more than a moderate level of atrioventricular valve
insufficiency, and patients underwent valve repair.
Progressive ventricular dysfunction was identified during the interim stage on patients that
underwent hybrid stage I. A Patient required heart transplantation after stage II palliation.
Another patient had aortic arch perfusion diminished, aortic isthmus obstruction,
myocardial dysfunction, and minor narrowing of the reverse BT shunt.
Cardiopulmonary bypass (CPB) is initiated with the arterial cannula placed in the main
pulmonary artery; this is done after the re-sternotomy procedure. For deep hypothermic
circulatory arrest (DHCA), the patient is cooled, the branch pulmonary artery bands are
removed. Atrial septectomy is performed when cardioplegic cardiac arrest is achieved.
Using a homograft patch, the aortic arch is reconstructed under DHCA condition along
with regional cerebral perfusion. With the standard technique, a proximal Damus-KayeStansel anastomosis is achieved. In most patients, an autologous pericardial patch from
hilum to hilum is used to enlarge the branch PA. The bidirectional cavopulmonary shunt is
placed with the standard technique while kept on-pump beating state. The final procedure
involves the closure of the sternum in most patients.
To facilitate aortic arch reconstruction, retained stented duct tissue is used in origin [30].
Upon DHCA, the main PA and the branch PA were transected and resected. The area
opposition between the stented ductus and ascending aorta is divided up to the orifice of
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the aortic isthmus. The patch for the aortic arch reconstruction is obtained from the remains
of the stented ductus. The reconstruction is achieved by sewing the divided native aortic
arch to the lateral edges of the divided ductus.
Advantages of using this modification are as follows, the stented material in place as in
natural transverse aortic arch, the risk of bleeding and recurrent laryngeal nerve injury is
significantly reduced as there is a continuity between the ductal material and the
descending aorta. Immunologic sensitization can be avoided as homograft material is not
used, thereby improving the potentiality of transplantation. Potential disadvantages include
the development of aneurysmal and recurrent obstruction at the aortic isthmus.
Honjo and Caldarone [31] concluded the study by mentioning that a conclusion cannot be
reached on the impact on the ventricular function and type of palliation based on
preliminary analysis. Hybrid patients appear to have a better ventricular function at the prestage II evaluation.
2.1.2.1.

Morbidity and Mortality

Recent studies show that there is 80-97% survival after stage I hybrid palliation; during
such studies, extreme high-risk patients were excluded [23], [29], [32]. [23], [29], [32].
Between 2004-2007, a study was conducted on neonates with HLHS and its variants that
have undergone Norwood and hybrid. No difference in survival was seen between patients
with or without reverse BT shunts. Neonates died, and additional neonates underwent heart
transplantation after stage I palliation. Neonates were in the interim death stage after the
hybrid palliation.
Clinical and investigations have reported the adoption of systemically derived accessory
pulmonary flow in bi-directional Glenn (BDG) [33], [34], [35], [36].).) [33], [34], [35],
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[36]. Van de Wal et al. [33]. [33] studied patients with an average age of 5.6 years, reported
no influence on survival rate. McElhinney et al. [34] [34] studied patients with an average
age of 7.8 months, reported higher but statistically insignificant mortality. Mainwaring et
al. [35] [35] studied patients with an average age of 10 months reported higher mortality.
2.1.2.2.

In-vitro and in-silico approach

Many researchers have conducted both in-vitro and in-silico simulations to address
problems that arise postoperatively. Pulmonary artery stenosis is one problem that is seen
in patient’s post-operative. The venovenous collateral vessel is the second problem seen in
31-33% of patients who undergo the BDG procedure. To improve the efficacy of the
procedure, the use of ABG is discussed. Results obtained by researchers show the
advantages of ABG and how it could potentially reduce the three-stage palliative procedure
to a two-stage palliative procedure. An in-depth analysis is done of the literature to
understand the need to improve this surgical technique. To overcome the surgical trauma
associated with BDG, a novel surgical technique is discussed at the end of the section that
mentions the procedure and its advantages compared with BDG and comprehensive stage
II.
Liancai et al. [37] [37] conducted a study that focused on patients with HLHS and unilateral
pulmonary artery stenosis after the Glenn procedure. Four three-dimensional Glenn models
with different left pulmonary artery stenosis rate by diameter were generated
(0%,25%,50%,75%). The extreme condition was considered to understand the effect of
stenosis on the flow field, which is the acute artery blockage by 75%.
A multiscale model was developed along with the lumped parameter model (LPM). Global
parameters that include average flow and total pressure at the pulmonary vein, the
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ascending aorta, the descending aorta, and the SVC can be computed [38]. [38]. The LPM
consisted of six blocks that included the single ventricle heart, left and right lung, the
ascending aorta, and lower and upper limb vein. The vessels' viscous, compliance, and
inertia were represented using the Windkessel models that consist of resistors, capacitors,
and inductors. To simulate the cardiac valves, diodes were used in the circuit. For each
compartment, the mass and momentum conservation laws were expressed using Qin (t),
Pin(t), Qout(t), and Pout(t), which represent the instantaneous volumetric flow rate and
pressure at the inlet and outlet of compartments [39].. [39].
The rhythmic contraction E(t) [40], [41], [42] [40], [41], [42] of a single ventricle was
represented as a function of pressure and volume. E(t) is the elastance function that changes
with time is represented as mmHg/ml. The elastance is expressed using

SvV  t  ,

representing the ventricle volume and pressure, and V0 refers to reference volume.
Boundary conditions were applied to the coupled 0D and the 3D model. Initial conditions
were imposed on the 3D model, the output obtained at each step was imposed on the 0D
model. The limitation in this study includes rigid boundary conditions on the walls of the
3D model, and fluid-structure interaction models were not taken into account. To guarantee
a convergent solution, five cardiac cycles were simulated. Parameters such as Wall shear
stress (WSS), total pressure, and flow were recorded every 10-time steps. For this model,
the boundary conditions set on the 3D model were the pressure on the pulmonary artery
distal branch and flow rate through the superior vena cava.
Further to the simulation result, models 2,3 and 4 showed imbalanced pulmonary perfusion
compared to model 1. Relation between blood flow to the localization of atherosclerosis
[43] [43] and the plaque rupture [44], [45] [44], [45] was proposed by the wall shear stress
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(WSS mechanism). There was a decrease RLPA/ SVC when stenosis was above 75%; this
results in abrupt pressure differences between distal and proximal stenosis. The
development of the PA tree may be complicated due to the unbalanced lung perfusion [46]
. [46]. Liancai et al. concluded the study by mentioning that if the stenosis rate above 75%
may lead to power loss and severely unbalanced blood perfusion into each lung. For the
patient’s development, this condition must be treated before Glenn.
Chiara et al. [47] [47] study focused on an eight-month-old patient who underwent bidirectional Glenn and was diagnosed with a venovenous collateral (VVC) vessel. Clinical
studies reported 31-33% of patients undergoing the BDG procedure have the venous
collateral vessel associated with several alterations of the physiological hemodynamics
[48], [49]. [48], [49]. The aim of the study was threefold (i) how to build a patient-specific
model and describe the hemodynamics with VVC presence (ii) quantitative hemodynamics
prediction by performing virtual VVC (iii) compare the prediction with measurements
obtained from post-operation. Four months after undergoing the BDG procedure, the stage
two patient was diagnosed with VVC. To improve the O2 saturations, closure of VVC is
performed. Closure of such collateral can have unintended consequences such as alteration
in systemic blood flow or elevation of pulmonary artery pressure.
The LPM layout for this study was similar to the one presented in Kung et al. [50] ... [50].
In addition, the VVC resistance was placed between the single atrium and the SVC, and
the aortopulmonary collateral vessels resistances connecting the aorta to each PA branch.
A multi-domain model of the four-month-old patient’s circulation was developed by
following the methodologies described by Corsini et al. [51] .[51]. To account for the
increase in body surface area (BSA) due to the growth and the different vessel growth in
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lungs, scaling factors were applied to the RLC circuit using the allometric equations [52],
[53], [54] [52], [53], [54]. PVR and SVR lower and upper values obtained were compared
to the patient-specific models. Differences between the three couples of vascular
resistances suggest that growth occurred in the four months after BDG surgery, and hence
consideration is needed in the post-operative LPM development. To obtain the eight-month
flow and pressure, the patient-specific LPM was tuned with four-month heart parameters.
The 3D virtual BDG, coupled with eight-month LPM, runs a pulsatile simulation and then
matches with clinical data. Another simulation was conducted by removing the VVC
resistance from LPM that is equivalent to the VVC closure.
Based on the growth factor, the PVR and SVR lower and upper values should have dropped
by 22, 25, and 13%, respectively. Results showed that this did not correspond to the patientspecific values that indicated a 17% increase in PVR, 37% decrease in SVR lower, and
51% decrease in SVR upper. A recent study showed that PVR increases due to abnormal
pulmonary flow that may alter the pulmonary vascular tone [55]. [55]. The PVR
vasoconstriction may have occurred due to non-physiological pulmonary flow due to the
BDG surgery on this investigated patient. This study's lack of extensive data led to
assumptions regarding parameters required to calculate the blood flow. These hypotheses
were based on mathematical relationships and reasonable assumptions. Vasodilation in the
upper body and vasoconstriction in the pulmonary vasculature in accordance with the SVC
and PA hypertension lead to the VVC formation [48]. [48]. Based on the clinical findings
of VVC formation after the BDG surgery [48], [49]. [48], [49]. VVC development on the
post-stage-2 model could be indicated based on the predicted SVC pressure, pulmonary
artery pressure, and trans-pulmonary pressure gradient.
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Chiara et al. [47] state that such a study could motivate data collection such as O2
saturations, systemic blood flow, and critical clinical outcomes. This study highlights only
one clinical case, and the developed approach can be applied to other patients if
heterogeneous patient-specific data were collected at different intervals. The introduction
of patient-specific modeling for growth and adaption with existing clinical data is not
feasible. Assumptions made in the allometric equations are high and only applicable to data
collected at two large intervals.
The study of Zhou et al. [56] [56] focused on assisted bidirectional Glenn (ABG), an
alternative to the mBT procedure; this was initially proposed by Esmaily-Moghadam et al.
[57][57]; the proposed procedure remains similar to the BDG but with an accessory shunt
that is added between the innominate artery to the SVC. Their study focuses on harvesting
the potential energy in the blood within the systemic arteries and increasing the pulmonary
flow using an ejector pump concept. The use of ABG has two advantages over Norwood
as it improves the systemic and coronary perfusion by reducing the volumetric overload on
the single ventricle [57], [58] . [57], [58]. Secondly, this reduces thrombotic risk by
providing stable pulmonary flow. Multi-scale in-vitro models were developed to compare
with Norwood candidate and previous multi-scale numerical simulation. Local
hemodynamics are considered in such multi-scale simulations by providing appropriate
boundary conditions to the anastomosis sites, this has been consistent with the clinical
measurements [38], [50], [57], [58], [59], [60], [61], [62].Local hemodynamics are
considered in such multi-scale simulations by providing appropriate boundary conditions
to the anastomosis sites, this has been consistent with the clinical measurements.Local
hemodynamics are considered in such multi-scale simulations by providing appropriate
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boundary conditions to the anastomosis sites, this has been consistent with the clinical
measurements [38], [50], [57], [58], [59], [60], [61], [62].
The MFL used for their study uses the LPM network model coupled with 3D models of the
pulmonary artery, anastomosis sites, and aorta. Several resistance and compliance values
were scaled during each circulation based on the body surface area or by using clinical
values [61], [62]. Vukicevic et al. [62][61], [62]. Vukicevic et al. [62] was followed in
modeling the resistance and compliance. PVR has effects on postoperative recovery and
hemodynamics of the infant [63], [64]. Cases that included high and low PVR were
replicated on the testbed [57] . [57]. In-line elastic tubes and trapped air were used as
pulmonary compliance [62], [65]. A 3.5 mm diameter shunt was used on the Norwood
circulation, and a 2.5 mm diameter shunt with a nozzle on the ABG circulation.
Resistance values were set according to the steady flow conditions. Measurement of air
volume and volume change with pressure change was used to set the compliance value. To
achieve the mean aortic pressure, ventricular assist device (VAD) pressure was adjusted,
and the aortic compliance element was adjusted to achieve the required aortic pulse
pressure. The numerical simulation uses a multiscale modeling approach, coupling the
closed-loop model to the local hemodynamics [60]. [60]. A 3D model along with a 0D
LPM was used to represent the heart and closed-loop model.
Using the low and high PVR values on the three circulations, the tests were conducted.
Results showed that there was no significant difference in the mean flow rate between
numerical and experimental analysis. Pulmonary flow rate and pulmonary pressure for the
mBT circulation were the highest. In mBT circulation, as PVR increased, the
corresponding SVC flow rate increased, competing with the shunt flow. SVC flow rate
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decreased in both ABG and BDG circulations. SVC pressure in ABG showed 2-3.7 mmHg
higher than BDG. The pulmonary flow rate of ABG provided a 30-38% improvement
compared to the BDG. Pulmonary pressure was lowest for BDG circulation. The ABG
provided the highest systemic oxygen delivery compared to the other three circulations,
irrespective of the PVR. Comparison between the numerical and experimental ABG model
showed that RPA and LPA flows and pressures are well produced. SVC flow predicted
numerically displayed pulsatility during systole, a possible mismatch in compliance
between models [62]. The mean SVC pressure did not show any significant difference.
Zhou et al. [56] stated that the initial aim of their study was to test the physical feasibility
of the ABG circulation and validate the results against the numerical model. By comparing
the pressure gradient between the PA and SVC relative to the pulmonary blood flow, the
effect of the ejector shunt used can be computed. The local flow resistance is reduced at
the PA-SVC junction by this ejector-shunt. However, with the current shunt, pulmonary
artery pressure and SVC pressure increased about the same value. Using the ABG
circulation procedure in place of Norwood would reduce the number of surgeries from
three to two. The shunt used in the ABG palliation can be shorter compared to the mBT
shunt. The flow through the shunt is drawn from the aorta providing blood at a higher
pressure and velocity. This will eventually reduce the risk of thrombosis and cyanosis due
to better pulmonary blood flow. The circulation is simplified to the Glenn circulation in
the event of mBT shunt occluding. An increase in the pulmonary arterial blood flow
increases the pulmonary arterial pressure and improved saturation over the Glenn [66],
[67]. McElhinney et al. suggest that pulmonary arterial pressure would improve exercise
tolerance and reduced baseline cyanosis.
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Ethan et al. [50] study focused on the virtual Hemi-Fontan model along with a multi-scale
simulation that predicts the patient’s hemodynamic and physiologic condition postoperation. The patients were five and six months old, respectively. The computational
model contained a 3D domain of the surgical junction along with a circulatory system that
describes the 0D domain. The resting and active conditions of the two patients were
considered, and a total of four simulations were performed.
The circulatory system in their study was modeled using 0D lumped-parameter network
(LPM). Five main circuit blocks were modeled to represent the heart, right and left
pulmonary vasculatures, and the upper and lower body vasculatures. The atrium and
ventricle were represented as elastances. Non-linear diodes are used to model the aorta
valves along with atrioventricular valves; this allows the unidirectional flow with
resistances proportional to the flow rate. The kidney, liver, and intestine were modeled as
the lower body and a venous valve in the leg venous block. Based on the outlet of the 3D
model, the pulmonary circulation is described using the

RCR blocks are arranged

parallelly. Coronary circulation, respiratory effects, and gravity are neglected [68].
Pulmonary LPM parameter values were described using a morphometric tree-based
impedance approach [69], [70] Systemic LPM parameters were represented using a
healthy adult with BSA= 1.8 m2 [71], [72], [73] Parameters were scaled by using the
allometric equations according to the patient’s BSA [54] . The LPM was tuned using the
resistance of the upper and lower body to simulate the patient’s resting condition. Patientspecific compliance was computed after modifying the resistance of each block while
keeping the proportion of impedance [52] [54]. The parameter values of large vessels and
the heart were manually tuned to match the mean value and waveforms obtained from
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clinical measurements during the resting condition. A set of LPM parameters that is
equivalent to active conditions was prescribed. The active state of the infant is compared
to the exercise state of an elderly patient. In the active condition, an assumption is
considered where the heart rate is generally around 120-160 bpm [74].
The entire circulation system was developed computationally by coupling the 3D
anatomical model and the 0D LPM model. An implicit coupling algorithm was used to
apply the Neumann boundary condition at the inlets and outlets of the 3D model [38]. Wall
shear stress (WSS) and particle residence time (PRT) was computed, pressure and flow
information was extracted from various points along with the instantaneous pulmonary
power loss.
Results showed that the flow from SVC transitioned smoothly into the pulmonary arteries
for patient A and swirling was observed for patient B, resulting in high velocities near the
circumference. WSS distribution plot in the surgical junction for both patients is uniformly
distributed; the band of high WSS characterizes the orientation of swirling flow. The power
loss results obtained are similar to previous modeling studies of the HF anatomy [75], [76].
Patient B showed three times higher power loss due to higher flow rates and flow
disturbances. There was an increased CO during the active condition, and in the pulmonary
blood flow, this increased the SVC pressure in both models. Coupled with the existing
SVC baseline pressure of 15.5, patient B had an SVC pressure of 18.8mmHg compared to
the SVC pressure, 11.7 mmHg . Patient B would exhibit superior venous hypertension or
SVC syndrome with headache, face swelling, and orbital edema based on prior clinical
experience. For both patients, the area under the pressure-volume loop during an
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operational condition is smaller than the loop during the resting condition; this indicates
that during each cardiac cycle, less work is performed.
Ethan et al. concluded the study by mentioning that further refinement is required within
the HF operation. Improving the surgical junction power loss has minimal impact on the
overall post-operative circulation in pressure and flow during the resting and active
conditions. PRT and WSS results from computation can assess the relative thrombotic risk;
this can be reduced if the PRT values are lower. Platelet activation is possible when the
values of WSS are in the range of shear-induced platelet [77]. Considering the junction as
a non-linear resistance proportional to the square of the flow rate would be the plausible
reason for the increased surgical junction power loss during active conditions [78]. The
difference in power loss between the two Hemi-Fontan models could affect systemic
parameters during strenuous activity [79].
Schiavazzi et al. [80] study focused on the postoperative hemodynamics of LPA stenosis
by using a multiscale computation study on single ventricle patients undergoing stage II
superior cavopulmonary connection (SCPC). Postoperative stenting or surgical
arterioplasty is often required to relieve LPA hypoplasia or stenosis [81], [82], [83], [84],
[85]. This adds complexity and time to the SCPC operation. The treatment of LPA stenosis
is still subjective and needs to rely on angiography data and clinical experience. This study
aimed to develop quantitative guidelines for the treatment of LPA.
Ninety patients were studied for various configurations in stenosis, in the main pulmonary
arteries, or their branches [86]. Data showed that discrete pulmonary artery stenosis was
frequent when combined with other anomalies. The local compression induced due to
augmentation of the aorta during stage I surgery is the primary reason for distortion in LPA
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[82], [83] [87]. This affects the ventricular-arterial coupling [88] that results in increased
and eccentric wall shear stresses [89].
Magnetic resonance imaging (MRI) data of each patient before stage II surgery was used
to develop the 3D models of the junction between BT shunt and pulmonary arteries.
Relevant vasculature was obtained using the combined segmentation and region-growing
technique [90]. The LPM model was constructed using a circuit model [72] to simulate the
preoperative and postoperative patient’s circulatory physiology[50],[51],[52], [91]. The
heart, upper and lower systemic, and left and right pulmonary circulations are characterized
using five circuit blocks; the remaining modeling technique is followed by the model done
by Migliavacca et al. [68] The LPM model was coupled with the 3-D streamline upwind
Petrov-Galerkin finite element navier-stokes solver [60], [92].
Results showed that LPA: RPA in patient P1 was weakly affected due to the severity of the
stenosis. The ratio in patient P1 was higher than the average compared to the flow split
ratio when at 80% stenosis and 35% stenosis. Between Glenn and Hemi-Fontan models,
all levels of stenosis showed a maximum relative difference of 4% in patients P1 and P3.
For a degree of stenosis at 60% of the diameter, the maximum relative difference in
pressure drop across the LPA was higher. A mean pressure drop of greater than 3mmHg
across the stenosis is considered clinically significant [84].
There was no change noticed on the pressure-volume loop for severe levels of stenosis. No
changes were observed in other clinical parameters such as

Qp
Qs

, power losses, systemic

and venous oxygen saturation. Pressure and LPA: RPA flow split falls in the range of
clinical concern when stenosis is greater than 65%. Pulmonary artery reconstruction is
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required in more than 50% of the cases, as pulmonary artery distortion and hypoplasia
occur most often in LPA[83], [84]. During stage II surgery, augmentation of central
pulmonary arteries is essential, while minimizing pulmonary artery distortion is the
primary factor to use the Hemi-Fontan rather than bi-directional Glenn. Treatment of
pulmonary stenosis is performed to avoid potential effects on suboptimal growth and
exercise tolerance and remodeling caused by reduced flow [93], [94]. Simulations were
performed, keeping all other modeling parameters constant. Results show that power loss
in the SVC-pulmonary artery junction is a small fraction of the total pulmonary power loss.
Parameters of clinical interest remained unchanged.
Schiavazzi et al. [80] concluded the study stating the limitations faced in the study as LPM
parameters were identified based on preoperative stage II clinical data. This approach is
under the assumption that there are minor physiological changes in the patients. Pulmonary
and cardiac dysfunction in the early postoperative period was not considered. The clinical
data used for this study came from a patient under sedation. Change in the flow into the
pulmonary arteries can influence the result.
Moghadam et al. [57] study focused on a novel surgical approach by using an ejector pump
for the flow in BDG to be assisted. The highest mortality was observed [95] in an initial
report of the classic Glenn procedure in patients. Inadequate pulmonary blood flow and
SVC syndrome were the primary reasons for death. Less formal attempts to use this
procedure have led to similar poor outcomes [96] [97] [98].
An ejector pump can be used in the SVC circulation, where the low-energy blood flow in
SVC can be assisted by additional energy from flow in the systemic circulation. By
assessing the use of ABG and quantify the consequences in hemodynamics due to change
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in PVR due to infant physiology. To couple local hemodynamics to a closed-loop model,
a multiscale framework is adopted [99]. An LPM network along with a 3D model of large
vessels for which Navier-Stokes equations have been solved. The 3D geometric model was
constructed based on the former study of the mBT shunt [38]. Three models were created
using realistic anatomy and clinically derived geometries. A 3.5 mm mBT shunt, the SVC
diameter was 4.5 mm , a 2.5 mm shunt was used in between the innominate artery and the
SVC for the ABG approach. The adopted LPM is based on the prior studies of the mBT
shunt circulation [100]. Component values for the blocks were obtained from the
angiographic data of 28 Norwood patients. A total of six simulations were performed to
examine the influence of high PVR during the early postnatal period.
Results showed that for ABG procedure without the distal clipping, at lower PVR, SVC
pressure increased, pulmonary flow increased, and oxygen delivery decreased. Once the
clipping is done, the upstream pressure from the SVC shunt is lower than the downstream
pressure. The energy in the flow is partly transferred to SVC from systemic, thereby
making the ejector pump concept feasible. The BDG model lowers the cardiac output,
maintains the oxygen delivery, and has higher SVC pressure compared to the mBT shunt.
Compared to BDG, the ABG had improved pulmonary blood flow, and the ABG model
achieved the highest oxygen delivery and oxygen saturation with the presence of PVR.
Moghadam et al. concluded the study stating that early application of BDG as first stage
palliation has been avoided based on outcomes. The ABG provides a different strategy;
based on the results obtained, complications from Glenn can be avoided. High SVC
pressure at high simulated PVR based on neonatal period remains a concern for ABG
application as the first-stage palliation. Use of ejector-pump shunt in the ABG can lead to
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early thrombosis due to lower flow residence as the length of the shunt is shorter than the
mBT shunt. Mathematical models cannot predict all biological responses, hence the need
for an animal model to examine the ABG shunt thrombosis.
Arbia et al. [101] study focused on the use of CFD in cardiovascular research to model
hemodynamics changes due to pathology [70], [102] [103] [104], changes due to surgical
repair [51], [105] and explore possible different scenarios for treatment [38],[50],[61],
[106], plan therapy [107] , design artificial devices or conduits that are subjected to stress
and pressure due to the blood flow [108] [109] [110].
To achieve an effective solution, necessary steps are taken to simulate blood flow that
includes geometrical mesh generation from image data, the required boundary conditions,
and the choice of numerical algorithm to compute flow and pressure. Inaccurate
performance in the numerical algorithm can lead to an erroneous result and thereby leading
to a misleading conclusion. Governing equations are discretized in space and time to
compute the solution close to the exact solution. Finite volume and finite element are two
discretization methods in space, within whom many variants existed for Navier-Stokes’s
equations [111] [112].
Arbia et al. discuss the use of computational fluid dynamics on superior cavopulmonary
connection (SCPC). The exact solution for the flow equations cannot be derived
analytically due to its complex geometry, compulsory three-dimensionality, and flow
characteristics. The SVC anastomosis was reconstructed from MRI data of SVC following
the Glenn operation. The geometric complexity with the most straightforward
hemodynamic setting is used to see its influence on the solution. Steady flow condition
was imposed on the inlet section, reference pressure at the outlet section, and zero flow at
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the wall. Using rigid-walled models will yield identical results regardless of the values used
for reference. A uniform mesh was generated, and a mesh comparison study was
performed. Results showed that mesh had a very minimal impact on the SVC pressure and
the flow split between two lungs. The change in the SVC pressure was clinically negligible
as they correspond to a small fraction when converted to mmHg.
The above literature discusses the conventional comprehensive stage II procedure with
patient-specific data applied on in-vitro and in-silico models and compares the data with
clinical generated data.
DeCampli et al. [113] study focused on a hybrid approach to the comprehensive stage II.
The “hybrid Norwood” consists of a procedure that is performed without the need for
cardiopulmonary bypass. This has a putative advantage in the avoidance of surgical trauma.
After using this approach, the outcome from various centers has been laudable, while others
report intermediate-term outcome that is not better when compared to the stage I palliation
[114], [115], [116] [117]. Deep hypothermia, circulatory arrest, and cardiopulmonary
bypass are required for comprehensive stage II palliation. Due to band-induced trauma,
bilateral pulmonary artery reconstruction is required and the management of the ductal
stent. To reduce the real trauma of the patient, an alternative technique for comprehensive
stage II palliation is proposed as shown in Figure 12. This applies to patients who can
sustain the upper body perfusion by having sufficient antegrade aortic flow. The creation
of the Damus-Kaye-Stansel connection and the need to create the aortic arch reconstruction
is avoided.
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Figure 12 Hybrid Comprehensive Stage II procedure conducted by DeCampli et al. [113]

Two patients were considered for this study. After undergoing hybrid stage I on day four,
Patient A had a hypoplastic aortic arch and aortic isthmus along with a sizeable ductal arch
with no obstruction to the left ventricle. The palliation procedure begins with the heart,
innominate, superior caval veins and great vessels being mobilized and the azygous vein
divided. The descending aorta, distal arch, or aortic isthmus are not mobilized. Dual arterial
cannulas were placed in the PA trunk and innominate artery. The venous cannulas were
placed in the innominate vein and right atrium, followed by the cardiopulmonary bypass.
Upon cooling to 18 C degrees , PTFE bands were removed from the branch pulmonary
arteries after arresting the heart and clamping the ascending aorta. The arch branches were
occluded, followed by PA cannula removal and the procedure for antegrade regional
cerebral perfusion. The RPA was opened at the proposed site of the SVC anastomosis. A
guide wire was advanced till the left lower lobe artery from the RPA incision. A baffle was
sutured partially using a pulmonary homograft material. This was done within the
pulmonary bifurcation from the right to the LPA orifices. A stenting procedure was
followed to prevent the baffle from being crushed due to the systemic flow; due to the
surrounding systemic circulation, a considerable amount of stress is exerted on the stunt,
thereby requiring a suture fixation.
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Upon completion of the surgery procedure, the patient made an unremarkable recovery and
became hypoxemic after postoperative day 5. Extensive thrombus condition was noticed
in the intra-pulmonary covered stent, LPA, and its lobar branches. The patient succumbed
to hypoxia on postoperative day 26.
After undergoing hybrid stage I on day six, Patient B had a double outlet right ventricle
and mitral atresia. A left posterior aortic root unobstructed pulmonary outlet and crowding
in the subaortic region were seen during the echocardiography. A similar technique was
followed, as mentioned above, for patient A. The central PA was opened longitudinally,
and the ductal stent was trimmed back to flush along with the PA bifurcation. A homograft
baffle was partially sutured between the left and right PA orifices. The same procedure
performed on patient A was performed on patient B.
Upon completing the surgery, the patient had a parainfluenza infection due to pulmonary
compromise for a prolonged duration. The patient recovered and was discharged on
postoperative day 53. The formation of the aneurysm on the intrapulmonary baffle was not
revealed during the angiography study. An echocardiography study at the age saw a good
RV function, unobstructed flow from the right ventricle, unobstructed flow from the native
aortic root, and unobstructed cavopulmonary connection of 15 months.
DeCampli et al. [113] concluded the study stating that this procedure has potential
advantages as it limits the baffle construction and arterial incision, shortened duration of
regional cerebral perfusion, and hypothermia. The complete avoidance of mobilization and
reconstruction of the isthmus, arch, and descending aorta decreases the risk of bleeding,
recurrent nerve, and phrenic nerve injury. The procedure has potential disadvantages,
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including baffle leak, LPA stenosis, stent migration with LPA occlusion, and recurrent
ductal arch stenosis.
The proposed procedure requires 1-2 stents placed; stent management is common with
conventional and standard hybrid staged approaches. Dave et al. [118] reported the
incidence of branch PA stenting was 17% and 38% for conventional management and
hybrid stages I and II. Reinhardt et al. [119] reported that catheter reintervention was
required for 37% in the conventional stage approach. Studies have claimed that PA and
aortic stents placed during the infant stage can be dilated to a diameter of an adult stent
with an average of three interventions [120], [121], [122].
The HCSII procedure is proposed as an alternative technique to the comprehensive stage
II procedure to reduce surgical trauma in patients. The HCSII procedure applies to patients
with sufficient antegrade aortic flow to sustain the upper body perfusion. The significant
advantage of the HCSII procedure avoids the creation of Damus-Kaye Stansel (DKS)
connection and aortic arch reconstruction. As discussed in section 1.6, the goal of this
research is to validate the efficacy of this surgical procedure by performing in-vitro
simulations.
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2.1.3. Stage 3: Fontan

Figure 13 Stage 3 Fontan

Francis et al. [123] performed the third stage operation on patients with tricuspid atresia to
route blood from vena cava into the pulmonary circulation, as shown in Figure 13. The
right atrium is bypassed and returns the oxygenated blood to the left side of the heart. As a
result, the systemic and pulmonary circulations are connected in series. The advantages of
the Fontan procedure are decreased load on the ventricle and better oxygen saturation. In
addition, flow through the pulmonary circulation is driven by the mechanical energy from
the post-capillary action. The downside of the Fontan procedure involves chronic
hypertension in the systemic vein [124]. Higher caval pressure is seen in the Fontan patients
due to the lack of a pump downstream of the systemic veins. As a result, the cardiac output
decreases as the ventricle pumps against the pulmonary and systemic resistance connected
in series.
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Choussat and Fontan stated that the patient must have good cardiac output and systemic
pressure at an acceptable value for the operation to be conducted [124]. In addition, the
patient must have good pulmonary arteries such that resistance in the pulmonary circuit is
not high. An ideal patient for the Fontan procedure will have a good ventricular function
and unobstructed ventricular flow. Fontan operation cannot be performed when the patient
is born as the veins are small and their corresponding resistance is high [124]. Hence, a
three-stage procedure is followed to allow the body to adjust to different hemodynamics
conditions introduced by the third stage.
When the patient attains 1-5 years old, based on the cyanosis at rest and during exercise
and the growth of the vascular structures, the stage III procedure is performed on the
patient. In the stage III procedure, the IVC is connected to the pulmonary artery. The two
methods for connecting to the pulmonary artery are Atriopulmonary connection (APC) and
TCPC. The right atrium acts as a valveless contractile chamber between the great systemic
vein and the pulmonary artery [125]. The problem associated with the APC connection
involves no ventricle to supply power, and the APC connection operates at a higher
pressure. In vitro studies have shown a loss of mechanical energy due to turbulence
generation when a compliant atrial chamber is placed in between the pulmonary arteries
and systemic veins. Superiorventricular arrhythmias and chronic atrial distension are
caused due to the APC technique making it an inefficient method within the Fontan
procedure [126].
In the TCPC procedure, IVC and SVC are directly connected to the pulmonary artery,
making the TCPC procedure superior to the APC procedure. IVC can be connected to the
pulmonary artery using two methods. The lateral tunnel method was developed in the
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1980s. A channel exists between the IVC and the pulmonary artery via a portion of the
lateral atrial wall and a prosthetic baffle in this technique. This method is used on younger
patients as the connection grows along with the patient [124]. The lateral tunnel method
leads to arrhythmias over a period of time as a small portion of the atrial tissue is exposed
to higher pressure. The second method is the extracardiac conduit method developed in
1990 [127] . In this method, a graft tubular in shape is placed in between IVC and
pulmonary artery. The right atrium is at low pressure, and the right side of the heart is
bypassed. The extracardiac conduit technique is available to patients who have grown large
enough such that the graft can be placed for the IVC flow and must have high Pulmonary
Vascular Compliance [124], [127]. Pleural effusion and protein-losing enteropathy are
associated with this technique if conditions are not met [128].
2.1.3.1.

Extra cardiac and intra cardiac Fontan

Alexi- Meskishvili et al. [129] conducted a clinical study to obtain the optimal size for the
Gore-Tex conduit for extra cardiac Fontan operation (ECFO). Recommendations to choose
the conduit diameter were based on minimizing the risk of thrombosis, and the diameter
should not exceed the diameter of IVC by 20%. It was recommended to perform ECFO on
patients between 2-4 years old as the distance from IVC to RPA is about 60-80% of an
adult.
Itatani et al. [130] conducted a study using CFD analysis to determine the conduit size of
the ECFO procedure. Optimum conduit size must be determined to balance the risk
associated with energy loss, flow stagnation, and thrombosis. When a smaller conduit is
used, there is a lesser chance for flow stagnation, as flow moves faster. In addition, higher
resistance and higher energy loss are associated with using a smaller conduit. The conduit
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must be large enough to avoid energy loss and flow stagnation as flow stagnation leads to
blood clotting, leading to catastrophic consequences for the patient. The variations in flow
are driven by respiration, making it non-pulsatile in nature. For different conduit sizes,
stagnation volume and energy loss were measured at rest and exercise; it was identified
that stagnation occurs during expiration. Stagnation decreased during exercise as the
overall flow rate increased. For patients as old as 2-3 years, conduit size lies in between
16-18 mm in diameter.
Penny et al. [131] studied the role of the lungs after the Fontan operation, where the subpulmonary atrium was connected to the pulmonary circulation. The study examined the
right atrium's role in supplying energy related to pulmonary blood flow’s energy provided
by respiration. At expiration, the contribution of the right atrial to the forward flow was
51.4%, with a standard deviation of 8.8%. During inspiration, the total forward flow was
63% higher than expiration, with a standard deviation of 35%. The contribution of the right
atrial to the forward flow was 52% during inspiration, with a standard deviation of 10%.
Hsia et al. [132] conducted a study on the effect of respiration and gravity on the flow in
the systemic veins in patients with Fontan and normal biventricular circulation. The Fontan
patients studied underwent TCPC and APC operations. The TCPC operation was further
divided into lateral tunnel method and extracardiac conduit. Patients who underwent TCPC
had significant fluctuations in the flow in the primary vein that returned from the liver and
the hepatic vein. Respiration effect was seen lower in APC operation compared to TCPC
operation. The average ratio of inspiratory to expiratory flow was 1.6 for APC patients, 3.4
for TCPC patients, and 1.7 for the control group. The inspiratory to expiratory flow ratio
in portal vein was 1.1 in APC patients, 1.0 in TCPC patients, and 0.8 for the control group.
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The gravity effect did not significantly affect the net forward or retrograded flow for
patients with normal circulation. For APC and TCPC patients, gravity reduced the net
forward flow and increased the retrograde flow.
Redington et al. [133] conducted a study on pulmonary artery respiration in patients with
a total cavopulmonary shunt. Patients have their right heart bypassed, and venous blood
from the liver and coronary sinus enters the right atrium. During inspiration and expiration,
blood flow increased and decreased in the pulmonary artery. Flow measurements were
made using Doppler echocardiography in the pulmonary artery.
Hjortdal et al. [134] conducted a study on the relationship between respiration and blood
flow during exercise and rested in Fontan patients with TCPC. Flows in the IVC and SVC
were monitored using MRI. SVC flow was not affected by respiration when the patient was
at rest. The inspiratory to expiratory flow ratio was 1.0 along with a standard deviation of
0.2; exercise did not significantly affect the ratios. During respiration, the IVC flow was
higher. The mean ratio of the patient at rest was 1.9, along with a standard deviation of 0.5.
Twice, the amount of flow in IVC during inspiration and exercise was driven by ventricular
activity, decreasing the ratio.
Mardsen et al. [135] conducted a study to understand the effects of respiration and exercise
on the TCPC using CFD analysis. In this study, realistic hemodynamic data was produced
that is close to clinically measured data. The exercise hemodynamics was affected due to
the respiration model.
Hsia et al. [136] conducted a study on the effect of diaphragm plication, a surgical
procedure done on normal and Fontan patients to relieve symptoms of diaphragm paralysis.
Ultrasound doppler evaluated the flow in the portal vein, the hepatic vein, and subhepatic
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IVC. Fontan patients under this study had TCPC operations. The normal control group had
a hepatic venous flow of 2.4 times higher during inspiration than expiration in the upright
position. Patients with diaphragm plication had a ratio of 1.4, showing the effect of
respiration diminished. In Fontan patients, the hepatic vein flow ratio was 3.2 in supine for
normal diaphragm position; for diaphragm plication condition, the ratio was 2.3. The
effects of respiration on systemic venous flow are essential in Fontan patients; for a patient
with diaphragm plication, this effect is lost. The phrenic nerve injury should be avoided by
all patients who have or will receive the Fontan operation.
Hsia et al. [137], de Level et al. [138], Mardsen et al. [135], and Bove et al. [139] performed
studies to modify the surgical procedure that could improve the Fontan hemodynamics. To
understand the effect of different design parameters on hemodynamics effect, CFD analysis
was performed. Parameters included effects on alternative Hemi-Fontan procedure,
inferior cavopulmonary connection (ICPC) diameter, Y-shaped ICPC, and ICPC location.
Ovroutski et al. [140] conducted a study on the effect of the Fontan operation on oxygen
and exercise capacity. Patients who had TCPC procedures, both adults and children, were
studied. Patients were monitored early and late postoperative exercise phase. During the
early phase, the mean cardiopulmonary oxygen capacity was higher in children than adults,
27.9 ml / min kg and 22.9 ml / min kg . Postoperative tests showed 30.1 ml / min kg and
16.9 ml / min kg in children and adults. Cardiopulmonary oxygen capacity in adults and
adolescents decreased compared to early and late postoperative. The exercise capacity was
better in children compared to adults. The median value for children was 2.2 W / kg and
1.9 W / kg for adults during early and late postoperative. Heart rates of patients were
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observed during early and late postoperative. The median rate was 136 bpm and 112 bpm
for children and adults.
2.1.3.2.

Fenestration and PVR

Gewillig et al. [124], [141] [142] [143] mention the need to address the pulmonary
vasculature in sick Fontan patients. Fenestration is a procedure that bypasses pulmonary
vasculature by returning IVC blood flow to the right atrium; this reduces IVC flow
congestion and improves cardiac output. Due to this process, the oxygen saturation
decreases, and identifying the optimum fenestration size has been difficult. A high level of
cyanosis can occur due to excess return flow, and smaller fenestration may not efficiently
reduce the IVC congestion. Ventricular dysfunction is the other main failure component.
Henain et al. [144] conducted a study on the effect of pulsatility on PVR by implanting
cavopulmonary shunt in 30 pigs surgically. Measurement on three control groups revealed
that PVR and pulmonary arterial pressure increased due to lack of pulsatility.
Goldstein et al. [145] analyzed the relationship between exercise capacity to diastolic
function and PVR. PVR decreased with exercise but remained constant in some patients.
It was found that in Fontan patients, the limitation on exercise was controlled by PVR.
Shachar et al. [146] found that PVR decreases during exercise in four of the five Fontan
patients studied. The relationship between the PVR and exercise is still not known.
Reeves et al. [147]

conducted a study on the normal human lung distensibility during

exercise rather than total PVR. A two percent increase in vessel diameter was seen for very
one mmHg pressure in the isolated arterials. The flow pressure increases during exercise
cause dilation in the lung vascular bed by 40%. An increased pulmonary flow was seen
due to the distensibility of lung arterioles that contributes to the reduction in PVR.
70

71
Forton et al. [148]measured the pulmonary arterial pressure (PAP), pulmonary flow,
exercise capacity, and PVR of healthy adult volunteers using Doppler echocardiography
under different exercise conditions. At peak exercise in all exercise conditions, the PVR
reduced by 40%.
Naeije and Chesler [149] stated that PVR is flow-dependent and it decreases curvilinearly
as the flow increases. The cardio output decreases as aging increases PVR. Vasodilators
such as nitric oxide and prostacyclin are released by pulmonary endothelium during
exercise, reducing the PVR. To detect dilation or constriction of pulmonary vessels or
changes in the arteriolar vessel caliber, PVR can be used as a good indicator.
Schmitt et al. [150] studied ten Fontan patients' effects on collateral blood flow and PVR
before and after administering dobutamine stress. Measurements were taken using MRI
catheterization techniques during continuous infusion of 10 ug / kg min dobutamine and
during free breathing. Cardiac output increased due to decreased systemic vascular
resistance, and no effect was seen on PVR when administered dobutamine. Due to the
increased cardiac output, the PVR decreased.
Rivera et al. [151]studied the relationship between PVR and pulmonary venous blood flow
during oxygen inhalation and free breathing. The study was done on 18 patients with CHD
with a left to right shunt. Using catheterization and echocardiography, the

Qp
Qs

and PVR

was measured. Measurements were taken before and after 100% oxygen inhalation (10
L / min oxygen masks). Pulmonary flow increased, and PVR decreased during oxygen

inhalation.
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Petrofski et al. [152] conducted a study on lowering PVR using mechanical ventricular
support. An adult patient with elevated PVR and heart failure was taken for this study. The
PVR decreased from 13.8 to 3.1 Wu after 24 hours of mechanical support to the pulmonary
and systemic systems.
2.1.3.3.

Morbidity and Mortality

The life expectancy of patients undergoing the Fontan procedure will usually be two or
three decades of a semi-normal life. The side effects caused due to this procedure lead to
congestive heart failure. Level et al. [125] states that reduced cardiac output and elevated
systemic venous are the primary reasons for complications. The elevated systemic venous
pressure causes plastic bronchitis, liver failure, and protein-losing enteropathy. Increased
lymph production is associated with elevated systemic venous pressure, which leads to
impairment in lymphatic resorption that leads to protein-losing enteropathy. As a result,
the patient experiences reduced exercise tolerance. The lack of ventricle causes flow
pulsatility in the pulmonary circulation, and hence the pulmonary compliances gradually
reduce over time. Stiffness is increased in the pulmonary circuit due to dilation that arises
from a lack of pulsatility. Higher pulmonary vascular resistance is seen due to increased
stiffness, which means lower cardiac output due to high systemic venous pressure. Hsia et
al. [132] state that gravity reduces the forward venous flow in patients.
Cavalcanti and Silvio [153] studied the failing Fontan operation to determine its factors
and correlation with the failing Fontan circulation. The hypothesis stated that the Fontan
operation's success or failure depends on the anastomosis site. Patients were categorized
into two groups for this study: symptomatic Fontan failure and no symptomatic Fontan
failure. There existed no statistical significance between the pulmonary artery and systemic
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arterial pressures between the two groups. The failing Fontan group had higher pressure at
the end of the pulmonary vein. Pressure in the SVC and IVC was 5.4 mmHg and 6.8
mmHg higher. The mean cardiac output of the failing Fontan group was 36% lower,

pressure loss over the cavopulmonary connections was higher; this was more significant in
the IVC connection. The total energy loss was studied across the cavopulmonary
connections between the two groups. The failing Fontan group had higher energy loss in
the inferior SVC. No statistical significance was seen in the energy loss in the superior
SVC. The possibility of reducing these elevated pressure drops depends on minimizing the
resistance and energy loss within the TCPC.
2.1.3.4.

In-vitro and in-silico approach

Snyder et al. [73] developed a numerical model of the cardiovascular system for NASA.
This model included the LPM approach to model characteristics of every branch of the
circulatory system. The LPM took into account the effect due to resistance, inductance,
and compliance. For this study, a three resistance-compliance element was used to model
the pulmonary system based on the average flow and pressure values. This model is split
into four sections, the head, thoracic cavity, abdominal cavity, and lungs. Additional
pressure generators and grounding relevant compliances to intrathoracic or abdominal
pressure were done, including gravity and respiration in this system. In modeling the
Fontan circulation, patient data is necessary as the patients have different pulmonary
compliance, flow characteristics in the pulmonary circulation, and systemic and venous
pressures.
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2.1.4. Passive and Active techniques to improve Fontan
To power the pulmonary system, mechanical assist devices have been proposed [154] [155]
[156] [157] [158] [159]. These mechanical devices have successfully dropped the IVC
pressure back to the normal value of 8 mmHg theoretically. Some current issues include
the requirement of two pumps, re-circulation induced by barriers, pumping in one direction,
obstruction, and the device cannot be shut off. With fenestration, these issues can lead to
pulmonary embolisms, driveline infection, or stroke [154].
Self-powered Fontan is the technique to tap the reserve mechanical energy of the native
heart and inject it into the Fontan system. The IJS is placed from the aorta to the Fontan
conduit. Assessment of energy losses due to flow mixing and flow jet impingement is
critical. Understanding the alternative surgical technique requires a multi-scale 3D and 0D
CFD analysis. The full 3D CFD model is tightly coupled to the LPM model, and the 0D
model does not model the TCPC. The pulmonary flow is tuned to increase by 50% in this
IJS model, directly affecting the PVR. Accurate PVR vs. flow models are not available as
other studies include other responses such as exercise, dobutamine stress, and oxygen
inhalation [145],[146],[147],[148],[149],[150],[151],[159], [160].
To have a maximum pressure drop at IVC, the IJS configuration was optimized. The nozzle
diameter and location were optimized using steady-state study conditions in a CFD model;
it was later implemented into three different models. Children’s Hospital of Philadelphia
gave a patient-specific model through MRI scans [75], [161], and synthetic models were
built using patient data average [79],130],.
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2.1.4.1.

Ejectors and Nozzles

Brahim et al. [162], Kandakure et al. [163], Yadav et al. [164] conducted a study on the
effect of liquid to gas mixing using ejectors in a convergent-divergent mixing chamber.
Design parameters such as nozzle to throat area ratio, primary to secondary flow ratio,
throat to nozzle length, and nozzle diameter were analyzed to optimize mixing, mixing
efficiency, and entrainment. Low entrainment rates are observed as the driving pressure
decreases due to a decrease in pressure.
Mukherjee et al. [165] conducted a study to analyze liquid to liquid dispersion efficiency
using ejectors. Energy loss could be minimized by selecting the optimal primary to
secondary flow ratios and the correct throat to nozzle area ratio. A decrease in efficiency
is attributed to mixing, flow channel shape, and friction.
The stage III literature mainly focuses on various alternative techniques to improve the
efficacy of the procedure. Along with the alternative techniques, the study on PVR, a
critical hemodynamic parameter, is conducted. Researchers have studied various factors
that affect the PVR, and the goal is to reduce the PVR in Fontan patients as complications
arise after the surgical procedure. The usage of injection jet, a passive technique to improve
the Stage III procedure, is proposed and discussed in section 2.1.4. As discussed in section
1.7, the goal of this research is to validate the in-silico simulations by performing the invitro simulation.

2.2. Mock Flow Loop
The MFL is a mechanical representation of the human cardiovascular system for in vitro
testing. The MFL was developed to test artificial heart valves, aortic balloon pumps, and
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other cardiovascular devices. The MFL consists of resistance valves that provide constant
flow by altering the pressure. Newer MFL includes additional features such as
compliance resistance, fluid inertia, pulsatile flow, atrial contraction, pulmonary and
systemic circuits.
The first MFL was developed to test the artificial heart valve; the artificial heartbeat was
created using pulse duplicators driven by stepper motors [166]. For valve flow
visualization, many systems included transparent and flexible ventricles [166], [167] [168]
[169] [170] [171] [172] [173]
Cornhill et al. [173] developed an MFL to test prosthetic heart valves. The MFL had a
collapsible silicone bag in a pressurized airtight box to mimic the left ventricle. The left
ventricle was supplied with pulses of compressed air, controlled by a solenoid valve. The
system having characteristic impedance, total arterial capacitance, and peripheral
resistance reproduced conditions to test the artificial heart valves. The system failed to
simulate the atrial systole, and inertial effects were ignored.
Kolff et al. [174] developed an MFL that consisted of both systemic and pulmonary sides.
The ventricles were operated using compressed air. Tall columns of water obtained
pressures in the pulmonary artery and aorta. Diastolic pressure could be changed by
changing the height of the fluid column. The excessive inertia produced by the water
columns had to be overcome to move the fluid up the tube. The inertia was overcome by
using a pressurized air chamber that surrounded the bottom half of the tube. For this MFL,
resistance valves were not used as resistance increased with increase inflow.
Reul et al. [175] developed an MFL using the flexible tube for the aorta and its branches.
The MFL was suspended in a Perspex box filled with water. The loop was connected to a
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Windkessel chamber with adjustable air volume for compliance. A tube membrane was
used to apply resistance to each branch of the system. The MFL was driven by a cam system
that supplied the pulsatile pressure to the mock ventricle. Inertance in this MFL is taken
into account by dimensioning the aorta and its branches. The MFL mimicked the systemic
circulatory system but did not include a method to connect and test VADs.
Donovan et al. [166] developed an MFL to test new artificial hearts in in-vitro conditions;
the cardiovascular device testing capabilities of the rig are limited due to the absence of
atria or ventricles. This system was compact and showed positive results in comparison to
the calf model.
Scotten et al. [176] developed an MFL to evaluate mitral valve prostheses. A cam created
a transparent mock ventricle and was driven to push the fluid in a sealed chamber that
includes the ventricle. The ventricle volume was found concerning time by examining the
cam position and the cam’s cross-sectional area concerning time. The ventricle pumped the
fluid into a compliant latex rubber aorta, then to the resistance and the compliance
elements. Resistance was simulated by using cellulose fiber water filters. These water
filters had a pore size of 5 and 50  m for characteristics and peripheral resistance,
respectively. The resistance values in this MFL could be altered by the cellulose fiber water
filters into a plastic tube when the MFL was in operation; the procedure produced discretely
variable resistance rather than a continuously variable system. Compliance for this MFL
was obtained by the volume of air trapped above the resistance elements. This MFL
produced pressure and flow results.
Rosenborg et al. [177] summarized the design and evaluation of the Penn State MFL. The
Penn state MFL was designed in 1971 for in-vitro testing of VADs. The MFL included
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compliance, resistance, inertance, systemic and pulmonary circulation, VAD connections,
and adjustable cardiac conditions. The values selected for the MFL with a cardiac output
of 5 L / min , MPAP of 15 mmHg , MAP of 100 mmHg , mean RAP of 2.2 mmHg , and
mean LAP of 7.5 mmHg . The resistance and compliance values used for this MFL were
based on a healthy male, as mentioned in Table 1. Inertance values were assumed to be
equal for systemic and pulmonary circulation, which were incorrectly assumed. This MFL
showed satisfactory results representing the human circulatory system and providing a
suitable method for in-vitro blood pumps.
Table 1 MFL parameters chosen by Rosenborg et al. [177]
Systemic

Pulmonary

Systemic

Pulmonary

Systemic

Pulmonary

resistance

resistance

capacitance

capacitance

Inertance

Inertance

1.36

0.14

1.33

4.4

0.0158

0.0158

mmHg.s/ml

mmHg.s/ml

mL/mmHg

mL/mmHg

mmHg.s2/mL mmHg.s2/mL

Verdonck et al. [178] created an MFL to test mitral valves, later altered. The MFL could
replace the aortic and mitral valves. Fluid enters the MFL from a preloaded reservoir
representing the lungs into the two pulmonary veins, which carry the fluid through the
mitral valve. The fluid from the left ventricle travels through the aortic valve into the
afterload system that consists of a Windkessel chamber for compliance and a hydraulic
resistor. A venous reservoir was included to obtain a constant venous pressure of 5 mmHg
. The latex atrium and silicone left ventricle were anatomically shaped and mounted in
Perspex housing filled with water. An external circuit controlled the pressures in the
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Perspex housing. A feedback system determined the pressure delivered to the ventricle.
For systole, positive pressures were induced, and for diastole, negative pressures were
used. The positive and negative pressure resulted in physiologically inaccurate ventricle
filling. This MFL was used by Vandenberge et al. [179] to assess intra-arterial LVADs
hydrodynamic performance.
Trittenwein et al [180] designed a neonatal MFL to investigate the effect of extracorporeal
membrane oxygenation. The loop was required to produce lower cardiac output with
decreased heart rate such that neonatal conditions could be mimicked. The authors
concluded by stating that this MFL is valuable in demonstrating conditions in neonates.
Due to lack of patient reaction and medication effect, this cannot replace clinical studies.
In neonates, biventricular heart failure could not be created as the system lacked pulmonary
circulation, resulting in inaccurate simulated ventricle preload.
Sharp et al. [181] conducted a study on the benefits of several Windkessel models from
basic two-element to advanced five-element Windkessels. An MFL was developed and
compared with existing MFL and natural heart results. A computer simulation was
conducted on RC, RLRC, RCLRC, and RC models; R stands for resistance, L for inertance,
and C for compliance. Results showed that as each element was added to the design, there
was an improvement in results compared to the human data. Four element windkessel
model showed slight improvement when compared to the three-element windkessel model.
The addition of a fifth element improved the circuit significantly. Due to the difficulty in
the construction of the RCLRC model, the RCR model was favored.
Baloa et al. [182] studied the elastance-based control of MFL. A new control strategy for
the MFL was developed by using the concept of elastance. Elastance is the instantaneous
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ventricular pressure vs. the ventricular volume of the ventricle. The maximum value of
elastance was taken at the point of end-systole or a measure of ventricular contractility.
The authors stated that the design was successful in using elastance-based control to the
ventricular chamber’s contractility. The inertial effects in the circulation and ventricle were
ignored, and only the systemic circulation was simulated.
Fiore et al. [183] designed an MFL to study the mitral valve surgical correction. The study
involved developing a flexible mock ventricle and studying the change of shape during the
cardiac cycle. This information was used to study the fluid dynamics of ventricular filling.
For this MFL, the end-systolic shape of the ventricle was chosen to keep the shape similar
when the ventricle fills with the fluid. The ventricle was constructed using the finite
element model (FEM) model, the structure was reinforced with five bands, and the model's
thickness was 0.21 mm . Negative pressure was applied around the mock ventricle to
induce ventricular filing. The system's inaccuracy did not exceed 3.5%, and the design
behaved naturally like a left ventricle. The mock ventricle represented that of a healthy
male. Larger ventricles volumes seen in conditions such as dilated cardiomyopathy could
not be replicated in this MFL.
Goodwin et al. [184] developed an infant MFL for education simulation. This study
replicated the cardiovascular parameters of the infant.
Pantalos et al. [185] aimed to create an MFL to mimic the Frank-Starling response in
normal, failed, and partial recovery situations of the heart. The MFL used a flexible
polyurethane atrium and ventricle. The ventricle was placed inside a pressurization
chamber with a semi-rigid dome for mounting inflow and outflow valve. The ventricle was
not anatomically shaped to produce accurate flow dynamics in the ventricle. The MFL
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allowed for aortic outflow cannulation and atrial and ventricular apex inflow. A
polyurethane aorta was connected to the ventricles that led to the systemic and coronary
vasculature. The inertial effect was taken into consideration through the cross-sectional
area and length of the tubing. The pressure-volume loop produced by the MFL represented
a natural situation, and the MFL mimicked the Frank-Starling response for all conditions.
The MFL also produced accurate hemodynamic waveform magnitudes and morphology
for all conditions. Limitations of this study involved a lack of pulmonary vasculature and
noise from the aortic pressure waveform. This MFL was later used by Glower et al. and
Koenig et al. [186] to evaluate artificial vasculature devices and investigate the
hemodynamic and pressure-volume response to continuous and pulsatile VAD.
Koenig et al. developed a systemic MFL to test continuous and pulsatile VAD. The
hemodynamic and ventricular pressure-volume response was tested at different levels of
assist for pulsatile and continuous flow devices. A mock ventricle was created in a hemiellipsoid shape with a semi-rigid dome with the aortic and mitral valves mounts. The
pressurized chamber controlled the system to obtain the required pressures and heart rate.
A high-fidelity pressure-volume conductance catheter was used to monitor the ventricular
pressure and volume. A compliant latex tube in a sealed chamber provided the resistance
in the MFL. Pressure from the driveline was supplied to the ventricle and the sealed
chamber to produce the required coronary flow. The limitation of the study involved the
absence of pulmonary circulation.
Litwak et al. [187] constructed an MFL with coronary vasculature. This MFL aimed to
study the aorta outflow graft location with continuous and pulsatile flow VAD. The atrium
and ventricle used in this MFL were made of flexible polymer sacs, and the ventricle was
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placed in a pressure chamber. The apex of the ventricle achieved ventricular cannulation
into the aorta. A coronary and systemic vasculature that includes the carotid artery was
included. At the downstream of the MFL, the artificial aorta was connected into the mock
vasculature. The accuracy of the cardiovascular simulation is improved by the inclusion of
coronary circulation and carotid artery. As the pulmonary circulation did not exist, the
venous return was ignored. A latex tube inside a pressure chamber mimicked the phasic
coronary resistance. The same pressure pulse that drove the ventricle source was used. As
a result, an elevated coronary resistance during the ventricular systole and reduced
coronary resistance during diastole was seen. The above phenomenon resulted in a biphasic
coronary waveform.
Liu et al. [188] developed an MFL to test continuous-flow LVADs, as seen in Figure 14.
Semi ellipsoidal-shaped silicone diaphragms used in pressure chambers mimicked the
ventricles. For diastole, negative pressure was applied, and for systole, pulses of
compressed air were sent to the chambers. Clear tygon tubing was used to connect all
components, VAD was connected via the apex of the mock ventricle and systemic arterial
tank. Check valves were used to achieve uni-directional flow. This MFL was sufficient to
test LVADs under various conditions. An accurate prediction of LVAD performance could
not be provided due to the inability the obey the Frank-Starling law.
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Figure 14 MFL by Liu et al. [188]

Timms et al. [3] developed an MFL to test VADs. The aim was to develop a new MFL that
could produce normal and heart failure conditions. The rig adhered to the Frank-Starling
law, but the ventricular volume could not be measured. The MFL produced accurate data
in terms of pressure and flow for normal and heart failure conditions. Limitations involved
the use of heavy brass check valves, restriction of flow in the pulmonary circuit, and lack
of measuring ventricular volume.
Kozarski et al. [189] developed a hybrid MFL. This system uses features of present
hydraulic and electrical models of the simulation. A flow generator was used to convert
the incoming electrical signal into an appropriate flow for the hydraulic. The hydraulic
component represented consists of characteristic arterial compliance, resistance, and
inertance. They include pulmonary circulation, accurate representation of fluid inertia, and
variable compliance.
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2.2.1. Resistance
There is a significant effect on the circulatory system due to the resistance to blood flow.
The resistance R increases as the radius r of arteries and veins decreases. Resistance is
also influenced by the length of the artery L and the viscosity of the blood  . Equation (2)
provides the governing equation (2)

R

.L
r

(2)

4

A small pressure drop is seen when blood enters and exits the aorta, exhibiting very little
resistance. Significant pressure drop on the blood is seen when blood enters the parts of the
systemic circulation that includes smaller arteries and the arterioles as they provider higher
resistance. By constricting or dilating the arteries, the body can change the resistance to
flow. Dilation decreases the resistance causing more blood to flow to the artery, and
constriction produces the opposite effect.
SVR is defined as the resistance by the whole systemic circulation to the flow of blood. If
the central venous pressure (CVP) is available. The value is usually assumed to be close to
zero if CVP is not available. Equation (3) provides the relation between SVR, MAP, CVP
and CO

SVR 

MAP  CVP
CO

(3)

The value of resistance is obtained by a flexible tube in conjunction with a pinch valve. A
variable level of resistance is obtained by lowering an electrical signal to occlude the
valve[3],[187], [190] [191] [192] [193].
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Donovan et al. [166] provided an innovative technique in obtaining the resistance. Figure
15 shows the mechanism used. Upon rotating the plate about a pivot to occlude the flow
tube, the resistance of the pulmonary and systemic system was obtained. The value
depended on the angle of rotation which was controlled by a lever arm. The lever arm is
connected to bellows placed inside a chamber having water at a specific pressure. The
bellows contract due to the pressure difference; this occurs when the aortic/pulmonary
arterial chamber pressure increases. Due to this contraction, the valve plate is rotated about
the pivot as the bellows are pulled on the lever arm. This makes the valve plate move,
making the fluid flow through the flow tube due to a more cross-sectional area. This also
lowers the resistance and lowers the arterial pressure. To obtain systemic resistance, an
extra spring was used in parallel to the bellows to accommodate for the higher pressure.

Figure 15 Resistance mechanism used by Donovan et al. [166]

Trittenwein et al.[180] and Liu et al. [188] used sintered aluminum oxide porous blocks to
supply resistance. The blocks had the necessary permeability to represent peripheral
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resistance and impedance characteristics. The resistance value was adjusted by blocking
unblocking the pores on the block; a moving sliding plate was used for this technique.
Scotten et al. [176] used Equation (4) and (5) to represent the pressure drop and resistance
P  R.Q

R

8..LR.
AR 2

(4)

(5)

R is the resistance, Q is the volumetric flow rate, µ is the fluid viscosity, P is the pressure
drop, and LR AR are the effective length and area of the resistance tubing. Figure 16 shows
the method to apply resistance by compressing small flexible tubes using a flat plate. A
higher value of resistance is obtained as the magnitude of compression is increased. Ferrari
obtained resistance by a slide that blocked the flow through a pipe when moved up and
down. Resistance could be adjusted by choosing a value for the mean arterial pressure or
by choosing a value that moved the slide.
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Figure 16 Resistance segment used by Scotten et al. [176]

Patel et al. [194] used a 1.5-inch gate valve to obtain the resistance value. Resistance values
for simulation of healthy were 0.85 mmHg.s / ml and for congestive heart failure was 1.21.4 mmHg.s / ml .
Pantalos et al. [185] obtained resistance for peripheral and proximal components by using
a chamber that contains open cell foam with different densities. To adjust the value of
resistance, the foam can be compressed by a sealed piston.
2.2.2. Inductor
The pulsatile nature of the blood requires constant change in motion when flowing through
the circulatory system. On the mock loop, this can be represented by including an inertance
component. This component can be achieved with the correct volume of fluid being flown
in each section of the circulatory system and representing these values on the mock loop
with pipe lengths and diameters.
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The Windkessel model models the circulatory system. The system represents features such
as resistance, compliance, and inertance in the form of electrical drawings. Many mock
loop simulations use arterial compliance C , characteristic resistance Rc , and peripheral
resistance R p for the three-element Windkessel model. A four-element Windkessel model
includes an inertial component L . This is shown in Figure 17
Stergiopulos et al. [195] reported that the inertance (Li) of a tapered wire can be represented
as shown in Equation (6)


L 
i

ls

o

Cu. .dx

(6)

A

Where ls is the segmental length, ρ is the blood density; A is the cross-sectional area, and
Cu is the coefficient considered for a non-flat velocity profile that equals 4/3 for low
frequencies. Similar to spring constant, inertance in series and parallel are calculated.
Inertance in series is the total sum of inertances and in parallel is shown in Equation (7)

1
1 1
 
L1  L 2 L1 L 2

(7)

Figure 17 Three and four element Windkessel model by Stergiopulos et al. [195]

Noble et al. [196] conducted a study in dogs on the contribution of blood momentum to
left ventricular ejection. This was conducted by placing a flow probe in the aorta and
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pressure transducers in the left ventricle and aorta. Controls noted and showed that the
ventricular pressure was higher during the ejection period and an increase in aortic pressure
above the ventricular pressure in the last 30-50% of the ejection. By placing an aortic
occlusion device around the aorta, that required 20 ms to completely close, a spike in the
ventricular pressure trace, and then a distant reduction in pressure. Results showed that
blood momentum affects ejection.
Scotten et al. [176] used Equations (8) and (9) to solve inertance when the three-element
Windkessel model was used.
 dQ 
P   . 

 dt 

  .

L1
A1

(8)

(9)

P is the change in pressure,  is the inertance, Q is the volumetric flow rate, t is time,

 is the fluid density, L1 and A1 represent the length and cross-sectional area of the pipe.
Stegiopulos et al. [195] aimed to find the difference between three and four-element
Windkessel models in dogs, humans, and a mock loop. The main aim was to find the
difference in pressure and flow measurements in the aortic section. The results obtained
can be seen in Figure 18, which shows a significant difference in accuracy between the two
models. The four-element Windkessel model presented a greater value of flow
measurement aortic pressure compared to the three-element Windkessel model.
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Figure 18 Comparison of measured aortic pressure trace vs three and four element windkessel
simulations[195].

Ferreira et al. [197] conducted a study on 26 human patients to estimate arterial compliance
using the three and four-element Windkessel model. Improved representation of the arterial
compliance was better seen by adding the fourth element.
2.2.3. Compliance
The tendency of the blood vessel volume to increase as blood pressure increases is defined
as Compliance [4]. Compliance is inversely related to stiffness, i.e., vessel walls stretch at
a higher value of compliance. It can be expressed as shown in Equation (10)
Compliance =

Change in volume (ml)
Change in pressure (mmHg)

(10)

Compliance of veins is approximately 24 times greater than that of arteries [4]. Hence veins
can hold a large volume of blood when compared to arteries. Ventricle’s pressure-volume
curve is influenced by ventricular compliance. The end-diastolic pressure for any given
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end-diastolic volume increases if the ventricle compliance is decreased. This is represented
in Figure 19

Figure 19 Effect of ventricular compliance [5]

Donovan et al. trapped the air volume in each chamber above the circulatory fluid to obtain
compliance.
Garrison et al. [198] designed a mock loop for hemolysis studies associated with VADs.
Two 70ml sacs and a sealed chamber were used as the compliance chamber. The chamber
designed was large to fit one full and empty sac inside. The chamber limiting volume
changes, hence compliance. This feature was used for aortic and venous compliance.
Marcus et al. [199] conducted a study on healthy patients. The aim was to determine the
arterial compliance and compare it with the two and three-element Windkessel model. The
hemodynamic profile of the population is mentioned.
Woodruff et al. [200] performed studies on cardiac performance in microgravity using a
compact mock loop. The Penn State mock loop was chosen as the base, and the weight of
the compliance chambers was reduced. In Figure 20, a new spring design was used to
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reduce size and weight. To accommodate many different spring diameters and to center the
spring, a conical seat is used. Target values for arterial and venous compliance were 1 and
10 ml / mmHg . Spring values were chosen at 5, 10, 15 ml / mmHg for venous compliance
and 0.5, 1, and 1.5 ml / mmHg for arterial compliance. Limitations in this study included
changing springs for each variation in compliance that resulted in inefficient testing
procedure, and approximations were made for the desired spring constants and their
corresponding compliance values. The weight and volume of the new design were 47%
and 64% lower compared to the Penn State design.

Figure 20 Compact spring compliance chamber by Woodruff et al. [200]

Arabia et al. [201] ,Figure 21, Ferrari et al. [202] used a spring capacitor to obtain
compliance. Arabia et al. used 3.6, 4.8, 82.5, and 10 ml / mmHg as compliance values for
systemic arterial, pulmonary arterial, systemic venous, and pulmonary venous. Pantalos et
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al. [185] used the concept of spring for compliance. The required amount of compliance
was obtained by using a spring-loaded piston on a roll sock diaphragm.
Kolh et al. [203] studied the effect of the increase in aortic compliance on ventricular
performance. The aim was to investigate the energetic cost of cardiac ejection and left
ventricular contractility when aortic compliance applied was increased. The results
obtained in this study showed that the effect of increasing aortic compliance had a
significant reduction in the energetic cost of the heart, and the effect on the contractile
function was minimal.

Figure 21 Spring compliance chamber by Arabia et al.[201 .

Lick et al. [204] adjusted the compliance chamber to further a previous study on an artificial
lung. Previous in vivo studies of an artificial lung produced a 50% right heart failure
immediately causing death. Initial designs were modified by including an inflow
compliance chamber, inflow separator, and modified outlet geometry. A solvent cast,
polyurethane, was included in the method to obtain the compliance chamber. Pressures
would not be generated externally of the chamber using the polyurethane bulging segment
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encased in open-faced housing. Significant improvement in results was noted in the new
in vivo trials.
Dumont et al. [190] developed a pulsatile bioreactor for the tissue engineering of an aortic
valve. The system used variable compliance, where the air pressure above the water inside
the chamber was altered. This design would give variable compliance under the assumption
that change in volume due to change in pressure is negligible. The mock loop only
represented systemic circulation and lacked pulmonary circulation. As the pressure
changes in the whole system due to varying compliance, this concept of a compliance
chamber is not suitable for full mock circulation. A value of 0.4-1.2 ml / mmHg was used
for compliance.
Papaioannou et al. [205] conducted a study on the effect of arterial compliance on the
effectiveness of intra-aortic balloon counterpulsation. Windkessel chamber with a variable
air volume was used to simulate the compliance. The isothermic air process assumed by
PV  constant , giving rise to the formula for compliance as C  V / P . Varying the

compliance between 1.05-2.62 ml / mmHg , the heart rate was between 80, 100, 120 bpm ,
and the mean aortic pressure was 55, 75, and 105 mmHg . Results showed that arterial
compliance is a significant factor that influenced the performance of intra-aortic balloons.
Left ventricle stroke volume increased by 6% for systolic dysfunction when the arterial
compliance was increased. No change was seen for diastolic dysfunction.
Bustamente et al. [191] created a compliance chamber using a flexible rubber wall. The
chamber was primarily clear plastic. A flexible rubber diaphragm was used on one wall to
dampen the pulse pressures. The diaphragm was removable to accommodate a new
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material having a different stiffness if the compliance needed to be changed. Using the
flexible rubber, positive results were recorded.
Haft et al. [206] developed an artificial lung compliance chamber. The mock loop model
did not include the inertance and adjustable resistance element but relied on the tubing
resistance and pulsatile flow VAD. Constant pressure was delivered into the VAD, which
delivered fluid to the compliance chamber; Figure 22 shows the compliance chamber made
from a flaccid polyurethane bag in an airtight box that receives compressed air to alter the
compliant nature of the bag. External pressure applied to the compliance element
maximized the value of compliance and altered its time scale by augmenting diastolic
emptying and before systole maximize the capacitance.

Figure 22 Compliance element used by Haft et al. [206]

Fiore et al.[183] The arterial compliance is used as part of the hydraulic side of the hybrid
system. This reduced the effect of mechanical and hydrodynamic disturbances and
improved the quality of pressure measurement. The value selected for the compliance was
1.2 ml / mmHg . Additional arterial compliance was added to the electrical circuit; altering
the arterial compliance can obtain a variable compliance value. Loh et al. [214] chose the
following values for compliance.
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The values for aortic and left ventricular compliance are higher compared to the other
literature. Airtight tanks with a trapped volume of air above the fluid were chosen for
compliance mechanism.[187],[188],[206], [207] [208] . Variable levels of compliance
[209] [210] [211] [212] [213] [214] [215] [216] [217] [218] are produced continuously by
these chambers. The mock loop requires a shutdown for each compliance change. Litwak
et al. used 43.6, 4.9, and 5.6 L as volumes for systemic venous, systemic arterial, and
pulmonary compliances. The volume of air is altered by incorporating an air valve.
Equation (11) was used to compute the compliance
C=

dVfluid Vair Vtank-Atank.hfluid
=
=
dPfluid Pair Pfluid-ρ.g.hfluid

(11)

C corresponds to compliance Vair and Pair are the volume and pressure (absolute) of air in

the tank and the tank's volume and cross-sectional area. Pfluid and h fluid are the pressure
(absolute) and height of the fluid.  is the density of the fluid and g is the acceleration due
to gravity.
Hassani et al. [219] developed a mathematical model to study aortic aneurysms.
Compliance, inertance, and resistance were included in the model. Equation (12) was used
to compute the compliance of an elastic vessel.
C

3. .R 3 .Z
2.E.h

(12)

C is the compliance, R is the radius of the vessel, Z is the length of the vessel, h the

thickness of the vessel, and e the elastic modulus of the vessel.
Timms et al. a [3]trial compliance was achieved by using an open to air chamber that
changes fluid volume in response to venous return. A pressure change is created due to the
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height of the fluid and hence changing the level of compliance. Using the fluid-filled
chamber with a trapped air method, the aortic, systemic vascular, and pulmonary arterial
and pulmonary vascular compliance was used.
Stergiopulos et al. [220]study was conducted into current methods to estimate the arterial
compliance and compared the results with the previously developed mathematical model,
including 55 arterial segments modeling the major arteries. Fluid inertia, fluid friction, and
nonlinear compliance were considered for this model. Three three-element Windkessel
methods were analyzed using various methods, and Four two-element Windkessel was
employed, including the area method, two-area method, and the integral method. All
methods based on the two-element Windkessel produced less than 10% errors than the
three-element Windkessle model. It was concluded that the three-element Windkeseel
model could be used to represent the arterial system accurately. The two-element
Windkessel model represents the systemic arterial tree at low frequencies.
Segers et al. [221] concluded that the pulse pressure method was consistent for estimating
total arterial compliance. The in vivo results of the pulse pressure method are compared
with stroke volume: pulse pressure ratio and the area method.

2.3. Summary
The three-stage palliative procedure is a series of surgical procedures to treat the HLHS
anomaly in neonates. Stage I involves the Norwood procedure, where the surgical
procedure aims to provide an unrestrictive systemic blood flow while balancing the
pulmonary flow. Stage II involves the Bi-directional Glenn/ comprehensive stage II, and
this surgical procedure aims to lower the load on the right ventricle and provide low97
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pressure pulmonary flow. The BDG procedure involves removing mBT shunt and
dissection of SVC from the right atrium and anastomosed to Right Pulmonary Artery
(RPA). The comprehensive stage II is an alternative to BDG. Similar physiology is
established between comprehensive stage II and the Glenn procedure. An in-depth literature
survey is conducted towards the in-vitro and in-vivo simulations to address complications after
the BDG and comprehensive stage II procedure.
Complications involve unilateral pulmonary artery stenosis. An alternate approach is also

known as the Assisted Bi-directional Glenn surgical procedure, is also discussed. A novel
surgical technique to the comprehensive stage II has been discussed in the literature to reduce
surgical trauma in patients. The HCSII procedure reduces the surgical trauma and avoids

creating aortic arch reconstruction and Damus-Kyle Stansel (DKS) connection. The HCSII
procedure applies to patients with sufficient antegrade aortic flow to sustain upper body
perfusion. Stage III involves the Fontan procedure; this procedure aims to connect the
systemic and pulmonary circulations in series. An in-depth literature study focuses on extra
cardiac Fontan operation and PVR. To improve the efficacy of the stage III procedure, a
novel passive surgery technique is discussed using an injection jet.
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3. Methodology
3.1. Anatomical model
3.1.1. HCSII
Arnold Palmer Children’s Hospital provided the patient-specific angiogram data to develop
the phantom for in-vitro simulation. Figure 23 A and B represents the native ascending
aorta, right subclavian artery (RSA), right carotid artery (RCA), left subclavian artery
(LSA), and left carotid artery (LCA). The diameters of the native ascending aorta, RSA,
RCA, LSA, and LCA were 9.96 mm , 4.53 mm ,4.53 mm , 5.75 mm , 4.36 mm . The lengths
of the native ascending aorta and LSA and LCA combined length was 29.19 mm , 13.21

mm . Figure 23 C and D represent the Glenn procedure performed. Figure 24 A, B, C, D
represents the aortic root and its dimensions. The main pulmonary artery (MPA) root, the
aortic arch, and the descending aorta having diameters of 22.67 mm , 8.26 mm (averaged),
and 9.88 mm . The lengths of the MPA root, the aortic arch, and the descending aorta were
20.68 mm , 20.59 mm , and 43.06 mm . DeCampli et al. mention that the hybrid
comprehensive stage II technique avoids creating Damus-Kyle-Stansel (DKS) connection
and aortic arch reconstruction. The HCS II procedure also involves suturing of baffle using
a pulmonary homograft material within the pulmonary bifurcation from the right to the
LPA orifice. By preserving every eigen feature of the physiology, the phantom was
designed to validate the clinical study conducted by performing in-vitro simulations. The
information obtained from the angiogram of three de-identified patients was used to design
the phantom.
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Figure 23 Angiogram data of three de-identified patients provided by Arnold Palmer
Children’s Hospital

Figure 24 Angiogram data representing the aortic root and their dimensions
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The development of the centerpiece is a two-part process; the top half contains all the
conduits designed based on the angiogram data. The conduits in the phantom represent the
diminutive aorta, MPA, LPA, and RPA. Since the RSA, RCA, LSA, and LCA diameters
are lower than other sections, a single conduit was designed to represent the upper
circulation. The diameter of this conduit is the summation of RSA, RCA, LSA, and LCA
diameters. Following the physiological procedure, the phantom is designed without the
patent ductus arteriosus, DKS connection, and the native aortic arch remains natural. The
region corresponding to the patent ductus arteriosus is stenosed. The main constrain to be
followed during the design stage was no baffle movement and the stent. An elliptical
section was designed on the MPA to place the baffle; the stent below the baffle. To
integrate the centerpiece with the MFL, barbed conduits are designed at six locations. The
pressure sensors are placed over the barbed conduits to obtain the phantom's hemodynamic
parameters for each heart cycle during in-vitro simulations. The bottom half of the
centerpiece covers the pulmonary arteries once the baffle and the stent are placed in their
respective locations. The top and the bottom half of the phantom were designed using
CATIAv.5 (Dassault Systèmes). Figure 25 shows the development of a 3D CAD model
using angiogram data.
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Figure 25 Development of 3D CAD model of HCSII centerpiece from angiogram A.
Diameter of RCA, RSA, LCA and LSA B. Diameter of MPA root C. 3D CAD model on
CATIAv.5 D. Diameters of the aortic arch and descending aorta E. Diameter of
ascending aorta F. Diameter of MPA

Figure 26 3D phantom printed with the conduits

Figure 26 represents the 3D printed centerpiece with labeled conduits
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In Figure 26, section 1 represents the flow towards the upper body. Section 2 and section
6 are connected together to form the PA (pulmonary artery). Section 3 forms ascending
aort, section 4 forms main pulmonary artery and section 5 forms descending aorta in the
3-D phantom.
3.1.1.1.

Initial Design

To increase the rigidity of the phantom, a rectangular block was added to the top half.
Figure 27 shows the initial design of the centerpiece with the rectangular block. Figure 27
A represents the native aorta being stenosed. Figure 27 B represents the front view of the
centerpiece along with the rectangular block. Figure 27 C represents the interior view of
the top half with the baffle location. Figure 27 D represents the side view featuring the
LPA-RPA conduit.
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Figure 27 Design 1 of the top half of the centerpiece A. Ascending aorta is stenosed B.
HCS II centerpiece within the rectangular block C. Interior view of the centerpiece with
rails D. Side view of the top half
The bottom half of the phantom was designed for easy accessibility of baffle and stent. The
bottom half was machined using acrylic, as seen in Figure 28 A. Lasers were used to
illuminate the characteristic features of the stent. To accommodate the addition of the laser,
three slots of equal diameter at an equidistant were extruded. To avoid stent migration
during in-vitro simulation, two equal diameter stubs at an equidistant were extruded. The
laser slots and stent stopper feature are represented in Figure 28 B. Two slots of equal
diameter were created at the opposite ends, and extruded cut was performed at an angle as
shown in Figure 28 C to capture the stent and baffle's movement using a camera.

Figure 28 Design 1 of the bottom half of the centerpiece A. Bottom half of centerpiece
with stent stopper and slots for laser C. Slots to place the camera
Two sets of rails were designed to reduce the slipping that could occur between the top and
bottom half and integrate both halves. The top and bottom half of the phantom went through
two iterative design changes. The initial prototype could not maintain the flow separation
between the pulmonary trunk and the pulmonary arteries. The barbed ends broke as they
could not sustain loads of the connectors used. Leakage was visible during the
experimentation due to the improper material selection for the baffle.
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3.1.1.2.

Design Iteration 1

The first iteration does not involve any changes to the conduits that represent the
physiological condition. Figure 29 A shows changes made to the bottom half of the
phantom to place an otoscope. To follow the exact procedure mentioned by DeCampli et
al. [115] for the baffle, a clip was designed to constrain the baffle movement; the clip is
placed onto the top half of the phantom, as seen in Figure 29 C. The railings designed to
ease the mating were removed, as seen in Figure 29 D.

Figure 29 Design iteration 1 for top and bottom half of the centerpiece A. Changes made
to the machined part with a slot for otoscope B. View of the centerpiece. C. Clamp
designed to hold the baffle D. Interior view of the top half of the centerpiece
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3.1.1.3.

Design Iteration 2

The second iteration involved considerable changes to the top half of the phantom. In this
design, the rectangular block was increased in length and breadth, as seen in Figure 30 A.
The barbed connectors protruding outside were removed, as seen in Figure 30 B. A step
cut feature was developed on the bottom half of the phantom. Figure 30 C shows the step
cut design such that the specula of the camera would touch the bottom to focus on a specific
area of the stent.

Figure 30 Design iteration 2 for top and bottom half of the centerpiece A. Interior view of
the top half and B. Front view of the top half C. Back view with the square slot

3.1.1.4.

Final Design

The final design of the phantom involves the modifications that were carried out in the
design iteration process 2. Extra layers on the bottom half were removed from the previous
design, and a layer of a gasket was added to avoid leaks, as seen in Figure 31 A. A throughhole feature was developed on the top half for the extended length, as seen in Figure 31 C.
To accommodate commercially available barb connectors to integrate the phantom with
the MFL, threading operations were performed on the remaining circular slots on the
centerpiece. Figure 32 A represents the 3D printed centerpiece. Figure 32 B represents the
top half of the rectangular block with the baffle placed behind the MPA section. Figure 32
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C represents the bottom half of the centerpiece with stent and gasket. Figure 32 D
represents the machined backplate with two slots extruded for laser slots.

Figure 31 Final design of centerpiece A. Gasket B. Front view of the top half of
centerpiece C. Interior view of top half D. Side view of the backplate E. Stent
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Figure 32 3D printed and machined centerpiece A. HSCII centerpiece B. The top half of
centerpiece with baffle C. Bottom half of centerpiece with stent and gasket D. machined
backplate

3.1.2. Fontan IJS
The in vitro study was modeled to validate the in-silico simulation of the Fontan patient
[222]. modeled the baseline TCPC on SolidWorks (Dassault Systèmes) using an averaged
dimensions of 2-4-year-old Fontan patient. Four models’ configurations were developed,
including the baseline, IJS, NES, and IJS with pulmonary artery radius increase. To
accommodate the increase in the pulmonary flow, the cross-sectional flow area of the

Qi
pulmonary arteries was modeled using the Poiseuille flow
Qf

4

 ri 
  . Keeping the
 rf 

correlation of the in-silico model, the 3D phantom was developed. The process involved
developing the TCPC and the IJS prototype with diameters of 2 mm , 3 mm , and 4 mm .
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The TCPC was developed by calculating the diameters of RPA, LPA, SVC, and IVC as 6

mm , 9 mm , 12 mm , and 18 mm . Their corresponding lengths of RPA and LPA were 40
mm and for SVC and IVC were 23 mm and 56 mm . A two-part process was carried out to
develop the top and the bottom half. The TCPC was developed using Acrylonitrile
butadiene styrene (ABS) and manufactured by 3D printing technology. Post
manufacturing, the top and bottom half are joined together using a sealant. The ends of the
TCPC are clamped when connected to the MFL.
The IJS was developed in three pairs having an internal diameter of 2 mm , 3 mm , and
4mm. The nozzle is placed on top of a coupler with a total length of 135.7 mm . The
diameter at the center section is 20 mm at the center and 9 mm at the ends. The IJS is
intruded into the LPA and RPA, and the nozzle orient parallels to the flow direction. The
role of IJS is to introduce an entrainment jet that flows concentrically to the pulmonary
artery flow. The entrainment jet exchanges momentum with the flow in the pulmonary
arteries, decreasing the localized vascular resistance in TCPC and decreasing the IVC
pressure. Figure 33 shows the 2D drawing of various IJS developed along with the 3D
printed prototypes. To ensure the concentricity of the flow, the diameter of the IJS
increases at the entrainment point. The cross-sectional area of the conduits is increased to
accommodate the excess flow and reduce the flow momentum effect. The IJS was coated
with a sealant to avoid any leaks during the experiment.
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Figure 33 2D drawing of 2mm, 3mm, and 4mm IJS (L), 3D printed IJS prototype

3.1.2.1.

Fontan model version 1

The in vitro study was modeled to validate the in-silico simulation of the Fontan patient.
The in-silico study involves patients' anatomies within 2-5 years of age, with a BSA of 0.7
m2 . The traditional Fontan procedure with fenestration is considered as the baseline for

the in-vitro study. The fenestrated 2Y graft TCPC connection with the proposed IJS at IVC
is another development. The fenestration having a diameter of 4.75 mm and length of 17.5

mm is located at the bifurcation of the Fontan conduit. The fenestration contributes to the
IVC pressure drop. In the proposed model, the IJS is designed to be collinear with the
fenestration. The excess fluid being injected is captured by the fenestration, thereby
enhancing the entrainment. Systemic oxygen saturation remains as part of the IJS flow
absorbed in the fenestration. Figure 34 A. represents the elliptical profile. Figure 34 B.
represents the IJS shunt. Figure 34 C. represents the diamond profile, and Figure 34 D.
represents the circular profile.
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The first iteration involves the development of TCPC using acrylic that was machined. A
two-part process was performed to carry out the manufacturing process. The TCPC was
modeled at a length, width, and thickness of 196 mm , 171 mm , and 34 mm . The diameters
of conduits for SVC and LPA were 11 mm , 9 mm for RPA, and 18 mm for IVC. A plane
along the LPA-RPA dissects the centerpiece into two parts. To integrate the TCPC
centerpiece with the MFL, four aluminum adapters of length 76 mm , width 25 mm , and
32 mm thick were machined.

Figure 34 2mm IJS shunt A. elliptical profile B. Side view of the IJS shunt C. Diamond profile D.
Circular profile

3.1.2.2.

Fontan model version 2

The second version involves the development of TCPC along with the IJS as a two-part
process. The fenestrated 2Y graft TCPC Fontan geometry was 3D printed by preserving
the physiological parameters of the in-silico model. For the in-vitro simulations, the
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conduits that represent the 2Y are simplified to a single conduit. The diameters of SVC,
LPA, and RPA are 12.7 mm , and IVC diameter is 19.05 mm . The TCPC is split into two
blocks. The top block contains the conduits representing the SVC, LPA, RPA, and fraction
of IVC conduit. The fenestration is developed at the bifurcation of the Fontan conduit.
A parametric study is being conducted on the different IJS types that could yield the
optimum pressure drop across the IVC. Four versions of the bottom blocks have currently
been developed that house the IJS. The versions are classified based on the shape and
number of the nozzles. The IJS nozzles are conically tapered and chamfered at the outlet
section and are collinear to the fenestration. Threaded bolts are used on the either side of
the IVC to integrate the top and bottom block. A lip with a compression fitting gasket is
implemented into the design to provide a tight fit.
Figure 35 shows a 2D model of the 2Y TCPC. Figure 35 A shows the side view
representing the lip section's dimensions for compression and the dimension related to the
IJS. Figure 35 B represents the front view of the TCPC centerpiece and the dimensions of
the top and bottom block. Figure 35 C represents the interior view of the bottom block
showing the two circular profiles of the IJS nozzle, each having a diameter of 1.41 mm .
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Figure 35 A Side view representing lip section and IJS dimension B. TCPC front view C. Interior
view of the bottom block with two circular profiles of the IJS nozzle

Figure 36 A represents the side view of the centerpiece Figure 36 B represents the front
view of the TCPC centerpiece and the lengths of SVC, IVC, RPA, and LPA. Figure 36 C
represents the interior view of the bottom block showing the two elliptical profiles of the
IJS nozzle.
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Figure 36 A. Side view of the TCPC B. TCPC front view with the length of the conduits C.
Interior view of the bottom block with two elliptical profiles of the IJS nozzle

Figure 37 A represents the interior view of the bottom block showing a single circular
profile of the IJS nozzle having a diameter of 2 mm . Figure 37 B shows the front view of
the TCPC and the diameters of SVC, IVC, LPA, and RPA.

Figure 37 A. Interior view of the bottom block with one circular profile of the IJS nozzle B. Front
view TCPC with the diameter of conduits
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Figure 38 A represents the side view of the centerpiece and the dimensions of the IJS
leading to the fenestration. Figure 38 B represents the front view of the centerpiece and the
dimensions of rectangular fittings designed to integrate the centerpiece with the MFL.
Figure 38 C represents the bottom block's interior view showing the IJS nozzle's one
elliptical profile.

Figure 38 A Side view of TCPC with IJS at fenestration site B. Front view of TCPC with adapters
C. Interior view of the bottom block with one elliptical profile of the IJS nozzle
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3.2. Lumped Parameter Model
As described in section 2.2, the LPM is an electric analogy used to replicate the circulatory
system of human circulation. Using this electric analogy, blood flow through various
sections in the cardiovascular system can be lumped and represented as electrical circuits
that include resistors, inductors, and capacitors. Each of these elements represents vascular
resistance, vascular inertance, and vascular compliance. As discussed in section 2.2,
different LPM setups have been modeled to experimentally replicate various reconstructed
cardiovascular physiologies in the last few decades. The main goal of the LPM setup is to
couple the fluid dynamic behavior within the 3D phantom to the dynamics of the peripheral
circulation.
To achieve the research objectives established in each problem statement, a specific LPM
has been modeled to replicate the proposed reconstructed physiology. Ideally, a
Windkessel compartment in the LPM consists of an arterial bed and venous bed. The
arterial bed is developed using an inductor, resistor, and capacitor, while the venous bed is
developed using the resistor and capacitor. In our experimental studies, each Windkessel
compartment is modeled by lumping the arterial and venous beds together, as shown in
Figure 39. Each Windkessel compartment consists of two elements, i.e., a resistor and
capacitor.
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Figure 39 Lumped Arterial and Venous bed coupled for LPM development

In this study, reduced-order LPMs have been modeled to develop both MFL setups.
Hence it is sufficient to control the correct overall resistance and compliance in each
branch of the system.
Vascular resistance:
Inlet and outlet pressures are tuned in the MFL. These inlet and outlet pressures generate
the pressure differential. This static pressure differential causes the flow to occur in the
system. The conduits in the MFL provide a certain amount of resistance, but additional
resistance is provided to the system by valves. As discussed in 2.2.1, resistance in a fluid
circuit is defined in (4) by Scotten et al. [176]. The pressure drop across each branch is
achieved by tuning the resistance in the conduits of MFL. As a result, the blood analog
will flow through each conduit across this pressure drop in the MFL setups. In this study,
resistance in each conduit of the MFL is achieved by placing a needle valve. Resistances
in each compartment of the MFL can be tuned by throttling the respective needle valve.
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Head loss across a valve is proportional to the velocity, head of a fluid [223] as shown in
Equation (13)
2

V
h  K
g

(13)

where h is defined head loss, K is the loss coefficient that is dictated by the position of
the valve, V is the average velocity of the fluid, g is the gravitational constant.
The needle valve resistors are manually actuated and precise. These resistors have a range
of seven color bands, and each color band has a setting ranging from 0-9, as shown in
Figure 40. The pressure drop produced across the needle valves is linear that majorly
contributes to the successful tuning of the MFL rigs.

Figure 40: Needle valve to replicate vascular resistnace in MFL

Vascular Inertance:
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Inductors affect only non-steady systems. In fluids, inertance is defined as the pressure
gradient to accelerate the flow. It is a parameter that describes how rapidly pressure field
changes will affect the flow field in the system. The inertance is defined by Equation (14)

L

2 x
A

(14)

In both of the discussed MFL setups, the inertance is captured by the length of the
vasculature. A specific length for each vasculature cannot be modeled as the arteries and
venous network of a human circulation are extremely long.
Vascular Compliance:
In biofluid mechanics, vascular compliance refers to the change in stored energy in a vessel
for a given change in pressure in the time domain. It is entirely analogous to capacitance
in electrical circuits. Like an inductor, this parameter does not affect the behavior of a
steady system. This parameter is critical in accurately modeling the effects of distensibility
of the arterial and venous beds in MFL, as described in Equation (10) from section 2.2.3.
Specific annular design-based compliance chambers have been developed to produce the
desired compliance (C) in this study. These compliance chambers are capable of matching
specific compliance in a Windkessel bed by altering the volume of the chambers for a
change in dynamic pressure of the fluid generated across that chamber in the MFL. In this
setup, a pair of concentric tubes were used to create the annular inner section of the
compliance chamber. The outer tube of the compliance chamber was constructed using the
clear schedule 40 and 80 pipes, and the inner wall is constructed by using solid Delrin rods,
as shown in Figure 41.
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Figure 41 Design of annular compliance chamber replicating the vascular compliances.

To obtain the effective radius, the outer diameter of the compliance chamber was constant
while the inner diameter varied for simulating different patient-specific cases. Using this
volume-controllable approach, no parameter such as entrapped pressure changes during an
MFL run reduces the uncertainty of the analysis. The Equations (15)-(17) show
relationships between the pressure and volume of the compliance chamber with the
effective radius,

Q(t ) 

d
{C (t )[ P(t )  Pg (t )]}
dt
t

1
P(t )   Q(t ).dt
C 
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(15)

(16)

121
C (t ) 

V (t )  Vo
 P (t )

(17)

To achieve the desired compliance value for the vascular compliance elements, the above
equation can be modified to describe the compliance as a function of the
compliance element geometry and fluid parameters as seen in Equations (18)-(20)

C

V
P

(18)

 re2 h
C
 gh

(19)

 gC


(20)

re 

Where re is the effective radius of the cylindrical compliance chamber.
In the following subsections 3.2.1 and 3.2.2, the construction of LPM for HCSII and
Fontan circulations has been discussed.

121

122
3.2.1. Lumped Parameter Model for HCSII

Figure 42 LPM representation of HCSII

As described above in 3.2, a complex circulatory system can be reduced to its equivalent
mathematical circuit for analysis using the lumped parameter modeling technique.
The reduced LPM used in this study derived from the full-scale LPM model of Hameed et
al. [224] The full-scale LPM is not practically feasible in a laboratory benchtop realization.
Tuning such an MFL with a full-scale LPM circuit would be difficult. Furthermore, the
number of elements requiring connectors and tubing would create too much inertance. The
full-scale LPM is reduced to a branched LPM of equivalent impedance to create a
practically feasible system. In-vitro study on HCSII circulation was conducted through a
dynamically scaled Mock Flow Loop (MFL) using patient-specific geometry. The MFL
was modeled to resemble the physiological anatomy of a patient with 0.34 m2 BSA. In this
MFL setup, the lumped compartments representing the peripheral circulations of the
patient are connected to the 3-D phantom of the HCSII geometry. The MFL consists of
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four compartments, and each compartment is developed with two elemental (i.e., resistance
and compliance) Windkessel models. Four compartments represent upper systemic, lower
systemic, right, and left pulmonary circulations, as shown in Figure 42. Each lump
represents the arterial and venous vasculature found within the physiological anatomy. The
voltage source represents the right ventricle. The ventricular septal defect (VSD) is not
modeled in the 3-D phantom but is represented in the LPM circuit. To replicate the VSD,
two resistor valves are placed between the bifurcation junction (upstream of the right
ventricle) and the inlet of the MPA and Asc. Aorta in the 3-D phantom. This study focuses
on the flowfield developed in the HCSII geometry; hence, the BDG section is in the LPM
circuit as shown in Figure 42. Every branch in the reduced LPM contains circuit elements
that correspond with a device in the MFL that serves as a physical realization of that
parameter. Table 2 Compliance values for MFL represent the compliance values
considered in each lump while conducting the experimental study.
Table 2 Compliance values for MFL

Compliance Value

Effective Diameter

 ml / mmHg 

 in 

C_upper

0.603

1.304

C_lower

0.735

1.276

C_lpa

0.640

1.295

C_rpa

0.640

1.295

Compliance sections in
MFL
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3.2.2. Lumped Parameter for Fontan

Figure 43 LPM representation of Fontan

Ni. et al. have developed a detailed full-scale LPM of Fontan circulation. This LPM
consists of carotid, subclavian, right pulmonary, left pulmonary, lower body, Fontan
TCPC, and coronary compartments. Each compartment contains an arterial and venous
bed. In this full-scale LPM model, every arterial bed is modeled with a three-element
Windkessel model. As discussed in the above paragraph 3.2.1, a laboratory benchtop
realization based on full-scale LPM is not practically feasible. Hence the MFL setup for
the Fontan circulation involved in this study is based on a reduced-order LPM derived from
Ni. et al. . The hydrodynamic variables measured in this study are the systemic arterial
pressure, the flow rates in arterial and venous branches, the pressures and flow rates at the
location of the Fontan connection, and the pressure at the end of the system in the atrium.
The reduced-order LPM modeled to develop the MFL consists of four compartments. As
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mentioned in section 3.2, every compartment of this model is developed with two elements
i.e., resistance and capacitance, as shown in Figure 43. This LPM has two systemic and
two pulmonary compartments. Two systemic compartments represent upper and lower
systemic circulations, and two pulmonary compartments represent right and left pulmonary
circulations, respectively. Each branch in the MFL contains a device that corresponds to a
circuit element of the reduced LPM. As mentioned in section 1.2, pulsatility plays a crucial
role in the hemodynamic behavior on the arterial side. Also, the arterial network and
capillary system of the systemic circulation provide significant vascular reistance and
vascular compliance to the flow field. These arterial networks act as low pass filters to the
pulsatile flowfield and effectively dampens out most of the pulsatility in the blood flow by
the time it reaches the TCPC. Furthermore, the Fontan circulation is especially less
pulsatile on the venous side due to the absence of the ventricle. In this study, the remaining
pulsatility from the cardiac cycle is not modeled. To accurately replicate the infant anatomy
while conducting the Fontan experiment, the values of compliance were determined based
on physiological values that correspond to body surface area (BSA) of 1.2 m2 .defined in
[64]
Table 3 shows the values of vascular compliances corresponding to different anatomical
sections.
Table 3 Vascular compliance of sections
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Upper compliance (Cupper)

3.12 ± 0.03

TCPC compliance (CTCPC)

0

IVC compliance (CIVC)

0.055

Liver compliance (Cliver)

4.41 ± 0.03

Lower compliance (Clb)

3.86 ± 0.06

Right compliance (Cright)

0.066

Left compliance (Cleft)

0.066

Due to the relative similarity between the IJS Fontan Mock Flow Loop used in this
experiment and the reduced lumped parameter network model utilized in, all but the
lower systemic compliance could be carried over. To calculate the lower systemic
compliance, the liver compliance and lower body compliance are combined in Equation
(21)
1

Clower

 1
1 


  Civc
C
C
liver 
 lb

Therefore, the resulting compliance values used in this experiment are given below in
Table 4
Table 4: Compliance values used for MFL
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(21)
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Vascular Compliance
Vascular Branch

 ml

mmHg 

Effective Radius

 in 

Cupper, Upper Systemic

3.12

0.3365

Clower, Lower Systemic

3.86

0.3742

Cleft, Left Pulmonary Artery

2.14

0.2787

Cright, Right Pulmonary Artery

2.14

0.2787

3.3. PVR
Pulmonary vascular resistance (PVR) is an essential hemodynamic quantity that is very
indicative of Fontan surgeries' outcomes. Abnormal growth of the pulmonary vasculature
and significant collateral flow can significantly alter PVR, leading to cardiovascular
malfunctions. In particular, elevated PVR can cause pulmonary hypertension, which
strongly affects the Fontan patient’s wellbeing. Several studies point to the possibility of a
strong correlation between pulmonary flow and PVR . The study attempts to quantify
changes in PVR between rest and exercise conditions induced by dobutamine
administration, which directly affects the heart rate and stroke volume. The data reveals
a negative correlation whereby an increase in pulmonary flow induces a drop in PVR.
This observation becomes of particular importance for our study as implementing an IJS
significantly enhances pulmonary flow. In the absence of any PVR response, the additional
flow would cause an increase in IVC pressure; however, if PVR decrease could be
considered, the additional flow would not build up in the Fontan circulation. A PVR drop
alone would negate any IVC pressure increase due to fluid build-up as well as potentially
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be directly responsible for additional pressure reduction. With the accommodation of the
IJS flow, if flow entrainment occurs, the IJS can directly cause a significant pressure drop.
Based on the data presented by Schmitt et al. [150] it is possible to derive a curve relating
the percent change is PVR with the percent change is pulmonary flow. Out of the ten
patients presented in the study, two were considered non-responders as the PVR hardly
changed following dobutamine administration although the observed flowrates reacted
accordingly. Due to the low population in this study the resulting statistical analysis an
accurate trend cannot be extracted, but nonetheless, it can be observed. As shown in Figure
44, for an increasing 𝑄𝑃 the PVR does in fact drop.

Figure 44 Correlation for percent PVR change too percent pulmonary flow change

The plot suggests that the PVR percent change lies in the region of 30−40% for a
maximum. This study will use these results to sequentially drop PVR following IJS
activation to observe what happens to the IVC pressure. This study will use these results
to sequentially drop PVR following IJS activation to observe what happens to the IVC
pressure.
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3.3.1. Pulmonary Vascular Resistance Calibration
The relationship between flow rate and needle valve resistance must be determined to
implement the PVR drop to increase pulmonary flow. To evaluate the pulmonary
resistances, a simple flow loop is set up with a continuous flow pump. The needle valve
resistance is calculated by measuring the pressure upstream and downstream of the valve
in conjunction with the flow rate Figure 45. Ohm’s law relates the scalar valve resistance
to the mean pressure gradient ratio to the flow rate. All the valve settings are tested for
three flow rates 1.45 L

min

, 1.75 L

min

, and 2 L

min

. The calibration procedure is carried

out on the right and left pulmonary resistances. Figure 45 B presents the most significant
range of valve settings tested for calibration. The curve shows that for the same valve
setting but incremental flow rates , the valve resistance grows. This becomes more evident
for more restricting valve settings (green to blue).

Figure 45 A. Resistance calibration loop and B calibration curves for pulmonary resistances for
3 flow rates (1.45 L⁄min, 1.75 L⁄min and 2 L⁄min).
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3.4. PVR and entrainment quantification
The drop in PVR may be considered a concomitant effect as the fluid is injected into the
Fontan conduits. There is a scarcity of studies to relate this phenomenon; hence pediatric
interventionists from the Arnold Palmer Children Hospital proposed a protocol to quantify
this effect in both in-vitro and in-vivo studies. This experiment is independent compared
to the IJS in the Fontan study but will support IJS placement in PAs. The efficacy of the
experiment, i.e., to study the variation in hemodynamic parameters when injections push
the fluid into the PAs, is obtained through this in vivo study. A keen interest is shown
towards the coronary effect that could arise during this process.
Table 5 shows the protocol provided by the pediatric interventionist. The protocol was
developed based on the instantaneous

Qp
Qs

equal of 1.5 with the injections and the cardiac

output of 2.5 L / min . The protocols are divided based on short multiple injections and
single long injections. The short multiple injections were further subdivided into five bursts
and ten bursts. The flow rate of the injection fluid was classified into 5 cc / s , 10 cc / s , 15
cc / s , and 20 cc / s . The total volume of the fluid injected depends on the number of

bursts and volume injected during each burst. For this experiment, the volume for each
burst was classified into 20 cc ,15 cc ,10 cc , and 5 cc .
Table 5 Injection protocols provided by clinicians at Arnold Palmer Hospital

Type of injection

Total volume ( cc )

Flowrate
( cc / s )

Short multiple injection

5

5  20cc injections (100 cc total volume)
5  15cc injections (75 cc total volume)
10  10cc injections (100cc total volume)
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10  5cc injections (50cc total volume)
10

5  20cc injections (100 cc total volume)
5  15cc injections (75 cc total volume)
10  10cc injections (100cc total volume)
10  5cc injections (50cc total volume)

15

5  20cc injections (100 cc total volume)
5  15cc injections (75 cc total volume)
10  10cc injections (100cc total volume)
10  5cc injections (50cc total volume)

20

5  20cc injections (100 cc total volume)
5  15cc injections (75 cc total volume)
10  10cc injections (100cc total volume)
10  5cc injections (50cc total volume)

Long single injection

5

1  50cc injection (50cc total volume)
1  100cc injections (100cc total volume)
1  150cc injections (150cc total volume)

10

1  50cc injection (50cc total volume)
1  100cc injections (100cc total volume)
1  150cc injections (150cc total volume)

15

1  50cc injection (50cc total volume)
1  100cc injections (100cc total volume)
1  150cc injections (150cc total volume)

20

1  50cc injection (50cc total volume)
1  100cc injections (100cc total volume)
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1  150cc injections (150cc total volume)

As shown in Figure 46, the key measurements in this study are the flow rates sampled at
each distal PA branch (LPA and RPA), upper body (SVC), and lower body (IVC)
circulations. As previously discussed, the pump settings determine the volume injected and
the volume flow rate per injection. This allows for a complete outlook of the flow field
properties upon injection: before, during, and after.

Figure 46 Fontan region of interest flow rate Q ̇ sampling schematic.

Two flow field properties have been identified to quantify the jet effect: entrainment and
jet relaxation time. Given a co-flow configuration with a high-speed jet surrounded by a
low-speed background flow, entrainment can be defined as the fluid transport across the
fluid-fluid interface caused by shear-induced turbulence resulting in an increased upstream
flow. Flow entrainment rate (𝑄̇𝑒𝑛𝑡 ) has been quantified in Equation (22)
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Qent  Qmeas , RPA  (Qbaseline , RPA  Qinj )

(22)

Where Qmeas , RPA is the measured flow rate distal of the injection site, Qbaseline , RPA is the
.

expected flow to RPA based on known Qs (systemic flow) and Pas flow split (set to 50-50)
and 𝑄̇𝑖𝑛𝑗 in the arranged injection rate. Entrainment results in a positive Qent , whereas
blockage would entail a negative Qent . Jet relaxation time is defined as the difference
between jet rise-time and fall-time. Rise-time can be understood as the time-spanning 10%
to 90% of the flow field response to the injection. Conversely, fall-time is the reverse
process as the jet winds down. We quantify the jet relaxation time trel in Equation (23)
trel  trise  t fall

(23)

Where trise is the rise-time and t fall is the fall-time. Positive trel indicates the low likelihood
of downstream fluid buildup as the co-flow takes longer to plateau than to dissipate the jet
effect. Negative trel would suggest a potential fluid buildup. Fluid buildup is an undesirable
feature in a Fontan circulation model where PVR is assumed constant. Jet relaxation time
is a particularly powerful quantification in the case of pulsed injection (closely resembling
actual physiology) as it could highlight a potential fluid buildup that would cascade over
many cycles.

3.5. Blood Analog
3.5.1. Newtonian and Non-Newtonian Fluid
Blood is considered to be a non-Newtonian, where the viscosity is inversely proportional
to the shear stress. The flow characteristic observed is approximated to a Newtonian fluid
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in large arteries [225] The blood carries the non-Newtonian properties at shear rates lower
than 100 s 1 . For in silico and in vitro simulations, the blood is considered to be a
Newtonian. The non-Newtonian behavior can affect the flow separation and the magnitude
of WSS. To validate the in-silico experiments using MFL, Newtonian and non-Newtonian
fluid were developed. For the HCSII and Fontan project, the Newtonian version of blood
was developed using water and glycerin. The non-Newtonian fluid consists of water,
glycerin, and nonlinear composition such as surfactant and corn starch compounds. A total
of thirteen fluids were developed to obtain the analogous version of blood used for in silico
simulation. The fluids were developed based on varying the percentage composition of
glycerin, water, and the nonlinear elements. Carreau-Yasuda model was used to develop
non-Newtonian blood using Equation (24)
.

 ( )    ( 0   )

(24)

1
.
1
2 3

[1  (  ) ]

0 is the zero-shear viscosity,   is the infinite-shear viscosity,  is the shear rate and
λ is the relaxation time constant

The viscosity was measured using The Digital Display Rotary Viscometer NDJ-55, as
shown in Figure 47. For the viscosity experiment, the rotational viscometer was chosen.
This viscometer has the advantage of operating continuously at a given shear rate, hence
preferred during the measurement of absolute viscosity. Viscosity is measured from a
rotating cylindrical rotor which varies in shape based on the fluid. Torque produced by the
rotor on the fluid depends on the radius of the rotor. The rotational viscometer identifies
the torque required to rotate the rotor at a constant speed when immersed in a fluid. The
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fluid shear stress is obtained from torque measurements at a given instance, thereby
determining the viscosity. The #0 rotor is used for fluids having viscosity values less than
15 mPa.s ; The rotor comes with a fixed sleeve, a test tube with and without a bottom, and
a fixed screw for the test tube. The test without the bottom was used to ensure the rotor
makes contact with the fluid. The test tube ensures that accurate measurements. A smaller
mirror allows the view of the rotor within the bottomless tube. The mirror ensures if the
rotor deflects on a specific side. If the rotor deflects, adjustments must be made to move
the rotor away from the test tube’s inner walls. The rotor should not touch the inner walls
of the test tube as it would generate skewed results. Further to the centering of the rotor,
water at room temperature is tested to ensure the viscometer measures accurately as the
viscosity of water is 1.002 mPa.s at 20 C

Figure 47 Viscometer used during the study
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Figure 48 Viscosity vs shear rate for non-Newtonian blood model

Figure 48 represents the plot that corresponds to the viscosity of non-Newtonian fluid vs.
theoretical value. Viscosity values that are away from the theoretical values due to large
standard deviations were eliminated. Three out of thirteen fluids developed matched closer
to the theoretical value having 20%, 40%, and 60 Hematocrit as shown in Figure 49. The
fluid with 42% ( 30ml) Glycerin + 44% (30.8ml) water + 13% (9.2ml) nonlinear
composition followed the viscosity profile that was similar to blood having 60%
Hematocrit. The fluid with 28.5% (20 ml) Glycerin + 57% (40 ml) water + 14.2% (10 ml)
nonlinear composition followed the viscosity profile that was similar to blood having 40%
Hematocrit. The fluid with 45% (18 ml) Glycerin + 52% (20.8 ml) water + 3% (1.2 ml)
nonlinear composition followed the viscosity profile that was similar to blood having 20%
Hematocrit.
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Figure 49 viscosity of non-Newtonian fluid vs theoretical value

3.6. Oxygenation model
3.6.1. Oxygenation model for HCSII
Santamore et al. [226] mentions the lack of natural animal models with HLHS defects. A
theoretical analysis was performed to determine the blood flow distribution between the
two circulations in terms of systemic oxygen delivery and its effect. A study was also
carried out to determine the effect on systemic oxygen delivery and cardiac output due to
bidirectional cavopulmonary anastomosis.
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Figure 50 Oxygenation model for HCSII

In the HCSII model, as shown in Figure 50 shows the right ventricle flow is distributed to
the upper and lower body circulation. Deoxygenated blood from the upper body flows
through the SVC to the PAs, and the blood from lower circulation flows through the IVC
to the right atrium. Flow split between the systemic and pulmonary flow is the primary
parameter for oxygen content. The oxygen model equations for HCSII are derived from
the approach carried out by Santamore et al. [226]. This is based on the oxygen uptake in
the pulmonary circulation, O2 consumption in the systemic circulation, and conservation
equation. Equation (25) represents the whole body oxygen consumption divided between
the upper body  .VO2 and lower body (1   )VO2

VO2   .VO2  (1   )VO2
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(25)
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Equation (26) represents the oxygen flow rate into the lower system as a product of lower
body blood flow QIVC and arterial blood content CaO2 . The lower body oxygen consumed
reduces the oxygen flow rate into the lower systemic circulation. The reduced oxygen flow
rate returns to the right atrium. BIVCO2 represents the oxygen content of the IVC blood.

CaO2 .QIVC  (1   )VO2  BIVCO2 .QIVC

(26)

Equation (27) represents the oxygen flow rate into the upper body system. The reduced
oxygen flow rate returns to the PA’s via the SVC
CaO2 .QSVC   VO2  CSVCO2 .QSVC

(27)

Equation (28) represents the PA’s blood flow is equal to the blood flow to the upper
systemic circulation. Equation (29) represents the total oxygen flow into the pulmonary
circulation and oxygen uptake into the lungs. This gives the oxygen flow rate that returns
to the atrium from the pulmonary circulation, CPVO2 representing the SVC blood's oxygen
content.
QP  QSVC

(28)

CSVCO2 .QSVC  VO2 , L  CPVO2 .QP

(29)

Equation (30) represents the relation between the total cardiac output to the upper and
lower systemic blood

CO  QIVC  QSVC  QIVC  QP

(30)

This is based on the assumption of a steady-state condition. Based on the law of mass
conservation at the cellular level, oxygen consumption and uptake must be equal
represented by Equation (31)
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VO2 , L  VO2   .VO2  (1   )VO2

(31)

CSVCO2 .QSVC from Equation (29) is replaced with Equation (27) and QP replaced by QSVC
substituted in Equation (31) gives

CaO 2 .QSVC  (1   ).VO 2  CPVO 2 .QSVC

(32)

From Equation (30)

CaO2 .CO  CPVO2 .CO  (1   )VO2  CaO2 .QIVC  CPVO2 .QIVC

(33)

CaO2 .QIVC  CPVO2 .QIVC  (1   )VO2 .QIVC / QSVC

(34)

Combining the Equation (33) and (34) gives rise to Equation (35)
CaO2 .CO  CPVO2 .CO 

1  QSVC / QIVC
.(1   ).VO2
QSVC / QIVC

(35)

3.6.2. Oxygenation model for Fontan
A good source of validation for cardiovascular experiments is to track the projected oxygen
transport across the model and evaluate the oxygen saturations in systemic and pulmonary
circulations.
The Fontan circulation can typically be considered a circuit in series. However, the addition
of a graft shunting flow from the aortic arch to the Fontan circuit generates a pseudoparallel circuit, as shown in Figure 51. The right ventricle (RV) generates a cardiac output
(CO) which splits in the systemic flow ( Qs ) and the injection jet shunt flow QIJS . In the
.

systemic circuit, oxygen consumption occurs ( C VO2 ), which depletes systemic oxygen
concentration ( CaO 2 ) to the systemic venous concentration ( C SCV O2 ) as described in
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.

equation 1. In the pulmonary circuit, the blood gains oxygen ( S V O2 ), increasing the
pulmonary arterial blood concentration ( CPAO2 ) to the pulmonary concentration ( CPVO2 ),
as modeled in Equation (36).

Figure 51 Oxygenation model for Fontan

.

(36)

.

(37)

C AO2 Qs  CVO2  CSVO 2 .Qs

CPAO 2 .Q p  S V O 2  CPVO 2 QP

The flow mixing between the systemic venous return and the systemic arterial flow shunted
by the IJS can be expressed as in Equation (38)
CSVO 2 .Qs  C AO2 QIJS  CPAO 2 .QP

141

(38)
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Based on the circuit schematic, it can be observed that that CPVO 2 QP  C AO2 .CO and
CO  Q p  Qs  QIJS which suggests that the systemic oxygen saturation matches the

pulmonary venous oxygen concentration. The oxygen consumption and assimilation are
.

.

assumed to occur under “steady” conditions hence C VO2  S VO2 . Using these observations
along with the balance equations derived, the systemic oxygen transport equation can be
expressed as in Equation (39) and (40)
C AO2 Qs  CPVO 2 CO

1
Q
1  IJS
QS

(39)

1
QP
QS

(40)

C AO2 Qs  CPVO 2 CO

These expressions require cycle-average flow rate inputs originating from experimental
measurements CO and literature-derived blood oxygen capacity and oxygen consumption
data. Pulmonary venous oxygen concentration is calculated from an assumed oxygen
saturation (100%, 95%, 90%, 85%, and 80%) depending on patient ventilation and a given
oxygen capacity 0.22 mLO2 /mLBlood . Oxygen consumption can be determined based on
literature derived per-weight oxygen consumption 9  mL / s  / kg ; hence the user must only
know the patient’s weight.
3.7. Stent and baffle characterization
Basic stent design involves successions of connectors and rings. Connectors withhold the
rings, thereby contributing to the longitudinal stability. Rings on the stent provide radial
support. Stent design and mechanical characteristics are defined based on the strut,
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connector, and the number of crowns. Based on the size of the vessel, the number of cells
and crowns change.
The stent used for the HCSII procedure and the in vitro simulations follow the Palmez stent
design; the Palmez Genesis Transhepatic Biliary Stent 2510B was used. The stent is
manufactured by laser-cut operation on a single piece Nitinol tube that follows a closedcell design. The need for a weldment is avoided by creating slots during the laser cut
operation; this manufacturing technique also improves the integrity of the stent. Scanning
Electron Microscope (SEM) imaging technique captured the characteristic features of the
stent. Figure 52 A and B represent the average length and width of the strut. Figure 52 C
and D represent the length and width of the spline feature. Figure 53 E represents the
distance between the strut and spline feature Figure 53 F represents the outer diameter of
the spline feature. Figure 52 G represents the diameter of the strut feature. Figure 53 H
represents the angle of the strut.
DeCampli et al. specifies the placement of the stent during the HCSII surgical procedure.
The proposed anastomosis site for RPA and SVC is opened, a longitudinal incision is made
into the pulmonary trunk to deploy the stent over a 9-2 Opta Pro balloon catheter. A guide
wire is then advanced incision made on RPA into the left lower lobe artery.
Table 6 represents the mechanical property of Nitinol material obtained by the annealing
technique. The mentioned mechanical properties will be used to compute the required
stresses for fatigue analysis. Table 7 represents the geometric parameter of the stent.
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Figure 52 Palmaz Genesis (PG) 2510B stent characteristic features obtained under SEM
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Figure 53 Palmaz Genesis (PG) 2510B stent characteristic features obtained under SEM
Table 6 Mechanical properties of Nitinol (annealed)

Mechanical property

Nitinol (annealed)

Young’s Modulus (E)

83 GPa

 

Yield Strength  yp

Ultimate tensile strength

195 MPa
1900 MPa
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Table 7 Geometric parameters of PG 2510B stent

Geometrical parameter

PG 2510B

Average length of the strut

2.445mm

Average width of the strut

193.866 µm

Average length of the spline

234.033 µm

Average width of the spline

112.6 µm

Angle between the strut line

91.2°

Diameter of the strut feature

618.4 µm

Inner diameter of the spline

182.8 µm

Outer diameter of the spline

419.9 µm

Alfonso et al. [227] mention that mismatches regarding mechanical/functional properties
between the vascular substitute and native vessel cause a higher failure rate in vascular
substitute. Commercially available substitutes all low compliance and a reduced distension capacity in physiological pulsations of the native arteries
The expanded polytetrafluoroethylene (ePTFE) grafts have different viscoelastic
characteristics compared to the native vessel.

Figure 54 Gore Preclude Pericardial Membrane

Gore preclude pericardial membrane made from ePTFE is the baffle material considered
during the HCSII surgical procedure and in-vitro simulations, as shown in Figure 54.
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DeCampli et al. specify the placement of the baffle during the HCSII surgical procedure.
The baffle material is sutured within the pulmonary bifurcation from the right to the LPA
orifice. To preserve this exact technique for the in vitro simulation, the baffle is placed
behind the MPA of the centerpiece. A clamp was designed and 3D printed in order to arrest
the movement of the baffle. The baffle and the stent complement each other, as the stent
protects the baffle from being crushed due to the high pressure from the systemic flow.
3.8. Fatigue Analysis
High stresses observed in the region of calcified plaque are sufficient to fracture the stent.
McGarry et al. [228] studied the mechanical performance of stents by modeling stents
based on the elasticity and isotropic hardening J2 flow theory ( von Mises flow theory).
Considering the size of the stent strut (< 0.1mm), microscale mechanical properties are
important. Crystal plasticity theory was used to develop the computational models; the
theory incorporated both the microscale deformation mechanism and microstructure.
Models having explicit grain representation is necessary as thin polycrystalline stent has a
small number of grains across the width. Modeling results showed smooth varying
localized stress and strain fields using the J2 flow theory compared to the crystal plastic
theory that predicted non-uniform and localized stress and strain fields. Elementary fatigue
analysis was performed by the application of pressure pulse to the stent model. Stresses
generated by the pulse were small compared to stresses during deployment and recoil.
Fatigue loading is vital for stent and modeling. In the crystal plasticity model, the rough
deformed stent surface can predict fatigue crack initiation and growth.
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Wei et al. [229] studied the structural and hemodynamic analyses to evaluate the
performance of six different stents. This included Palmaz-Schatz shaped, Xience Prime
shaped, and Cypher shaped. The other three stents were C-Rlink, C-Rcrown, and C-Astrut.
Different materials were assigned to the stents, most of them assigned with 316L stainless
steel. During this study, the Dogboning and recoiling phenomena were observed.
Dogboning refers to the expansion of the two ends of the stent larger than the center section;
this has a more significant effect on thrombosis and hyperplasia. Recoiling is defined as
the “spring back” due to the stent's elastic-plastic deformation.
Further to simulation, the maximum plastic strain for the six different shapes showed that
larger plastic strain values meant that the stent could sustain the deformation and results in
a more significant diameter change. The plastic strain value directly impacted the von
Mises stress as the change in diameter induced the stress. Combining structural and
hemodynamic properties, the Palmaz-Genesis stent performed better than the Xience Prime
and Cypher shaped.
Stents are prone to fail under various axial, circumstantial, radial loading, and other
anatomical bending. They also tend to fail due to buckling due to artery wall pressure.
The displacements in the x and y direction obtained are used to compute the strains in the
x and y-direction. Since no torque is involved, shear strain and strain in the z-direction are
excluded. Equations (41) and (42) are used to compute the  x strain in the x-direction and

 y the strain in the y-direction

x 

u
x
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v
y

(42)

Using the stress-strain relation,  x , the stress in x-direction and  y , the stress in ydirection are computed using Equations (43) and (44)

 x  E x

(43)

 y  E y

(44)

The principal stress  1, 2 of the stent is calculated using Equation (45). As the stent material
is ductile, the liberal failure criterion is used to understand if the stent fails for the given
loading conditions. Von-misses criterion, using von misses stress,  v along with a factor
of safety two is computed as shown in Equation (46)

 1, 2 

 x  y
2

  x  y 
2
 
   xy
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 v  12   1 2   22 
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High cycle fatigue involves elastically applied stress and a large number of cycles to
failure. The stress on the component is low, and plastic deformation can occur at any crack
tip within the elastic region. Fatigue life is defined as the number of cycles to failure at a
specified stress value. The number of cycles to failure increases as the applied stress level
decreases. The number of cycles to failure is also determined by the crack growth rate, i.e.,
the change in the crack length for each cycle. Stress concentrations exist due to the crack
presence. Figure 55 shows the relation between the cyclic stress intensity factor and the
crack growth rate. Region I represent no crack growth until K reaches the Kth (threshold
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value). Once the threshold value is attained, the crack growth is at a rapid phase. Region II
and III represent the steady-state crack growth and unsteady crack growth.

Figure 55 Relation between cyclic stress intensity and crack growth rate

The Paris power law is used to compute the number of cycles to failure, Equation (47).
da
is the crack growth rate, K is the difference of maximum and minimum stress
dN

intensity factor. C and m are material constants. In this study, two critical locations were
considered for the crack to initiate, and based on the critical crack length, the number of
cycles to failure change

da
 C K m
dN

(47)

The analytical approach to compute the number of cycles to failures involves computing
the various stresses acting on the stent due to the MPA pressure and baffle. Considering
the stent to be a cylindrical element, circumferential stress, axial stress, radial stress, and
shear stress are defined using the thin wall cylinder theory. As per the boundary conditions
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established, the stent goes through a uniform loading acting on one side of the
circumference.
In this experiment, there exists no axial stress due to the absence of axial loading. The
method involves computing the hoop stress  h of the stent with the given MPA pressure.
Equation (48) represents the hoop stress, where p is the pressure acting on the stent, r is
the radius and t is the thickness of the stent

h 

pr
t

(48)

Using Von-misses and criterion and Paris law, the number of cycles to failure can be
predicted. The experimental and analytical study can be validated if the stent will sustain
the loading condition or fail after the surgical procedure.
3.9. Otoscope
The newly formed Intra-pulmonary junction is 18mm in length and 13mm in width on an
8mm diameter cylindrical surface to measure the normal loading on the baffle surface and
shear stress due to the fluid flow over the baffle surface. To measure the stress, different
techniques were analyzed. As stress is a measure of a local variable and it changes based
on the surface. Hence, strain measurement was considered a global variable, from strain
compound stress acting on the baffle, can be identified. Due to the complexity of the
patient-specific geometry, various measuring techniques were analyzed. Also, the
experiment will be running for 12 days continuously. Hence waterproof and sensor
reliability are considered.
Some of the techniques considered during the literature survey are Force (Piezoelectric)
Sensors, Strain gauges, Pressure sensors, Micro Electronic Mechanical Systems (MEMS)
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based sensors, Non-intrusive optical measurement techniques, and intrusive optical
measurement techniques.
Many sensors were ruled out because of the very small dimension and the need for
flexibility in the sensing element. Force sensors are not considered because of the
measurement of stress instead of strain. Strain gauges and pressure couldn’t be used as it
excited when to bend to our desired shape. MEMS were considered for best options for
this case, but no such off-the-shelf sensors are available; they need to be fabricated as a
custom product. The fabrication time usually takes a minimum of 6-8 months with testing
and verification, so these sensors were not used. As the entire geometry is complex in
shape, rapid prototyping was considered an option for developing a centerpiece. As the
region of interest is below the pulmonary artery, a direct view of the baffle is obstructed
even when printed using a transparent material. In the end, intrusive optical measurements
were considered.
Design limitation in selecting intrusive cameras is that the diameter of the probe should be
less than 5mm as the total diameter of the pulmonary arteries is 8mm. The cut section of
the pulmonary artery allows the opening of 5.2mm to view the baffle. The camera probe
should not block the flow passing through the pulmonary artery. Hence endoscopic camera
and borescopes were considered as an option to get the video of the deformation of baffle—
another limitation in the fluid that passes through the pulmonary artery. The camera should
be able to view the distal end of the pulmonary artery when fluid is passing. The borescope
camera lacks clarity, and fixed focus also lacks magnification. In the end, Firefly, Digital
Video Otoscope, as shown in Figure 56 A. Otoscope angle and ditance B. Slot for otoscope
C. Side view of Otoscope and stent D. The Firefly Digital Video Otoscope, is considered
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due to its magnification ability similar to the microscope and varying focus but came with
a drawback as it’s not waterproof. Hence camera should place away from the surface by
keeping a transparent material. The specula provided with the camera is 3 and 4 mm in
diameter, which suits our requirement.
The Firefly Digital Video Otoscope became the preferred device to capture the stent and
baffle movement. For a wider field of area, the 4mm probe is selected. The Digital otoscope
has a proper 1.3 Megapixel resolution and a variable magnification up to 150X (digitally)
and up to 50X (Optically). Video is captured at a rate of 30 fps. The software comes with
a measuring tool and recording tool for easy post-processing of the images for dimensions.
Placing the camera at an angle and capturing the whole stent was the constrain as
components blocked the lens in the centerpiece. Hand calculations show that the camera
should be placed 19.263mm from the proximal end of the stent and 4.84mm in depth at an
angle of 24.333⁰. The values are computed based on the CAD design discussed in section
3.1.1.3. The specula are not interfering with any components of the centerpiece and can
view three markers on the stent along the length.
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Figure 56 A. Otoscope angle and ditance B. Slot for otoscope C. Side view of Otoscope and stent
D. The Firefly Digital Video Otoscope

3.10.

Uncertainty

Uncertainty quantification is the process in which the uncertainties are characterized
quantitatively and reduced in an application. Their likelihood of specific outcomes is
determined if some aspects of the system are not known. Uncertainty existence is possible
in a mathematical and experimental model, which can be categorized into various sources
such as parameter, structural, exponential, interpolation, aleatoric and epistemic.
Experiments mentioned in this report use the sensors to obtain the required output.
Uncertainty of sensors can be classified into three types, point, interval, and probabilistic.
3.10.1. Type B Estimates
Type B Estimate is used when the statistics of error distribution is done by knowledge of
the error in certain quantities. Uncertainty estimates resulting from reference attribute bias,
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display resolution, operator bias, along with computational and environmental factors, are
determined using this technique.
Normal Distribution
If the measurement error data is normally distributed, the uncertainly is given by Equation
(49)

u

L
 1 p 
 1 

 2 

(49)

 L is defined as the containment limit,  1 the inverse normal distribution function, and
the containment probability [230] Generally, the containment limits are obtained from
manufacturer tolerance limits, calibration records, or statistical process control limits. The
containment probability is derived from service data from the past. This study aimed to
understand the effect of system-level uncertainty on pressure and flow readings obtained
during in-vitro simulations
For the pressure sensors, errors associated with accuracy that combines errors due to
linearity, hysteresis, and repeatability are considered. Other errors that are considered
include setting zero offset and span error, the total error band that includes errors due to
thermal hysteresis, and thermal errors.
Upon establishing the type of error, the corresponding error limits are defined as a number
or as a percent of the full-scale reading. The error limits are to be defined by the confidence
interval or by a specified level of probability. All the error sources associated with each
individual system are assumed to follow a normal distribution. For calculation purposes,
the errors are interpreted as a 95% confidence limit if not mentioned by the manufacturer.
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Based on the equation, the uncertainty due to each error is computed based on the error
limit. This leads to the development of the standardized error model along with the
sensitivity coefficients. The model is further simplified as no correlation exists between the
individual error sources. The degree of freedom and confidence limit are considered for
the final uncertainty.
3.11.

Statistical Analysis

3.11.1. Hypothesis
Hypothesis testing is defined as the procedure that involves making decisions based on
the nature of the distribution (nonparametric) or the parameter's value (parametric).
Standard parametric hypothesis tests involve the z test and t-test. Nonparametric
hypothesis tests involve median test and KS test.
3.11.2. Statistical testing
The null and the alternate hypothesis are formulated along with the significance level (α).
The test statistic Y(X) = Y(X1,X2,X3….Xn) is constructed, and its distribution has to fall
under H0. A critical region U is defined for the test statistic Y. The critical region
determines whether H0 is rejected if Y falls inside the region, such that
PH 0(Y ( X ) U )  

PH0 indicates the inequality is true for all parameters of the population which belong to H0.
The value of the critical region is given by Y(X), and the value does not fall under the null
hypothesis. y(x) = Y(x1,x2,x3….xn) is computed based on the sample data X1= x1, X2= x2.
The null hypothesis is rejected, and alternate accepted if y(x) falls inside the critical region.
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The null hypothesis is not rejected when y(x) falls outside the critical region. A test is
considered statistically significant if and only when the H0 is rejected.
3.11.3. p-value
The p-value is often used in replacement for the critical region to accept or reject the null
hypothesis. The p-value for the given test stat Y(X) is given as by Equation (50)

two sided: PH 0(| Y | y( x))  p  value

(50)

 PH 0(Y  y( x))  p  value 
one sided:

 PH 0(Y  y( x))  p  value 
For the null hypothesis to be rejected, the p-value should be smaller than the significance
level α. The p-value is a random variable, and it follows a normal distribution under the
null hypothesis.
3.11.4. Z-test
Another way of performing a hypothetical test is using the z-test, where the statistic follows
a normal distribution curve. The normal distribution is mostly used in real-life scenarios.
The central limit theorem states that if the sample size is at least 30 and the sample size
remains the same, the distribution of the sample mean is approximated by a normal
distribution. A variable X follows a normal distribution if the probability density function
(PDF) is given by Equation (51)
1  x 
 

 
1
f ( x) 
e 2
 2

2

,   x  

(51)

The above equation is usually represented as X ~ N(µ,σ2) and the parameters of the
equation are given by -∞ < µ < ∞ and σ >0. The standard normal distribution is defined as
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a normal distribution with parameters mean, µ =0 and standard deviation  =1 denoted by
Z~ N(0,1). The above (PDF) is given by Equation (52)

f ( z) 

1  12 z 2
e
,   z  
2

(52)

The test statistic for the z test is represented as Equation (53), where x is the observed
value, µ is the mean and  is the standard deviation

z

(x  )

(53)



The value obtained is compared against the p-value, and the corresponding step involves
the acceptance or rejection of the null hypothesis.
Experiments associated with HCSII, and Fontan are conducted with different objectives.
Such experiments are conducted multiple times that represent ‘n’ number of heart cycles
having the same hemodynamics characters to that of the patient who recently underwent
the clinical procedure.
The hypothesis testing for HCSII involves a comparison of in-vitro results obtained with
in-vivo results. This comparison is done by conducting a z-score. The null hypothesis for
this testing is the studies performed are indifferent with respect to the hemodynamics
parameter. The alternate hypothesis is hemodynamic parameters are different.
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4. Results
4.1. Experimental Set-Up
As discussed in section 3.2, both MFL setups discussed in this study are based on a reduced
LPM. Each R, L, C parameter in the LPM has a specified value derived from clinical
measurements. The values for these parameters are physically realized in both MFL setups
through respective replicating components as explained in 3.2.1 and 3.2.2. The key to
achieving meaningful results in MFL setups highly depends on the accurate tuning of these
individual components and data acquisition. Great precision is maintained during the
tuning process. Imprecision of one component can lead to an incorrect response of the
whole system. As discussed in section 2.2, there are various methods by which MFL setups
can be devised for conducting different kinds of experiments. In this study, each MFL is
specifically designed to investigate the hemodynamics of the two proposed surgical
procedures. Though both MFL setups have been developed to achieve distinctly different
research objectives, both MFL setups share the same principal tuning approach.
Both the MFL setups are systematically tuned by following a bottom-up procedure that
involves the sequential execution of the following steps:
I.
II.
III.

Set the correct Atrium pressure
Tune the Harvard Apparatus pulsatile blood pump to produce the required CO
Turn ON the NI DAQ 9361, NI 9205, and open the developed LabVIEW project
code to start data acquisition

IV.

Tune the systemic and pulmonary resistances to achieve the flow splits by shutting
off the compliance chambers.
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V.

After attaining the correct flow splits in every compartment, then open compliance
chambers to attain the correct pressure waveforms in every compartment of the
MFL

VI.

Log the hemodynamic data from the flowmeters and pressure sensors using the
LabVIEW code.

VII.

Import the unfiltered logged data using the Matlab post-processing scheme to
compute the final filtered results.

In the following subsection, experimentation of both HCSII and Fontan procedure is
explained in detail.
4.1.1. Experimentation of HCSII
The experimentation of HCSII was conducted for two patient subsets with different CO.
As mentioned in 3.2.1, the MFL setup majorly consists of four compartments, i.e., Upper
systemic, lower systemic, left pulmonary, and right pulmonary circulations. The 3-D
printed phantom replicating the reconstructed HCSII physiology, described in 3.1.1.4, has
been integrated with the physical components replicating the R, L, and C parameters of
the reduced LPM. Figure 57 shows the complete MFL setup of the HCSII circulation.
This research study's prime focus is to investigate the hemodynamics of the proposed
HCSII circulation; hence, VSD and the Glenn procedure are modeled in the LPM as a
peripheral component to this simulated surgical procedure. Hence to physically represent
the VSD feature in the MFL, two resistor valves are used, and the Glenn procedure is
replicated using a T junction.
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Figure 57 MFL set up of HCSII circulation

Figure 58 shows the location of resistors, flow, and pressure sensors in all four
compartments of the MFL. After the Harvard apparatus pump is tuned to produce the
required CO, these upper and lower systemic resistors need to be tuned such that the flow
split between the upper and lower systemic is maintained. Also, the pulmonary resistances
need to be tuned in such a way that the

Qp
Qs

ratio is maintained.

Figure 59 shows the integration of the sensors and the resistors to the 3-D phantom in the
MFL. Pressure and flowrate in the MPA, ascending, and descending aorta are maintained
by tuning those respective resistances. Pressure from the MPA section over the baffle,
ascending, and descending aorta are collected with these integrated pressure sensors.
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Figure 58 Position of devices in the MFL setup

Figure 59 3-D phantom integration with the MFL
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Figure 60 shows all the four compartments of the MFL. Once the correct flow splits are
achieved by tuning these resistances, then all the compliance chambers are re-engaged. In
this way, clinically correct hemodynamic can be achieved in these compartments of the
MFL.

Figure 60 Systemic and Pulmonary circulation in the MFL

To conduct an in-situ PRT experiment a high-speed SONY DSC-RX10 III cybershot
camera is installed in the MFL by calculating the hyperfocal distance between the camera
lens and the MPA conduit present in the 3-D phantom as shown in Figure 61. Two non
rectified light sources have been installed on MFL by focusing on the MPA conduit.
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Figure 61 In-situ Image acquisition in the MFL setup

Figure 62 shows the front panel of the LabVIEW code that has been developed to acquire
the hemodynamic data from the MFL. All the integrated digital and analog sensors in the
MFL are connected to NI DAQ 9205 (analog module) and NI DAQ 9361 (digital
module). All live transient and cycle averaged hemodynamic waveforms acquired from
each integrated sensor in the MFL are visualized through this panel.
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Figure 62 Developed data acquisition and User interface

While acquiring the data during experimentation, noise interference is observed. The
trend of noise interference has been consistent for both experimental runs (patient-1 and
patient-2). A low-pass Chebyshev type-2 filter is designed to filter the noise. The filter
characteristics are shown in Figure 63 and Figure 64.
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Figure 63 Magnitude and Phase response of filter A. Patient 1 B. Patient 2

Figure 64 Pole-Zero Plot for filter A. Patient 1 B. Patient 2
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Hence after conducting an FFT spectral analysis of the waveform obtained for both
patient subsets, a proper cutoff frequency is selected. The spectral analyses of pressure
and flowrate waveforms for both patients can be seen in Figure 65-Figure 68.

Figure 65 FFT of flowrate waveform for Patient 1
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Figure 66 FFT of flowrate waveform for Patient 2

Figure 67 FFT of pressure waveform for Patient 1
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Figure 68 FFT of pressure waveform for Patient 2

Finally, after implementing the chebyshev type-2 filter, another digital filter called
savitzky- Golay filter is applied to smoothen out the waveforms. To keep the brevity, the
effect of this combined filtering algorithm is shown in Figure 69 for the pressure
waveform of patient-2.

169

170

Figure 69 Orginal and filtered Pressure waveforms of Patient 2

4.1.1.1.

In-Situ Stent Deformation

As explained previously in 3.9, an in-situ stented baffle tracking in the PA conduit is one
of the key aims of this study. The stented baffle displacement is occurring due to the
pulsatile loading of the MPA conduit. Stented baffle tracking is done by developing an
in-house computer vision code. This code is developed based on the Lucas Kanade
Tracker algorithm. While conducting the MFL experimentation, videos of the stented
baffle displacement are acquired by using the otoscope. These videos are acquired under
varying lighting conditions and focus. After importing the videos using the computer
vision code, a bounding box is created on the region of interest. The tracker algorithm is
used to track the Eigen features of the stent during each cardiac cycle as shown in Figure
70. Finally, each tracked location is post-processed and the displacement of each tracker
during each cardiac cycle is converted to Euclidean distance.
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Figure 70 Stent and baffle tracking

4.1.1.2.

Particle Residence Time

The particle residence time (PRT) analysis explains the probability of thrombus
formation and pathological flows in this reconstructed physiology. To achieve this goal,
particles of 2mm diameter in size are injected into the flow stream of MPA. The injected
particles closely matched the density of the blood analog that is acting as the working
fluid in the MFL setup as shown in Figure 71.
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Figure 71 PRT: A: Early systole, B: Peak systole, C: Early Diastole, D: Late Diastole

To track the pathlines of the injected particles, a multi-object Kalman tracker is developed.
The main goal of the tracker is to successfully track all the particles once they enter the
MPA conduit till those exits out through the DA conduit. The high-resolution video of
particle motion was captured with 1000 FPS using the camera. Video has been
preprocessed by running a stabilizing scheme to control the blurring and video vibration.
Finally, the Kalman tracker for multi-object is launched on the video. The tracker

172

173
properties are tuned for detecting the particles during systole and diastole as shown in
Figure 72

Figure 72 Particle tracking study using Kalman tracker during systole and diastole a original
video b. preprocessing c. Kalman tracker

4.1.2. Experimentation of Fontan
The Fontan circulation is modeled in a way the upper systemic circulation receives
approximately 30% of the total systemic blood flow while the lower systemic circulation
receives approximately 70% of the total systemic blood flow. In the pulmonary circulation,
the left and right branches each receive approximately 50% of the pulmonary blood flow.
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Thus, the vascular resistances are initially adjusted or tuned to control the ratio of flow
within two parallel lumps of the flow loop. Once the flow ratios had been met, the
compliance chambers are engaged while maintaining the appropriate flow ratios. Then, IJS
graft line is turned on by incorporating the correct IJS graft as mentioned in 3.1.2. In this
experiment, various sizes of the IJS nozzle and different angles of anastomosis, and the
effect of PVR are simulated, as shown in Figure 73 and Figure 74.

Figure 73 Mock Flow Loop set up for Fontan circulation with IJS in PAs
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Figure 74 Mock Flow Loop set up with DAQ and compliance chambers

Figure 75 Magnitude and phase response of flowrate at A. Upper B. Lower C. Left D. Right for 3
mm IJS
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There is a significant amount of noise interference in the flow and pressure field during
experimentation once various parameters are tested out. A butterworth filter and the
savitzky-Golay filter are applied to the final post-processed data to filter out these noises.
To maintain the brevity in this section, only the performance of the most qualified cases
from each of the three parameters (nozzle size, anastomosis angle, PVR %) are discussed
here. The filters are applied to the flowrate waveforms for each lump and IVC pressure.
Figure 76-Figure 83 shows the filter characteristics for each of the most qualified cases.
Pole-zero plots of all these filters show that the designed filter is very stable in
performance. Each filter's magnitude and phase response describes a smooth transition
from the passband to stopband frequency.

Figure 76 Pole-zero plot of flowrate at A. Upper B. Lower C. Left D. Right for 3 mm IJS
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Figure 77 Magnitude and phase response of flowrate at A. Upper B. Lower C. Left D. Right for 3
mm IJS at 5 degree

Figure 78 Pole-zero plot of flowrate at A. Upper B. Lower C. Left D. Right for 3 mm IJS at 5
degree
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Figure 79 Magnitude and phase response of flowrate at A. Upper B. Lower C. Left D. PVR 30

Figure 80 Pole-zero plot of flowrate at A. Upper B. Lower C. Left D. Right for PVR 30
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Figure 81 A. Magnitude and phase response B. Pole-Zero plot of IVC pressure for 3mm IJS

Figure 82 A. Magnitude and phase response B. Pole-Zero plot of IVC pressure for 3mm IJS at 5
degree
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Figure 83 A. Magnitude and phase response B. Pole-Zero plot of IVC pressure for PVR 30

The spectral analysis on all flowrate waveforms for all three parametric studies has been
performed to understand the noise interference pattern, as shown in Figure 84 - Figure
86. Depending on the peak frequency, a cutoff frequency has been selected and applied to
develop the filters.

Figure 84 flowrate FFT 3mm IJS
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Figure 85 flowrate FFT of 3mm IJS at 5 degree

Figure 86 flowrate FFT PVR30

Figure 87- Figure 89 show the unfiltered flowrate waveforms for the qualified cases of
each parametric group. These unfiltered waveforms are embedded with high-frequency
noise.
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Figure 87 Unfiltered flowrate for 3mm IJS

Figure 88 Unfiltered flowrate for 3mm IJS at 5 degree
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Figure 89 Unfiltered flowrate for PVR30

Figure 90 to Figure 92 show the comparison of the filtered and unfiltered flowrate
waveforms after implement this filtering scheme. By comparing the systolic and diastolic
features between filtered and unfiltered waves, it can be seen that embedded noise is
filtered out.
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Figure 90 Filtered and Unfiltered flowrate for 3mm IJS

Figure 91 Filtered and unfiltered flowrate for 3mm IJS at 5 degree
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Figure 92 Filtered and unfiltered flowrate for PVR30

In the same fashion, the filtering scheme has been applied to the analog pressure sensors.
To successfully implement the filtering scheme, spectral analyses have been performed
on each of the pressure sensors present in each compartment of the MFL, as shown in
Figure 93 to Figure 95.
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Figure 93 Pressure FFT 3mm IJS

Figure 94 Pressure FFT of 3mm IJS at 5 degree
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Figure 95 Pressure FFT PVR30

Figure 96 to Figure 98 show the unfiltered pressure waveforms for all the best cases of
parametric studies.
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Figure 96 Unfiltered Pressure for 3mm IJS

Figure 97 Unfiltered Pressure for 3mm IJS at 5 degree
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Figure 98 Unfiltered Pressure for PVR30

Figure 99 to Figure 101 compares the filtered and unfiltered pressure waveforms after
implementing this filtering scheme. By comparing the systolic and diastolic features
between filtered and unfiltered waves, it can be seen that embedded noise is filtered out.

Figure 99 Filtered and unfiltered pressure for 3mm IJS
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Figure 100 Filtered and unfiltered pressure for 3mm IJS at 5 degree

Figure 101 Filtered and unfiltered pressure for PVR30

190

191

4.1.3. PVR and entrainment study

Figure 102 MFL setup for PVR study

Figure 46 represents the TCPC used for this experiment. The catheter is represented by
the conduit placed on the RPA side. The site of the injection site is shown in Figure 102.
A 7Fr catheter (outer diameter 2.3368 mm) was used with the injection pump during the
experiment. The injection pump is user-controlled equipment that was used during the
experiment. The controls on the pump allow the user to vary the flow rate, and the
volume to inject during each burst. The pump is programmed manually prior to a given
experimental condition. The MFL setup for this experiment includes the upper, lower,
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right pulmonary and left pulmonary circulation. The loop is tuned by setting the Harvard
pulsatile pump to 80 bpm and 30 cc / s as the stroke volume, thereby replicating a cardiac
output of 2.4 L

min

. A single cardiac beat represents 30% systolic and 70% diastolic.

Resistors were tuned to achieve the required flow splits in the conduits. The upper
circulation is having 30% flow and 70% flow towards the lower circulation. At the
Fontan TCPC, the flow is equally split between the LPA and RPA. The baseline attained
is of normal Fontan. The MFL operated with the baseline condition for one minute. After
60-70 seconds, the injections were pushed. Each protocol developed by the
interventionist was conducted 3 times.
4.2. Experimental Results
4.2.1. HCSII
In this section, first, the hemodynamic quantifications are discussed and then followed by
quantitative and qualitative analyses of other parameters like stented-baffle displacements
and particle residence time are presented.
4.2.1.1.

Hemodynamic

As mentioned in the previous section 4.1.1, experimental runs are made to match the
catheter reports of two patients. Table 8 and Table 9quantifies and compares the
hemodynamics of both patients obtained by experimental runs and the catheter reports
provided by our clinical partners. This table shows that results obtained by in-vitro
experiments closely match with the in-vivo results. Results show that flow splits in the
systemic and pulmonary circulations fall under the clinically acceptable range in the
experimental runs. In Table 8, QUpper QLower QRPA QLPA represents flow rate measured in
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the upper systemic, lower systemic, left pulmonary, and right pulmonary circulations,
respectively.
Table 8 Hemodynamic flowrate results obtained using Catheter data and MFL for patients 1 and 2

P1
Catheter data

MFL

Catheter data

MFL

]

1.25

1.288

0.76

1.079

]

1.74

1.865

0.99

0.747

]

0.50

0.646

0.31

0.527

]

0.75

0.642

0.45

0.552

2.99

3.153

1.75

1.826

Qupper [ L

min

Qlower [ L

min

QLPA[ L

min

QRPA[ L

min

CO[ L

min

P2

]

Table 9 Hemodynamic pressure results obtained using Catheter data and MFL for patient 1 and 2

P1

P2

Catheter data

MFL

Catheter data

MFL

Pmpa  mmHg 

65

57.303

52

40.712

Pu  mmHg 

9

19.407

15

19.811

Pao  mmHg 

65

65.387

48

49.181

Pda  mmHg 

54

58.524

50

47.915

Plpa  mmHg 

8

14.845

11

14.877
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Prpa  mmHg 

8

10.835

11

12.726

In Table 9, the Pmpa, Pu, Pao, Pda Plpa Prpa represent pressure measured in MPA conduit,
Upper systemic, ascending aorta, descending aorta, left pulmonary artery, and right
pulmonary artery, respectively.
Our clinical collaborators provided the following catheter waveforms for two deidentified
patients, as shown in Figure 103 to Figure 105.

Figure 103 Pressure plots obtained from catheter data for patient 1
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Figure 104 Pressure plots obtained from catheter data for patient 1

Figure 105 Pressure plots obtained from catheter data for patient 2

Flowrate:
Figure 106 and Figure 107 depict the features of the filtered flowrate waveforms obtained
from the experimental runs.
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Figure 106 Filtered flowrate of patient 1

Figure 107 Filtered flowrate of patient 2

Pressure:
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These are the pressure waveforms as shown in Figure 108, and Figure 109 are obtained
from the MFL experimental runs. These waveforms closely match with features of the
catheter waveforms.

Figure 108 Filtered pressure of patient 1

Figure 109 Filtered pressure of patient 2
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4.2.1.2.

Statistical analysis (z score)

The hemodynamic parameters obtained after conducting the experiment are compared
against the catheter data. The null hypothesis for this testing states no difference in the
hemodynamic parameters between the surgical and experimental procedures. The alternate
hypothesis states that there is a difference in the parameter’s values. The two tail z-score
test was performed at a significance level of 0.1. The p-value for this test was 0.784. The
p-value obtained during testing is greater than the significance level 0.1, thereby rejecting
the alternating hypothesis and accepting the null hypothesis.

4.2.1.3.

Oxygen transport

Oxygen transport is reported for both patient subsets. The oxygen delivery and saturation
are reported with different pulmonary vein saturations values (100%, 95%, 90%, 85%) as
shown in the Figure 110
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Figure 110 Systemic Oxygen saturation level between patient 1 and patient 2

In-vitro oxygen transport analyses for patient 1 closely matches with the in-silico findings
conducted by Hameed et al. [224].
4.2.1.4.

Stented-Baffle tracking

The tracking algorithm has successfully tracked the displacement of the stented baffle
geometry under the pulsatile loading condition for eight cases, as shown in Figure 111.
The marked minimum displacement 0.17 mm and maximum displacement 1.88 mm. The
average displacement is 0.65 mm. It is also observed from Table 10 that stented- baffle
displacement is a function of CO. As the CO decreases the stented- baffle displacement
also gradually decreases.
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Figure 111 Final stent and baffle tracked in different location for Patient 1
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Table 10 Displacement of stent at various sites for patient 1 and patient 2

Location #

Patient 2 ( mm )

Patient 1 ( mm )

Case 1

0.2406

0.2382

Case 2

0.4176

0.8643

Case 3

1.4352

0.219

Case 4

0.3116

0.3717

Case 5

0.3973

0.3493

Case 6

1.886437

0.4345

Case 7

0.1324

0.4712

Case 8

0.1701

0.0258

Average

0.6554

0.3717

4.2.1.5.

Fatigue Study

The crushing of the baffle is due to the stress from the outside system flow. The pressure
value of MPA is obtained for each heart cycle, and the pressure acts on the baffle, thereby
causing the stent to displace from its original location. For each pulsatile loading, the stent
is being displaced. The following paragraphs explain the numerical computation carried
out to obtain the stress acting on the stent.
As the stent is placed horizontally and parallelly to the PA conduits, the pressure between
the LPA and RPA sides is used to compute the hoop stress acting on the cylinder. The
maximum hoop stress is computed, and the minimum hoop stress is zero. For the given
loading condition, the principal stress is computed and compared with von-misses stress
with a factor of safety 2. Using the modified Paris law equation, the number of cycles was
obtained.
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Patient 1 had an average LPA-RPA pressure of 12.840234 mmHg that corresponds to
1711.89 Pa

 hoop 

Pr
t

 hoop  0.067 MPa
As the stent does not have any loading in other directions and there is no torsion loading,

 x and  xy is equated to zero. Therefore, there exists one principal stress. For the given
loading conditions, the principal stress obtained through

 1, 2 

 x  y
2

  x  y 
2
 
   xy
2


2

1  y
 1  0.067 MPa
The above value represents the  1 , i.e., the principal stress acting normal to the plane in
which the shear stress is zero. The first principal stress is the maximum value seen on the
stent material during the loading conditions. Von-mises stress criterion with Factor of
Safety 2 identifies if the stent will be crushed due to the pulsatile loading during a given
instance. The yield strength of Nitinol is 195 MPa .
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 0.067 
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2

2

From the above equations, it can be established that the maximum stress acting on the stent
and minimum stress is zero. The stent reaches the maximum and minimum stresses in a
repetitive pattern (cyclic). The cyclic pattern occurring for ‘N’cycles makes the stent
undergo a fatigue failure at the Nth cycle. The principal stress obtained above provides an
insight that the stent will undergo high cycle fatigue failure as the stress applied falls well
within the elastic region.
For calculation purposes, critical crack length was identified at two specific locations, as
shown in Figure 112. Figure 112A represents location one, and Figure 112 B represents
location two to compute the number of cycles to failure if a crack occurs at the crack tip.,
The exact number of cycles to failure can be computed by knowing the change in the crack
length after each cycle.
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Figure 112 Critical locations for crack propagation

For calculation purposes, few assumptions are taken into consideration. The initial
critical crack length is assumed to be zero, and a steady crack growth rate is assumed at
the location of failure. The Paris law equation is used to provide the number of cycles to
failure. The Paris law is based on the material properties and loading conditions. The
equation is integrated using two different limits; the crack length is integrated from initial
to final crack length, the number of cycles is integrated from zero to final. The modified
Paris law equation is given by Equation (54).
 n2 
  n 2 2 




2  ac
 ai 2  



Nf  
n
n
(n  2)C. y . . n /2

(54)

Where N f is a number of cycles to failure, ac is critical crack growth, ai initial crack
growth,  the difference in maximum and minimum stress, n , C , and y are material
constants.
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Using the critical length at the exact location 1, the number of cycles to failure N1 is
computed

2(197.106 )0.6
N1 
(3.2  2).(1.62.1012 ).(1)3.2 .(0.067)3.2 .( )3.2
N 1  9.0.1011 cycles
For location 2, the number of cycles to failure N 2 is computed

N2 

2(112.3.106 )0.6
(3.2  2).(1.62.1012 ).(1)3.2 .(0.067)3.2 .( )3.2

N 2  1.13.1012 cycles
Patient 2 had an average LPA-RPA pressure of 13.8015035 mmHg that corresponds to
1840.05 Pa

Stress acting on stent  y =

Pr
t

 y  0.072 MPa
 1, 2 

 x  y
2

  x  y 
2
 
   xy
 2 
2

1  y
 1  0.072 MPa
The above value represents the  1 , i.e., the principal stress acting normal to the plane in
which the shear stress is zero. Using Von-mises criterion
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From the above equations, it can be established that the maximum stress acting on the
stent is lower than the yield stress of Nitinol. Using the Paris law given by Equation 51 to
compute the number of cycles to failure at two different locations with two different
critical crack lengths.
For location 1 the number of cycles to failure N1 is computed

N1 

2(197.106 )0.6
(3.2  2).(1.62.1012 ).(1)3.2 .(0.072)3.2 .( )3.2

N 1  7.15.1011 cycles
For location 2 the number of cycles to failure N 2 is computed
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N2 

2(112.3.106 )0.6
(3.2  2).(1.62.1012 ).(1)3.2 .(0.072)3.2 .( )3.2

N 2  1.42.1012 cycles
The number of cycles to failure is computed for the critical locations and compared based
on the LPA-RPA pressure values. It is seen that the stent goes through high cycle fatigue
failure for the giving loading conditions. Table 11 provides the summary for the fatigue
study conducted based on patient one and patient two data.
Table 11 Conclusion summary of fatigue study on the stent for patient 1and patient 2 data
Type of study

Location

Number of cycles to failure

Circumferential Stress (patient 1)

1

9.1012 cycles

2

1.13.1012 cycles

Circumferential Stress (patient 2)

7.15.1011 cycles

1

1.42.1012 cycles

2

4.2.1.6.

Particle Residence Time

Particle residence time is the amount of time taken by a particle in the flow stream to exit
an outlet boundary. PRT study indicates any pathological flow present in the domain and
the risk of thrombus formation. In Figure 113, the Kalman tracker has successfully
tracked all the particles injected in the flow field. The particles have been tracked in the
early systole, peak systole, early diastole, and late diastole stages.
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Figure 113 Tracked PRT: A: Early systole, B: Peak systole, C: Early Diastole, D: Late Diastole
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Figure 114 Particle path lines (left) Particle velocity (right)

After analyzing all the path lines generated from each tracked particle, as shown in
Figure 114, the result showed that, on average, each particle exited the MPA conduit
within 2.8 s to 3.2 s. This result proves that this reconstructed physiology does not have
any pathological flow or any probability of flow recirculation.
4.2.2. Fontan with IJS
4.2.2.1.

Comparative study of IJS nozzles: 2mm, 3mm, and 4mm

The purpose of this study is to determine whether the implementation of an IJS would
prove beneficial for Fontan patients. To this goal, the MFL is first tuned to match the
physiological conditions of a failing Fontan with elevated caval pressure around 20 mmHg
and a systemic flow of 2.03 L

min

. Following tuning, the study assesses the IJS viability

by altering two parameters. First, the IJS is sequentially activated to mimic various
proximal aortic anastomosis angles, and then the PVR is reduced, as shown in Figure 115.
Table 12-Table 14 provides an overview of the flow and pressure measurements obtained
by conducting the parametric study on IJS nozzle diameter, change in anastomosis angle,
and change in PVR drop.
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210
IJ

Aorta

90° anastomosis

0° anastomosis
Figure 115 IJS proximal anastomosis angle.

As it can be seen from Table 12, the 3mm IJS nozzle has proved to be the best candidate
in the parametric study on IJS nozzle size. By using the 3mm IJS nozzle, a caval pressure
drop of 5mmHg is achieved. This caval pressure drop occurs at the expense of

Qp
Qs

1.5.

Hemodynamic pressure and flowrate waveforms for all the cases of nozzle study are shown
in Figure 116 to Figure 121. First, all the flowrate waveforms generate from all three nozzle
sizes are discussed and then, followed by all the pressure waveforms are discussed.
Table 12 Pressure and flow measurement for baseline and various IJS diameters

IJS diameters
No-IJS

2 mm

210

3 mm

4 mm

211


Qs  L
 min 


Qp  L
 min 

Qp

1.51

1.499

1.35

1.24

1.53

2.05

2.03

2.038

1.00

1.366

1.503

1.643

20.75

15.4

15.245

16.2

54.38

97.015

97.017

97.017

Qs

PIVC [mmHg ]

PAO [mmHg ]

Flowrate:

Figure 116 Filtered flowrate 2mm IJS
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Figure 117 Filtered flowrate 3mm IJS

Figure 118 Filtered flowrate 4mm IJS
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213
Pressure

Figure 119 Filtered pressure 2mm IJS

Figure 120 Filtered pressure 3mm IJS

213

214

Figure 121 Filtered pressure 4mm IJS

4.2.2.2.

Comparative study of angles : 5,45 and 90 degree

In Table 13 the implementation of the IJS clearly results in a significant pressure drop in
IVC. Upon tuning the measured IVC pressure is of 20.75 mmHg with a systemic flow of

1.51 L

min

, following the IJS implementation at a 90 angle the pressure drops to 17.58

mmHg and the systemic flow is 1.03 L min . At an 45 angle the pressure further drops

to 16.38 mmHg and at 0 angle the pressure is found to be 16.20 mmHg . Once the IJS
is activated the Qs remains mostly constant however the IVC pressure sees up to a 1.38
mmHg drop. This notable pressure drop is due to the kind of pressure the proximal IJS

takeoff is subjected to. In the 90 case the flow across the IJS is driven solely by the static
pressure in the aortic arch. On the other hand, in the 0 case the IJS flow is powered by the
combination of the static pressure and in part to the dynamic pressure of the moving flow
214

215

in the arch. For each case the

Qp
Qs

constraint is met at about 1.65. Hemodynamic pressure

and flowrate waveforms for all the cases of IJS anastomosis angles are shown in Figure
122 to Figure 127. This study does not include a feedback mechanism to maintain
homeostatic systemic flow. This results in the observed drop in Qs following the IJS
activation.
Table 13 Pressure and flow measurement for active 3mm IJS with varying angle

Active 3mm IJS


Qs  L
 min 

Qp  L
 min 

Qp
Qs
PIVC [mmHg ]

PAO [mmHg ]

No-IJS

𝟗𝟎°

𝟒𝟓°

𝟓°

1.51

1.32

1.38

1.41

1.53

2.03

2.03

2.03

1.00

1.537

1.471

1.439

20.75

17.58

16.38

16.20

54.38

97.122

97.017

97.017

In Table 13 it can be observed that Q p increases following IJS activation from the baseline
value of 1.53 L

min

to 1.69 L

min

.
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Flowrate

Figure 122 Filtered flowrate of 3mm IJS at 5 degree

Figure 123 Filtered flowrate of 3mm IJS at 45 degree
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Figure 124 Filtered flowrate of 3mm IJS at 90 degree

Pressure:

Figure 125 Filtered pressure of 3mm IJS at 5 degree
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Figure 126 Filtered pressure of 3mm IJS at 45 degree

Figure 127 Filtered pressure of 3mm IJS at 90 degree

4.2.2.3.

Comparative study of PVR drop by 10 and 30 percent

218

219
Per our hypothesis, as flow to the pulmonary system increases PVR drops. Table 14
summarizes results for varying PVR. As PVR decreases there is not a significant change is
either Qs or Q p . IVC pressure however is significantly affected. Staring from the most
optimal IJS implementation angle of 0 the PVR is first dropped by 10% resulting in a
14.41 mmHg IVC pressure. A further PVR drop to 20% of baseline decrease IVC pressure
to

13.45 mmHg . While dropping PVR the constraint on

Qp
Qs

is maintained.

Hemodynamic pressure and flowrate waveforms for all the cases of IJS anastomosis angles
are shown in Figure 128. Figure 131.
Table 14 Pressure and flow measurements for active IJS and decreasing PVR

Active 3mm IJS 0°
10% PVR Drop 30% PVR Drop


Qs  L
 min 

1.187

1.00

2.03

2.03

1.710

2.03

PIVC [mmHg ]

14.41

13.75

PAO [mmHg ]

97.0177

97.0177


Qp  L
 min 

Qp
Qs

Before dropping PVR, the IVC pressure drop totals at 4.55 mmHg . Once PVR is reduced,
the IVC pressure drop increases to 7.30 mmHg . These results suggest that the surgical
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implementation of an IJS alone can be very beneficial to a Fontan patient. The further
benefit arises from the hypothetical PVR drop.

Flowrate

Figure 128 Filtered flowrate PVR10
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Figure 129 Filtered flowrate PVR30

Pressure

Figure 130 Filtered Pressure PVR10

221
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Figure 131 Filtered Pressure PVR30

4.2.2.4.

Oxygen transport

Following the tabulated Table 13 and Table 14 flow measurements presented in the earlier
section, the oxygen transport in the systemic arterial and venous sides can be evaluated.
Due to the lower 𝐶𝑂 used in these experiments, the oxygen consumption rate per unit
weight had to adjust accordingly. As described in the literature, the oxygen consumption
rate can have a linear relationship to the cardiac out, hence based on these results the
consumption rate was linearly scaled down to 6.3 mL / s kg . The results that follow present
oxygen saturations for the systemic arterial and venous circuits for different pulmonary
venous saturation (representing various degrees of oxygen extraction by the lungs) for each
Fontan model explored offers a complete overview of the oxygen saturation calculations.
It can be readily observed that, as mentioned in the oxygen model description, the systemic
saturation for a non-fenestrated Fontan geometry matches the pulmonary venous
222

223
saturation. The arterial saturations calculated fall within the acceptable range. Due to the
oxygen transport model employed, the systemic venous saturations are highly dependent
upon the correct implementation of the consumption rates. As mentioned earlier, the
consumption rate found in the literature was scaled down accordingly to match the CO
used in these experiments. The resulting systemic venous saturation falls within the
expected range, particularly for the baseline case, which can be readily compared to clinical
data. This indicates that the consumption rate scaling was performed correctly. Baseline
and models implementing the IJS only differ for systemic venous saturations. This
difference is due entirely to the strong drop-in Qs that occurs when the IJS valve is opened.
Once the IJS becomes active, proximal shunt anastomosis angle and PVR reduction do not
strongly affect oxygen saturation. In general as the pulmonary venous saturation drops the
systemic arterial and venous saturation follow the same trend.
Figure 132 takes a closer look at the arterial and venous saturation separately. The
decreasing trend in oxygen saturation with dropping ventilation is clear. The strong drop
in systemic venous saturation upon IJS activation has been highlighted as well as the lack
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of noticeable change in saturations (especially on the venous side) due to model alterations
(IJS takeoff angle and PVR).
Systemic Arterial O2 Saturations across MFL loop
100
90
80

Sat [%]

70
60
50
40
30
20
10
0

A

Baseline

90°

SpvO2 100%

SpvO2 95%

45°
SpvO2 90%

0°
SpvO2 85%

10% PVR

20% PVR

SpvO2 80%

Systemic Venous O2 Saturations across MFL loop
80
70
60

Sat [%]

50
40
30
20
10
0
Baseline

B

90°

SpvO2 100%

SpvO2 95%

45°
SpvO2 90%

0°
SpvO2 85%

10% PVR

20% PVR

SpvO2 80%

Figure 132 - Systemic arterial (A) and venous (B) oxygen saturations for various pulmonary
venous saturations (SpvO2) in all the models explored.

The results presented in this section offer a good degree of validation for the oxygen
transport model implemented. The computed quantities match expected trends and can be
readily compared to clinical data.
4.2.3. PVR entrainment Study
4.2.3.1.

Hemodynamics for PVR protocol

As per the described protocol in section 3.3, experimental runs for all short and long bursts
of injections in the LPA conduit are conducted. The pressure levels in all four sections are
observed along with the pressure in the aortic section. The tables below show the averaged
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value of each protocol that was conducted for three times. From Table 15 to Table 22, it
can be concluded that there is no appreciable change to the pressure in the PAs. In this
result section, Figure 133 to Figure 148 plots the hemodynamic response of the MFL for
all significant type of short and long bursts of injections.
Flow rate and pressure waveforms are captured during the experiment. Peaks of pressure
waveform tend to be consistent during the experimentation, proving that the injection
protocol does not increase the pressure at the injection site during in-vitro studies.

Table 15 Short multiple injections at 5cc/s A. Flowrate values B. Pressure values
A

Flow rates ( L / min)
5cc/s

Qupper

Qlower

QRPA

QLPA

Qp
Qs

5 x 20cc

0.796

1.497

1.229 1.190

1.055

0.795

1.530

1.227 1.214

1.049

0.798

1.530

1.230 1.212

1.048

0.795

1.528

1.219 1.208

1.045

(100cc)
5 x 15cc
(75cc)
10 x 10cc
(100cc)
10 x 5cc
(50cc)

Pressure  mmHg 

B
5cc/s

Pupper

Plower

225

PRPA

PLPA

Paortic

226
5 x 20cc

16.565

18.779

7.272

7.9

94.197

16.579

18.763

7.311 7.546

98.132

16.517

18.832

7.239 7.518

99.040

16.561

18.749

7.299 7.537

97.825

(100cc)
5 x 15cc
(75cc)
10 x 10cc
(100cc)
10 x 5cc
(50cc)

Figure 133 Filtered flowrate for 5cc/s with 20cc volume for five shots
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227

Figure 134 Filtered pressure for 5cc/s with 20cc volume for five shots

Table 16 Short multiple injection at 10cc/s A. Flowrate values B. Pressure values
A

Flow rates ( L / min)
10cc/s

Qupper

Qlower

QRPA

QLPA

Qp
Qs

5 x 20cc

0.788

1.522

1.225 1.208

1.053

0.796

1.524

1.225 1.208

1.048

0.801

1.526

1.232 1.211

1.049

0.798

1.537

1.226 1.211

1.049

(100cc)
5 x 15cc
(75cc)
10 x 10cc
(100cc)
10 x 5cc
(50cc)

227

228

Pressure  mmHg 

B
10cc/s
5 x 20cc

Pupper

Plower

16.569

18.816

7.266 7.590

97.954

16.684

18.866

7.379 7.580

98.416

16.626

18.889

7.321 7.610

98.856

16.535

18.844

7.330 7.599

99.607

PRPA

PLPA

Paortic

(100cc)
5 x 15cc
(75cc)
10 x 10cc
(100cc)
10 x 5cc
(50cc)

Figure 135 Filtered flowrate for 10cc/s with 20cc volume for ten shots
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229

Figure 136 Filtered pressure for 10cc/s with 20cc volume for ten shots

Table 17 Short multiple injection at 15cc/s A. Flowrate values B. Pressure values
A

Flow rates ( L / min)
15cc/s

Qupper

Qlower

QRPA

QLPA

Qp
Qs

5 x 20cc

0.804

1.508

1.255

1.178

1.051

0.797

1.512

1.266 1.1582

1.049

0.800

1.511

1.271

1.162

1.053

0.798

1.506

1.258

1.156

1.047

(100cc)
5 x 15cc
(75cc)
10 x 10cc
(100cc)
10 x 5cc
(50cc)

229

230

Pressure  mmHg 

B
15cc/s
5 x 20cc

Pupper

Plower

16.990

19.217

7.526 8.437

96.882

17.418

19.55

7.664 8.940

96.8

17.338

19.544

7.615 8.912

96.808

17.289

19.501

7.664 8.948

96.541

PRPA

PLPA

Paortic

(100cc)
5 x 15cc
(75cc)
10 x 10cc
(100cc)
10 x 5cc
(50cc)

Figure 137 Filtered flowrate for 15cc/s with 20cc volume for five shots
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Figure 138 Filtered pressure for 15cc/s with 20cc volume for five shots

Table 18 Short multiple injection at 20cc/s A. Flowrate values B. Pressure values
A

Flow rates ( L / min)
20cc/s

Qupper

Qlower

QRPA

QLPA

Qp
Qs

5 x 20cc

0.808

1.514

1.274 1.168

1.051

0.804

1.517

1.269 1.164

1.048

0.808

1.509

1.234 1.199

1.049

0.808

1.512

1.265 1.163

1.047

(100cc)
5 x 15cc
(75cc)
10 x 10cc
(100cc)
10 x 5cc
(50cc)

231

232

Pressure  mmHg 

B
20cc/s
5 x 20cc

Pupper

Plower

17.603

19.751

7.704 8.940

1.051

17.422

19.639

7.654 8.938

1.048

17.542

19.726

7.737 9.001

1.049

17.509

19.675

7.706 9.030

1.047

PRPA

PLPA

Paortic

(100cc)
5 x 15cc
(75cc)
10 x 10cc
(100cc)
10 x 5cc
(50cc)

Figure 139 Filtered flowrate for 20cc/s with 20cc volume for five shots
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Figure 140 Filtered pressure for 20cc/s with 20cc volume for five shots

Table 19: Long single injection at 5cc/s A. Flowrate values B. Pressure values
A

Flow rates ( L / min)
5cc/s

Qupper

Qlower

QRPA

QLPA

Qp
Qs

1 x 50cc

0.796

1.497

1.229 1.190

1.055

0.795

1.530

1.227 1.214

1.049

0.798

1.530

1.230 1.212

1.048

(50cc)
1 x 100cc
(100cc)
1 x 150cc
(10cc)

233

234

Pressure  mmHg 

B
5cc/s
1 x 50cc

Pupper

Plower

PRPA

PLPA

Paortic

16.565

18.779

7.272

7.9

94.197

16.579

18.763

7.311 7.546

98.312

16.517

18.832

7.239 7.518

99.040

(50cc)
1 x 100cc
(100cc)
1 x 150cc
(10cc)

Figure 141 Filtered flow rate for 5cc/s with 100cc volume for one long shot
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Figure 142 Filtered pressure for 5cc/s with 100cc volume for one long shot

Table 20 Long single injection at 10cc/s A. Flowrate values B. Pressure values
A
10cc/s

Flow rates ( L / min)
Qupper

Qlower

QRPA

QLPA

Qp
Qs

1 x 50cc

0.798

1.501

1.260 1.170

1.056

0.799

1.506

1.270 1.179

1.062

0.791

1.509

1.285 1.183

1.072

(50cc)
1 x 100cc
(100cc)
1 x 150cc
(10cc)

235

236

Pressure  mmHg 

B
10cc/s
1 x 50cc

Pupper

Plower

17.417

19.612

7.694 8.266

98.384

17.590

19.831

7.794 8.244

98.505

17.785

20.011

7.731 8.295

99.259

PRPA

PLPA

Paortic

(50cc)
1 x 100cc
(100cc)
1 x 150cc
(10cc)

Figure 143 Filtered flow rate for 10cc/s with 100cc volume for one long shot
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Figure 144 Filtered pressure for 10cc/s with 100cc volume for one long shot

Table 21 Long single injection at 15cc/s A. Flowrate values B. Pressure values
A
15cc/s

Flow rates ( L / min)
Qupper

Qlower

QRPA

QLPA

Qp
Qs

1 x 50cc

0.775

1.513

1.251 1.164

1.055

0.774

1.512

1.264 1.166

1.062

0.766

1.510

1.272 1.169

1.072

(50cc)
1 x 100cc
(100cc)
1 x 150cc
(10cc)
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Pressure  mmHg 

B
15cc/s
1 x 50cc

Pupper

Plower

PRPA

17.284

19.488

7.750 8.229 98.702

17.273

19.511

7.633 8.177 98.792

17.361

19.599

7.792 8.208 97.960

PLPA

Paortic

(50cc)
1 x 100cc
(100cc)
1 x 150cc
(10cc)

Figure 145 Filtered flow rate for 15cc/s with 100cc volume for one long shot
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Figure 146 Filtered pressure for 15cc/s with 100cc volume for one long shot

Table 22 Long single injection at 20cc/s A. Flowrate values B. Pressure values
A
20cc/s

Flow rates ( L / min)
Qupper

Qlower

QRPA

QLPA

Qp
Qs

1 x 50cc

0.806

1.509

1.262 1.160 1.048

0.802

1.504

1.277 1.163 1.058

0.798

1.499

1.287 1.166 1.067

(50cc)
1 x 100cc
(100cc)
1 x 150cc
(10cc)
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Pressure  mmHg 

B
20cc/s
1 x 50cc

Pupper

Plower

17.390

19.453

7.643 8.994

97.361

17.426

19.616

7.612 8.899

96.878

17.462

19.615

7.662 8.988

96.772

PRPA

PLPA

Paortic

(50cc)
1 x 100cc
(100cc)
1 x 150cc
(10cc)

Figure 147 Filtered flowrate for 20cc/s with 100cc volume for one long shot
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Figure 148 Filtered pressure for 20cc/s with 100cc volume for one long shot

4.2.3.2.

Entrainment Quantification

Once the experimental protocol has been completed, flow rates sampled at described
locations are time-averaged. Entrainment is calculated from Equation 21 and reported for
.

the whole parameter space explored in Table 23. Green values Qent  0 represent cases for
.

which entrainment was detected, and red values Qent  0 are cases where the blockage
occurred.
One can observe how for either continuous or pulsed injections, varying the total volume
injected has no significant influence on the entrainment rate across all injection rates. On
the other hand, increasing injection rate results in a reduction in entrainment consistent
across all injected volumes for both injection conditions. Given the constant diameter shunt
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2.6 mm used in this experiment, this outcome suggests that entrainment is strongly
correlated to the co-flow velocity ratio (and flow rate ratio) and weakly correlated to the
total injected volume. In addition, Table 24 offers significant insight on the differences
between injection conditions (continuous vs. pulsed). In Table 24-A, the entrainment cutoff
.

appears to be Qinj ~ 0.6 L

min , whereas in Table 23-B the cutoff occurs from a smaller

.

flow rate Qinj ~ 0.3 L

min . To better understand the degree of entrainment, the tabulated
.

.

maximum values (for Qinj  0.3 ) can be normalized by the Qinj . After averaging across the

column, for a continuous injection

.

.

Qent

Qent

.

 0.63 and

Qinj

 0.16

.

for a pulsed

Qinj

injection . This stark contrast highlights a clear difference between injection conditions
which emphasize the importance of ensuring proper physiological modeling: pulsatility
cannot be overlooked. Conversely this opens the door for a discussion involving pulsatility
modulation to enhance entrainment. Since, the shunt diameter is kept constant, an
increasing flow rate indicated an increased co-flow velocity ratio ( V jet Vbackground ), it would
sound counterintuitive to have increasingly positive results for a decreasing velocity ratio.
However, results presented in the following section for the jet relaxation time will provide
further insight in the jet dynamics and clarify this puzzling outcome.
Table 23 Jet relaxation time [ s ] for various injection rates Qinj and injection volumes Vinj for (A)
continuous and (B) pulsed injections. Green values trel  0 and red values trel  0 .

𝑄̇𝑖𝑛𝑗 [𝐿/𝑚𝑖𝑛]

(A)
0.3

0.6
242

0.9

1.2

243

Vinj [ L]

0.05

0.1646

0.0015

-0.1084

-0.2263

0.1

0.2125

0.0389

-0.0860

-0.2265

0.15

0.1985

0.0144

-0.0866

-0.2454

𝑄̇𝑖𝑛𝑗 [𝐿/𝑚𝑖𝑛]

(B)
0.3
Vinj [ L]

0.6

0.9

1.2

0.015

0.0441 -0.1494 -0.4581 -0.7167

0.02

0.0496 -0.1353 -0.3395 -0.6096

Table 24 offers an overview of the calculated jet relaxation time 𝑡𝑟𝑒𝑙 for the same parameter
space explored in the previous section. Green values ( trel  0 ) represent lack of potential
fluid buildup and red values ( trel  0 ) would indicate a high likelihood of fluid buildup.
Due to the choice of sampling rate in the experimental phase the following tabulated
observations may show some inconsistency, nevertheless for most cases a trend can be
perceived.
In Table 23-A, aside from the data reported for Vinj  0.1 which displays an opposite
tendency, for continuous injections it can be observed that varying the injected volume Vinj
.

does not significantly alter trel . On the other hand, increasing Qinj appears to display
.

decreasing trend with a maximum for Qinj  0.6 . This would indicate that for increasing
injection flow rate, the fall-time tends towards the rise-time; suggesting that for increasing
co-flow velocity ratio the flow field requires significantly more time to dissipate the jet
effect. A similar trend can be seen for pulsed injections. Such an outcome is to be expected.
This flow relaxation feature helps understand the counterintuitive observation made for the
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entrainment quantifications where for lower co-flow velocity ratio enhanced entrainment
is registered. This observations become even more relevant for the pulsed injection cases.
Table 24 Jet relaxation time [ s ] for various injection rates Qinj and injection volumes Vinj for (A)
continuous and (B) pulsed injections . Green values trel  0 and red values trel  0 .

𝑄̇𝑖𝑛𝑗 [𝐿/𝑚𝑖𝑛]

(A)

Vinj [ L]

0.05

0.3
0.497

0.6
0.891

0.9
0.398

1.2
0.198

0.1

0.103

0.100

0.509

0.504

0.15

0.495

0.607

0.399

0.107

𝑄̇𝑖𝑛𝑗 [𝐿/𝑚𝑖𝑛]

(B)

Vinj [ L]

0.3

0.6

0.9

1.2

0.015

0.715

0.341

0.118

0.151

0.02

0.196

0.315

0.809

0.021

4.3. Uncertainty Analysis
Table 25 provides the types of errors specified by the manufacturers of the pressure
sensor. The uncertainty due to the different types of error is computed using the Type B
estimate.
Table 25 Error parameters for Pressure sensor

Parameter Description

Mean
Value

244

Error limits

Percentage
confidence
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Papp

Calibration Pressure

7.5 psi

E1

Accuracy (Combined

0

±0.25% FS

linearity, hysteresis,

95

(mv/V)

repeatability)

E2

Setting Zero Offset

0

±2% FS

and Span
E3

Total Error band

95

(mv/V)
0

±2% FS

95

(mv/V)
S

Sensitivity

9.974
mV/V

Vex

Applied Excitation

10 V

95

Voltage

Sensitivity - influence coefficient
Pressure(P) :m  Voltage(V) [calibration equation]

Equation from calibrated sensor P:150.37* V

Pv 

P
 150.37
V

Uncertainty due to error is computed using Equation (49) discussed in section 3.10.1
Uncertainty due to Accuracy (E1):

0.125
 0.0638V
1.9600

Uncertainty due to Setting Zero Offset and Span (E2):

Uncertainty due to Total error band (E3):

0.1
 0.051V
1.9600

0.1
 0.051V
1.9600

The total uncertainty model is given by Equation (55)
245

246

u  var(cx. x  cy. y  cz. z)

(55)

Where u is the total uncertainty, c x , cy , cz are sensitivity coefficients and  x ,  y ,  z are
uncertainty due to a errors in the system. There exists no correlation between error
sources within the pressure sensor. The uncertainty model is re-written

u  cx2 . x2  c y2 . y2  cz2 . z2

u  (0.0638) 2  (0.051) 2  (0.051) 2  0.0963 V
The pressure sensor's combined error is converted mmHg to compute the error values at
different sections, thereby establishing the true pressure value. Figure 149 shows the
mean IVC pressure values for the various MFL parameters tested.

Figure 149 IVC mean pressure value with the error band
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5. Conclusion
Overall, through this research work, the implementation of experimental methodologies
has been demonstrated to quantify and qualify the detailed hemodynamics of two novel
surgical techniques, i.e., HCSII and the self-powered Fontan circulation. These in-vitro
investigations allowed us to determine the potential presence of any pathological flow
fields and estimate the efficacy of tools implemented to improve patient care.
A multiscale model of the HCSII circulation is designed and developed. In this study, the
MFL experimentally quantifies the stented baffle deformation over periodic cardiac cycles.
The in-situ observation of the stented baffle deformation shows that the stent placed in the
PA conduit goes for a minimal deformation for each heart cycle. Fatigue analysis on this
stent deformation proves that the stent will not fail under the pulsatile loading condition
produced due to the systemic circulation at the MPA site. Hence the pulmonary artery will
remain unobstructed. Experimental particle residence time analyses elucidate that there is
a minimal chance for the occurrence of any pathological flow and the probability of
thrombus formation in this reconstructed physiology is very low.
Secondly, another multi-scale model of the Fontan circulation has been constructed. The
MFL used in this study experimentally simulates the effect of the IJS implementation in
the TCPC. The MFL setup is also calibrated to simulate the PVR effect. This in-vitro model
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combines the 0-D scale of the patient’s circulation in the LPM with a 3-D centerpiece
physiological representative TCPC model. Various patient generic TCPC models and IJS
prototypes have been developed using stereolithography technology. The outcome of these
experimentations has successfully satisfied the hypothesis as established in the objective
of the study. A parametric study on IJS nozzle diameter, IJS anastomosis angles, and PVR
effect have been conducted in these experiments. The comparative study on the IJS nozzle
shows that the 3mm nozzle is the most efficient for entraining the flow in the PAs. The IJS
anastomosis angle study shows that the IJS nozzle can entrain better in the PAs as the angle
becomes shallower. Finally, by incorporating the PVR effect along with the 3mm IJS
nozzle, the desired pressure drop of 5mmHg is achieved. While conducting these
experiments, as the IJS nozzles are introduced to the flow field, pulsatility in the PAs has
been increased, and comparatively, high-frequency noise is introduced. This highfrequency noise is filtered by conducting spectral analysis. Few benefits of the IJS include:


Increased Pulmonary flow Qp



Increased systemic oxygen



Lesser pathological flow in TCPC

Thirdly, another in-vitro analysis is conducted to experimentally quantify the change in the
hemodynamics of a sick Fontan while performing the PVR protocols as provided by our
clinical collaborators from Arnold Palmer Hospital for Children. The outcome of the PVR
injection study is twofold. The preliminary in-vitro analyses show that PVR injections do
not elevate the PA pressure beyond any critical threshold. For all long and short bursts of
injections, no pathological flows have been observed in the systemic, pulmonary, and
TCPC sections. These analyses infer that in-vivo trials will be clinically safe to perform on
248
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patient subsets. The entrainment study quantitatively shows that the degree of entrainment
varies with the long and short burst of injections. Jet relaxation time provides a good insight
into the IJS dynamics.
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6. Recommendations and Future Work
This research has successfully demonstrated the capabilities of various types of invitro setups that can be used to investigate and validate in-silico and in-vivo results.
However, there are certain limitations to this study. Few of these limitations can be
overcome in future work. Both MFL setups do not have any feedback mechanism, which
is especially important for conducting investigations like self-powered Fontan circulation.
We aim to couple a fully automated Hardware in the Loop-based Harvard apparatus pump
with the MFL loops in our future work. This modification will incorporate some amount
of autoregulatory feedback mechanism in the MFL setups.
In HCSII circulation research project, currently, only a particle diameter of 2mm
has been injected. In the future, different size particles should be injected into the MPA
conduit to complete the PRT studies.
The proof of concept study on Fontan will help us to proceed to more complex
models. The 3-D phantoms should be made of a compliant material to validate the fluidstructure interaction studies. Also, particle image velocimetry capabilities should be
incorporated into MFL setups.
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Appendix A
1.1 Instrumentation wiring schematic

Figure 150 DAQ instrumentation schematic
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1.2 Fontan hemodynamics
1.2.1

2mm IJS

Figure 151 Filtered and unfiltered flowrate (U) and pressure (L) for IJS with 2mm diameter
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1.2.2

4mm IJS

Figure 152 Filtered and unfiltered flowrate (U) and pressure (L) for IJS with 4mm diameter
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1.2.3

3mm IJS at 45 degree

Figure 153 Filtered and unfiltered flowrate (U) and pressure (L) for 3mm IJS at 45 degree
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1.2.4

3mm IJS at 90 degree

Figure 154 Filtered and unfiltered flowrate (U) and pressure (L) for 3mm IJS at 90 degree
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1.2.5

PVR10

Figure 155Filtered and unfiltered flowrate (U) and pressure (L) for PVR10
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1.3 PVR injection experiment
1.3.1 Case 1: 5 cc/s short injection
1.3.1.1 5 x 15cc injections (75cc total volume)

Figure 156 Filtered flowrate (U) and pressure (L) for 5cc/s with 15cc volume for one short shot
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1.3.1.2 10 x 10cc injections (100cc total volume)

Figure 157 Filtered flowrate (U) and pressure (L) for 5cc/s with 10cc volume for one short shot
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1.3.1.3 10 x 5cc injections (50cc total volume)

Figure 158 Filtered flowrate (U) and pressure (L) for 5cc/s with 5cc volume for one short shot
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1.3.2 Case 2: 10 cc/s short injection
1.3.2.1 5 x 15cc injections (75cc total volume)

Figure 159 Filtered flowrate (U) and pressure (L) for 10cc/s with 15cc volume for one short shot
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1.3.2.2 10 x 10cc injections (100cc total volume)

Figure 160 Filtered flowrate (U) and pressure (L) for 10cc/s with 10cc volume for one short shot
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1.3.2.3 10 x 5cc injections (50cc total volume)

Figure 161 Filtered flowrate (U) and pressure (L) for 10cc/s with 5cc volume for one short shot
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1.3.3 Case 3: 15 cc/s short injection
1.3.3.1 5 x 15cc injections (75cc total volume)

Figure 162 Filtered flowrate (U) and pressure (L) for 15cc/s with 15cc volume for one short shot
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1.3.3.2 10 x 10cc injections (100cc total volume)

Figure 163 Filtered flowrate (U) and pressure (L) for 15cc/s with 10cc volume for one short shot
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1.3.3.3 10 x 5cc injections (50cc total volume)

Figure 164 Filtered flowrate (U) and pressure (L) for 15cc/s with 5cc volume for one short shot
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1.3.4 Case 4: 20 cc/s short injection
1.3.4.1 5 x 15cc injections (75cc total volume)

Figure 165 Filtered flowrate (U) and pressure (L) for 20cc/s with 15cc volume for one short shot

303

304
1.3.4.2 10 x 10cc injections (100cc total volume)

Figure 166 Filtered flowrate (U) and pressure (L) for 20cc/s with 10cc volume for one short shot
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1.3.4.3 10 x 5cc injections (50cc total volume)

Figure 167 Filtered flowrate (U) and pressure (L) for 20cc/s with 5cc volume for one short shot
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1.3.5

Case 5: 5 cc/s long injection

1.3.5.1 1 x 50cc injections (50cc total volume)

Figure 168 Filtered flowrate (U) and pressure (L) for 5cc/s with 50cc volume for one long shot
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1.3.5.2 1 x 150cc injections (150cc total volume)

Figure 169 Filtered flowrate (U) and pressure (L) for 5cc/s with 150cc volume for one long shot
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1.3.6

Case 6: 10 cc/s long injection

1.3.6.1 1 x 50cc injections (50cc total volume)

Figure 170 Filtered flowrate (U) and pressure (L) for 10cc/s with 50cc volume for one long shot
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1.3.6.2 1 x 150cc injections (150cc total volume)

Figure 171 Filtered flowrate (U) and pressure (L) for 10cc/s with 150cc volume for one long shot
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1.3.7

Case 7: 15 cc/s long injection

1.3.7.1 1 x 50cc injections (50cc total volume)

Figure 172 Filtered flowrate (U) and pressure (L) for 15cc/s with 50cc volume for one long shot
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1.3.7.2 1x 150cc injections (150cc total volume)

Figure 173 Filtered flowrate (U) and pressure (L) for 15cc/s with 150cc volume for one long shot
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1.3.8

Case 8: 20 cc/s long injection

1.3.8.1 1 x 50cc injections (50cc total volume)

Figure 174 Filtered flowrate (U) and pressure (L) for 20cc/s with 50cc volume for one long shot
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1.3.8.2 1 x 150cc injections (150cc total volume)

Figure 175 Filtered flowrate (U) and pressure (L) for 20cc/s with 150cc volume for one long shot
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